https://phrma.org/home 2026-04-03 daily 0.8 https://phrma.org/about 2026-04-03 daily 0.8 https://phrma.org/about/leadership 2026-04-03 daily 0.8 https://phrma.org/about/leadership/douglas-j-langa 2026-04-03 daily 0.8 https://phrma.org/about/leadership/chris-round 2026-04-03 daily 0.8 https://phrma.org/about/leadership/emma-walmsley 2026-04-03 daily 0.8 https://phrma.org/about/leadership/barry-greene 2026-04-03 daily 0.8 https://phrma.org/about/leadership/richard-f-pops 2026-04-03 daily 0.8 https://phrma.org/about/leadership/michael-petroutsas 2026-04-03 daily 0.8 https://phrma.org/about/leadership/ashley-magargee 2026-04-03 daily 0.8 https://phrma.org/about/leadership/kyle-gano-ph-d 2026-04-03 daily 0.8 https://phrma.org/about/leadership/pascal-soriot 2026-04-03 daily 0.8 https://phrma.org/about/leadership/tsutomu-nakagawa 2026-04-03 daily 0.8 https://phrma.org/about/leadership/lori-m-reilly-esq 2026-04-03 daily 0.8 https://phrma.org/about/leadership/elizabeth-carpenter 2026-04-03 daily 0.8 https://phrma.org/about/leadership/james-c-stansel 2026-04-03 daily 0.8 https://phrma.org/about/leadership/steve-schaefer 2026-04-03 daily 0.8 https://phrma.org/about/leadership/miguel-fernandez-alcalde 2026-04-03 daily 0.8 https://phrma.org/about/leadership/tracey-merchant 2026-04-03 daily 0.8 https://phrma.org/about/leadership/renuka-iyer 2026-04-03 daily 0.8 https://phrma.org/about/leadership/lucy-vereshchagina-phd 2026-04-03 daily 0.8 https://phrma.org/about/leadership/jean-michel-boers 2026-04-03 daily 0.8 https://phrma.org/about/leadership/robert-zirkelbach 2026-04-03 daily 0.8 https://phrma.org/about/leadership/elcin-barker-ergun 2026-04-03 daily 0.8 https://phrma.org/about/leadership/robert-m-davis 2026-04-03 daily 0.8 https://phrma.org/about/leadership/chris-boerner 2026-04-03 daily 0.8 https://phrma.org/about/leadership/robert-a-bradway 2026-04-03 daily 0.8 https://phrma.org/about/leadership/thomas-gibbs 2026-04-03 daily 0.8 https://phrma.org/about/leadership/alexander-hardy 2026-04-03 daily 0.8 https://phrma.org/about/leadership/julie-kim 2026-04-03 daily 0.8 https://phrma.org/about/leadership/david-loew 2026-04-03 daily 0.8 https://phrma.org/about/leadership/david-ricks 2026-04-03 daily 0.8 https://phrma.org/about/leadership/tatsuyuki-yasuno 2026-04-03 daily 0.8 https://phrma.org/about/leadership/jennifer-taubert 2026-04-03 daily 0.8 https://phrma.org/about/leadership/jean-christophe-tellier 2026-04-03 daily 0.8 https://phrma.org/about/leadership/vasant-vas-narasimhan 2026-04-03 daily 0.8 https://phrma.org/about/leadership/chris-viehbacher 2026-04-03 daily 0.8 https://phrma.org/about/leadership/sebastian-guth 2026-04-03 daily 0.8 https://phrma.org/about/leadership/albert-bourla 2026-04-03 daily 0.8 https://phrma.org/about/leadership/tarek-rabah 2026-04-03 daily 0.8 https://phrma.org/about/leadership/daniel-o-day 2026-04-03 daily 0.8 https://phrma.org/about/leadership/ken-keller 2026-04-03 daily 0.8 https://phrma.org/about/leadership/stephen-j-ubl 2026-04-03 daily 0.8 https://phrma.org/about/leadership/brad-bailey 2026-04-03 daily 0.8 https://phrma.org/about/ethics-codes-guidelines 2026-04-03 daily 0.8 https://phrma.org/about/jocelyn-ulrich 2026-04-03 daily 0.8 https://phrma.org/about/david-korn 2026-04-03 daily 0.8 https://phrma.org/about/jim-stansel 2026-04-03 daily 0.8 https://phrma.org/about/john-corea 2026-04-03 daily 0.8 https://phrma.org/about/kate-sikora 2026-04-03 daily 0.8 https://phrma.org/about/larry-kerr 2026-04-03 daily 0.8 https://phrma.org/about/lauren-olcott 2026-04-03 daily 0.8 https://phrma.org/about/lindsey-seidlitz 2026-04-03 daily 0.8 https://phrma.org/about/megan-van-etten 2026-04-03 daily 0.8 https://phrma.org/about/michelle-nyman 2026-04-03 daily 0.8 https://phrma.org/about/ali-lapidus 2026-04-03 daily 0.8 https://phrma.org/about/drew-voytal 2026-04-03 daily 0.8 https://phrma.org/about/abigail-lore 2026-04-03 daily 0.8 https://phrma.org/about/amber-lyons 2026-04-03 daily 0.8 https://phrma.org/about/amey-sutkowski 2026-04-03 daily 0.8 https://phrma.org/about/anita-roach-ms 2026-04-03 daily 0.8 https://phrma.org/about/anne-mcdonald-pritchett-phd 2026-04-03 daily 0.8 https://phrma.org/about/ashley-czin 2026-04-03 daily 0.8 https://phrma.org/about/ashley-flint 2026-04-03 daily 0.8 https://phrma.org/about/bill-chin-m-d 2026-04-03 daily 0.8 https://phrma.org/about/brian-newell 2026-04-03 daily 0.8 https://phrma.org/about/brooke-ringel 2026-04-03 daily 0.8 https://phrma.org/about/caitlin-carroll 2026-04-03 daily 0.8 https://phrma.org/about/camille-jackson 2026-04-03 daily 0.8 https://phrma.org/about/chris-moore 2026-04-03 daily 0.8 https://phrma.org/about/christian-clymer 2026-04-03 daily 0.8 https://phrma.org/about/eileen-cannon 2026-04-03 daily 0.8 https://phrma.org/about/emma-van-hook 2026-04-03 daily 0.8 https://phrma.org/about/gabriela-lavezzari 2026-04-03 daily 0.8 https://phrma.org/about/hannah-mooney-mack 2026-04-03 daily 0.8 https://phrma.org/about/holly-campbell 2026-04-03 daily 0.8 https://phrma.org/about/jeff-francer 2026-04-03 daily 0.8 https://phrma.org/about/jennifer-bryant 2026-04-03 daily 0.8 https://phrma.org/about/john-castellani 2026-04-03 daily 0.8 https://phrma.org/about/john-tunnell 2026-04-03 daily 0.8 https://phrma.org/about/mark-reisenauer-and-stephen-j-ubl 2026-04-03 daily 0.8 https://phrma.org/about/nicole-longo 2026-04-03 daily 0.8 https://phrma.org/about/tiffany-haverly 2026-04-03 daily 0.8 https://phrma.org/about/saumil-pandya-and-emily-donaldson 2026-04-03 daily 0.8 https://phrma.org/about/samantha-hinkle 2026-04-03 daily 0.8 https://phrma.org/about/ryan-garofalo 2026-04-03 daily 0.8 https://phrma.org/about/richard-moscicki-m-d 2026-04-03 daily 0.8 https://phrma.org/about/myisha-gatson 2026-04-03 daily 0.8 https://phrma.org/about/katie-verb 2026-04-03 daily 0.8 https://phrma.org/about/katie-koziara 2026-04-03 daily 0.8 https://phrma.org/about/juliet-johnson 2026-04-03 daily 0.8 https://phrma.org/about/joseph-havey 2026-04-03 daily 0.8 https://phrma.org/about/joe-vandigo 2026-04-03 daily 0.8 https://phrma.org/about/jasmine-gossett 2026-04-03 daily 0.8 https://phrma.org/about/jackie-mcrae 2026-04-03 daily 0.8 https://phrma.org/about/ieva-m-augstums 2026-04-03 daily 0.8 https://phrma.org/about/guest-contributor 2026-04-03 daily 0.8 https://phrma.org/about/gretta-stone 2026-04-03 daily 0.8 https://phrma.org/about/giovanni-caforio-m-d 2026-04-03 daily 0.8 https://phrma.org/about/ernest-kawka-and-douglas-petersen 2026-04-03 daily 0.8 https://phrma.org/about/emily-donaldson 2026-04-03 daily 0.8 https://phrma.org/about/emilie-signora 2026-04-03 daily 0.8 https://phrma.org/about/dr-steven-thomas 2026-04-03 daily 0.8 https://phrma.org/about/dr-freda-lewis-hall 2026-04-03 daily 0.8 https://phrma.org/about/debra-deshong 2026-04-03 daily 0.8 https://phrma.org/about/allyson-funk 2026-04-03 daily 0.8 https://phrma.org/about/alex-schriver 2026-04-03 daily 0.8 https://phrma.org/about/carolyn-ha 2026-04-03 daily 0.8 https://phrma.org/about/jay-taylor 2026-04-03 daily 0.8 https://phrma.org/about/rebecca-marklund 2026-04-03 daily 0.8 https://phrma.org/about/scott-laganga 2026-04-03 daily 0.8 https://phrma.org/about/sharon-lamberton 2026-04-03 daily 0.8 https://phrma.org/about/matthew-norawong 2026-04-03 daily 0.8 https://phrma.org/about/mark-keida 2026-04-03 daily 0.8 https://phrma.org/about/nick-mcgee 2026-04-03 daily 0.8 https://phrma.org/about/sarah-k-martin 2026-04-03 daily 0.8 https://phrma.org/about/kristin-williams 2026-04-03 daily 0.8 https://phrma.org/about/mike-ybarra 2026-04-03 daily 0.8 https://phrma.org/about/kevin-haninger 2026-04-03 daily 0.8 https://phrma.org/about/douglas-petersen 2026-04-03 daily 0.8 https://phrma.org/about/andrew-powaleny 2026-04-03 daily 0.8 https://phrma.org/about/liz-mahar 2026-04-03 daily 0.8 https://phrma.org/about/rebecca-nebel-phd 2026-04-03 daily 0.8 https://phrma.org/about/sarah-ryan 2026-04-03 daily 0.8 https://phrma.org/about/gabby-migliara 2026-04-03 daily 0.8 https://phrma.org/about/hannah-loiacono 2026-04-03 daily 0.8 https://phrma.org/about/molly-jenkins 2026-04-03 daily 0.8 https://phrma.org/about/ernest-kawka 2026-04-03 daily 0.8 https://phrma.org/about/robert-zirkelbach 2026-04-03 daily 0.8 https://phrma.org/about/lori-reilly 2026-04-03 daily 0.8 https://phrma.org/about/elizabeth-carpenter 2026-04-03 daily 0.8 https://phrma.org/about/rachel-weissman 2026-04-03 daily 0.8 https://phrma.org/about/brian-picone 2026-04-03 daily 0.8 https://phrma.org/about/courtney-christian 2026-04-03 daily 0.8 https://phrma.org/about/cynthia-hicks 2026-04-03 daily 0.8 https://phrma.org/about/richard-kane 2026-04-03 daily 0.8 https://phrma.org/about/samantha-dougherty 2026-04-03 daily 0.8 https://phrma.org/about/stephen-j-ubl 2026-04-03 daily 0.8 https://phrma.org/about/gabby-migliara1 2026-04-03 daily 0.8 https://phrma.org/about/john-corea1 2026-04-03 daily 0.8 https://phrma.org/about/jonathan-kimball 2026-04-03 daily 0.8 https://phrma.org/about/josephine-martin 2026-04-03 daily 0.8 https://phrma.org/about/kelsey-lang 2026-04-03 daily 0.8 https://phrma.org/about/lauren-dipaola 2026-04-03 daily 0.8 https://phrma.org/about/mark-grayson 2026-04-03 daily 0.8 https://phrma.org/about/michelle-drozd 2026-04-03 daily 0.8 https://phrma.org/about/mit-spears 2026-04-03 daily 0.8 https://phrma.org/about/mollymae-metheny 2026-04-03 daily 0.8 https://phrma.org/about/olivia-shopshear 2026-04-03 daily 0.8 https://phrma.org/about/pete-martinez 2026-04-03 daily 0.8 https://phrma.org/about/priscilla-vanderveer 2026-04-03 daily 0.8 https://phrma.org/about/rebecca-davison 2026-04-03 daily 0.8 https://phrma.org/about/rick-smith 2026-04-03 daily 0.8 https://phrma.org/about/sarah-spurgeon 2026-04-03 daily 0.8 https://phrma.org/about/sascha-haverfield 2026-04-03 daily 0.8 https://phrma.org/about/setareh-samii 2026-04-03 daily 0.8 https://phrma.org/about/stephanie-fischer 2026-04-03 daily 0.8 https://phrma.org/about/stephen-j-ubl-and-giovanni-caforio-m-d 2026-04-03 daily 0.8 https://phrma.org/about/tina-stow 2026-04-03 daily 0.8 https://phrma.org/about/emily-ortman 2026-04-03 daily 0.8 https://phrma.org/about/kristen-booze 2026-04-03 daily 0.8 https://phrma.org/about/brianna-allen 2026-04-03 daily 0.8 https://phrma.org/about/elise-shutzer 2026-04-03 daily 0.8 https://phrma.org/about/fabian-lucero-and-nielah-tucker 2026-04-03 daily 0.8 https://phrma.org/about/eliza-maciag 2026-04-03 daily 0.8 https://phrma.org/about/mark-allen 2026-04-03 daily 0.8 https://phrma.org/about/alexander-hardy 2026-04-03 daily 0.8 https://phrma.org/about/miguel-fernandez-alcalde 2026-04-03 daily 0.8 https://phrma.org/about/jean-michel-boers 2026-04-03 daily 0.8 https://phrma.org/about/tracey-merchant 2026-04-03 daily 0.8 https://phrma.org/about/lucy-vereshchagina-phd 2026-04-03 daily 0.8 https://phrma.org/about/james-c-stansel 2026-04-03 daily 0.8 https://phrma.org/about/renuka-iyer 2026-04-03 daily 0.8 https://phrma.org/about/caroline-dunne 2026-04-03 daily 0.8 https://phrma.org/about/ken-keller 2026-04-03 daily 0.8 https://phrma.org/about/julie-kim 2026-04-03 daily 0.8 https://phrma.org/about/douglas-j-langa 2026-04-03 daily 0.8 https://phrma.org/about/david-loew 2026-04-03 daily 0.8 https://phrma.org/about/vasant-vas-narasimhan 2026-04-03 daily 0.8 https://phrma.org/about/richard-f-pops 2026-04-03 daily 0.8 https://phrma.org/about/tarek-rabah 2026-04-03 daily 0.8 https://phrma.org/about/david-ricks 2026-04-03 daily 0.8 https://phrma.org/about/chris-round 2026-04-03 daily 0.8 https://phrma.org/about/jennifer-taubert 2026-04-03 daily 0.8 https://phrma.org/about/jean-christophe-tellier 2026-04-03 daily 0.8 https://phrma.org/about/chris-viehbacher 2026-04-03 daily 0.8 https://phrma.org/about/emma-walmsley 2026-04-03 daily 0.8 https://phrma.org/about/tatsuyuki-yasuno 2026-04-03 daily 0.8 https://phrma.org/about/michael-petroutsas 2026-04-03 daily 0.8 https://phrma.org/about/kyle-gano-ph-d 2026-04-03 daily 0.8 https://phrma.org/about/ashley-magargee 2026-04-03 daily 0.8 https://phrma.org/about/pascal-soriot 2026-04-03 daily 0.8 https://phrma.org/about/tsutomu-nakagawa 2026-04-03 daily 0.8 https://phrma.org/about/steve-schaefer 2026-04-03 daily 0.8 https://phrma.org/about/elcin-barker-ergun 2026-04-03 daily 0.8 https://phrma.org/about/thomas-gibbs 2026-04-03 daily 0.8 https://phrma.org/about/barry-greene 2026-04-03 daily 0.8 https://phrma.org/about/karyn-schwartz 2026-04-03 daily 0.8 https://phrma.org/about/lauren-neves 2026-04-03 daily 0.8 https://phrma.org/about/rachel-licata 2026-04-03 daily 0.8 https://phrma.org/about/randy-burkholder 2026-04-03 daily 0.8 https://phrma.org/about/ken-e 2026-04-03 daily 0.8 https://phrma.org/about/daniel-o-day 2026-04-03 daily 0.8 https://phrma.org/about/albert-bourla 2026-04-03 daily 0.8 https://phrma.org/about/chris-boerner 2026-04-03 daily 0.8 https://phrma.org/about/robert-a-bradway 2026-04-03 daily 0.8 https://phrma.org/about/robert-m-davis 2026-04-03 daily 0.8 https://phrma.org/about/sebastian-guth 2026-04-03 daily 0.8 https://phrma.org/about/tom-wilbur 2026-04-03 daily 0.8 https://phrma.org/about/stami-turk 2026-04-03 daily 0.8 https://phrma.org/about/reid-porter 2026-04-03 daily 0.8 https://phrma.org/about/tim-mcclung 2026-04-03 daily 0.8 https://phrma.org/about/yolanda-hutchins 2026-04-03 daily 0.8 https://phrma.org/about/anjam-aziz 2026-04-03 daily 0.8 https://phrma.org/about/brad-bailey 2026-04-03 daily 0.8 https://phrma.org/about/will-may 2026-04-03 daily 0.8 https://phrma.org/about/mike-doustdar 2026-04-03 daily 0.8 https://phrma.org/biologics-biosimilars 2026-04-03 daily 0.8 https://phrma.org/contact-us 2026-04-03 daily 0.8 https://phrma.org/drug-shortages 2026-04-03 daily 0.8 https://phrma.org/blog 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-part-d-premiums-expected-to-drop-in-2018 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-companies-reaffirm-commitment-to-patients-in-updated-principles-on-conduct-of-clinical-trials-and-communication-of-clinical-trial-results 2026-04-03 daily 0.8 https://phrma.org/blog/12-years-of-the-partnership-of-prescription-assistance 2026-04-03 daily 0.8 https://phrma.org/blog/130-medicines-in-development-for-asthma-allergies-and-other-respiratory-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/17-years-and-more-of-medical-discoveries 2026-04-03 daily 0.8 https://phrma.org/blog/2015-guiding-principle-building-on-our-2014-focus-on-patients 2026-04-03 daily 0.8 https://phrma.org/blog/2016-bci-survey-a-pro-innovation-environment-is-essential-for-biopharmaceutical-investment 2026-04-03 daily 0.8 https://phrma.org/blog/2017-research-and-hope-awards-honor-innovators-in-mental-health 2026-04-03 daily 0.8 https://phrma.org/blog/2020-fda-approvals-show-innovation-despite-covid-19-pandemic-challenges 2026-04-03 daily 0.8 https://phrma.org/blog/3-takeaways-from-politicos-health-care-summit 2026-04-03 daily 0.8 https://phrma.org/blog/3-things-about-the-phrma-foundation 2026-04-03 daily 0.8 https://phrma.org/blog/3-points-you-need-to-know-about-the-federal-governments-health-spending-projections 2026-04-03 daily 0.8 https://phrma.org/blog/3-reasons-patient-engagement-is-the-backbone-of-scientific-discovery 2026-04-03 daily 0.8 https://phrma.org/blog/3-things-that-support-robust-biopharmaceutical-research-and-development 2026-04-03 daily 0.8 https://phrma.org/blog/3-things-to-know-about-2016-drug-approvals 2026-04-03 daily 0.8 https://phrma.org/blog/3-things-to-know-about-the-importance-of-post-approval-research-and-development 2026-04-03 daily 0.8 https://phrma.org/blog/3-things-voters-are-concerned-about-when-it-comes-to-their-health-care-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/3-tiers-4-tiers-5-tiers-and-more-a-look-at-tiering-in-health-insurance-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/340b-grows-and-grows-but-patients-do-not-see-the-savings 2026-04-03 daily 0.8 https://phrma.org/blog/340b-program-continues-to-drive-shift-in-care-to-more-expensive-hospital-settings 2026-04-03 daily 0.8 https://phrma.org/blog/340b-program-reaches-100-billion-in-sales-while-patients-are-left-behind 2026-04-03 daily 0.8 https://phrma.org/blog/340b-sales-go-up-free-or-reduced-cost-care-offered-at-hospitals-goes-down 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spending-is-exploding-forcing-prices-up-for-patients-employers-and-government-programs 2026-04-03 daily 0.8 https://phrma.org/blog/340b-101-three-charts-show-the-program-maximizes-hospitals-bottom-line-with-little-consideration-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/340b-continues-to-drive-shift-in-site-of-care-for-physician-administered-medicines-to-more-expensive-hospital-settings 2026-04-03 daily 0.8 https://phrma.org/blog/340b-hospitals-among-those-that-provide-lowest-levels-of-community-benefit-across-the-country 2026-04-03 daily 0.8 https://phrma.org/blog/340b-hospitals-and-for-profit-pharmacies-generating-significant-revenue-from-program-meant-to-help-needy-patients 2026-04-03 daily 0.8 https://phrma.org/blog/340b-keeping-a-promise-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/340b-mega-guidance 2026-04-03 daily 0.8 https://phrma.org/blog/340b-paradox-as-the-uninsured-rate-drops-340b-program-continues-to-grow 2026-04-03 daily 0.8 https://phrma.org/blog/340b-program-remains-second-largest-federal-drug-program-yet-little-solid-evidence-of-benefits-to-patient 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-340b-hospitals-account-for-majority-of-part-b-reimbursements 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-340b-hospitals-continue-to-benefit-from-consolidation-at-expense-of-patients 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-a-lack-of-charity-care-among-340b-hospitals 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-a-look-at-340b-eligibility-and-charity-care 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-a-look-at-340b-purchases 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-audit-findings-show-importance-of-increased-oversight-of-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-despite-access-to-discounts-many-340b-hospitals-fail-to-comply-with-aca-charity-care-requirements 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-health-care-costs-rising-from-increase-in-340b-hospital-acquisitions-of-physician-practices 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-hospital-system-adds-voice-to-comments-about-flawed-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-how-for-profit-middlemen-are-taking-advantage-of-a-program-meant-to-support-nonprofit-entities-and-patients 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-how-much-money-are-hospitals-pocketing-under-340b-and-what-are-they-doing-with-those-profits 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-icymi-340b-hearing-new-reports-highlight-growing-need-for-program-reform 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-icymi-ajc-looks-at-how-some-georgia-hospitals-are-profiting-off-340b 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-icymi-new-study-on-hospital-physician-practice-consolidation 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-new-analysis-finds-340b-program-growth-continues-to-accelerate-despite-false-claims 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-new-charity-care-data-shows-most-hospitals-with-contract-pharmacies-provide-little-charity-care 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-new-pieces-of-legislation-continue-momentum-to-fix-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-new-report-raises-questions-about-eligibility-metric-for-340b-hospitals 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-program-continues-to-grow-with-no-end-in-sight 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-rapid-growth-of-contract-pharmacies 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-trends-in-shifting-site-of-care 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-what-are-contract-pharmacy-arrangements 2026-04-03 daily 0.8 https://phrma.org/blog/4-key-facts-on-medicine-prices-and-spending 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-about-phrmas-new-50-state-poll 2026-04-03 daily 0.8 https://phrma.org/blog/4-truths-about-state-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/blog/4-facts-on-why-drug-importation-is-bad-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/four-reasons-why-the-radical-pelosi-plan-is-the-wrong-approach 2026-04-03 daily 0.8 https://phrma.org/blog/4-recommendations-for-icer 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-about-biopharmaceutical-efforts-to-fight-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-about-the-iqvia-2018-and-beyond-outlook-and-turning-points-report 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-about-the-iqvia-medicine-use-and-spending-report 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-about-the-medicare-part-d-premium-announcement 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-about-the-quintilesims-drivers-of-medicine-spending-in-the-u-s-report 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-about-the-quintilesims-medicines-use-and-spending-in-the-u-s-report 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-think-about-when-choosing-your-health-plan 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-you-need-to-know-about-the-administrations-latest-part-b-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/4-ways-to-better-engage-and-empower-patients 2026-04-03 daily 0.8 https://phrma.org/blog/40-years-of-hatch-waxman-how-can-we-secure-its-legacy 2026-04-03 daily 0.8 https://phrma.org/blog/40-years-of-hatch-waxman-how-does-the-hatch-waxman-act-help-patients 2026-04-03 daily 0.8 https://phrma.org/blog/40-years-of-hatch-waxman-what-is-the-hatch-waxman-act 2026-04-03 daily 0.8 https://phrma.org/blog/41-new-medicines-approved-in-2014 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-americas-biopharmaceutical-industry-supports-4-7-million-jobs 2026-04-03 daily 0.8 https://phrma.org/blog/5-facts-about-the-phrma-foundation 2026-04-03 daily 0.8 https://phrma.org/blog/5-public-opinion-polling-trends-to-watch 2026-04-03 daily 0.8 https://phrma.org/blog/5-questions-to-ask-about-your-prescription-medicine-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/5-things-to-consider-when-choosing-your-health-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/5-things-to-know-about-the-cms-part-d-data-release 2026-04-03 daily 0.8 https://phrma.org/blog/5-things-you-didn-t-know-about-researching-and-developing-a-new-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/5-ways-to-improve-icers-value-assessment-framework 2026-04-03 daily 0.8 https://phrma.org/blog/5-ways-your-insurer-may-prevent-you-from-getting-your-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/6-things-to-know-before-the-hhs-forum 2026-04-03 daily 0.8 https://phrma.org/blog/69-percent-of-patients-abandon-medicines-when-cost-sharing-is-more-than-250 2026-04-03 daily 0.8 https://phrma.org/blog/8-reasons-to-celebrate-world-kidney-day 2026-04-03 daily 0.8 https://phrma.org/blog/86-percent-of-aarp-members-support-the-medicare-rebate-rule-that-aarp-opposes 2026-04-03 daily 0.8 https://phrma.org/blog/a-conversation-with-dr-mike-ybarra-on-the-current-state-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/a-conversation-with-sepsis-alliance-president-and-ceo-thomas-heymann-as-world-amr-awareness-week-kicks-off 2026-04-03 daily 0.8 https://phrma.org/blog/a-guide-to-medpacs-part-b-vote-today 2026-04-03 daily 0.8 https://phrma.org/blog/a-key-fact-the-white-house-is-reluctant-to-admit 2026-04-03 daily 0.8 https://phrma.org/blog/a-win-for-indiana-patients-sharing-the-savings-legislation-now-law 2026-04-03 daily 0.8 https://phrma.org/blog/a-call-to-action-on-overdose-awareness-day 2026-04-03 daily 0.8 https://phrma.org/blog/a-candy-today-keeps-the-doctor-away 2026-04-03 daily 0.8 https://phrma.org/blog/a-conversation-with-barry-greene-ceo-of-sage-therapeutics 2026-04-03 daily 0.8 https://phrma.org/blog/a-conversation-with-william-pao-chief-development-officer-of-pfizer 2026-04-03 daily 0.8 https://phrma.org/blog/a-critical-opportunity-to-prevent-prescription-drug-abuse 2026-04-03 daily 0.8 https://phrma.org/blog/a-disruptive-call-for-innovation-focus 2026-04-03 daily 0.8 https://phrma.org/blog/a-global-focus-on-ending-the-covid-19-pandemic 2026-04-03 daily 0.8 https://phrma.org/blog/a-life-saving-lifes-work-impact-of-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/a-look-at-how-to-best-promote-healthy-lifestyles-and-adherence-to-diabetes-medication 2026-04-03 daily 0.8 https://phrma.org/blog/a-new-era-in-alzheimers-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/a-new-era-in-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/a-new-era-in-genomics 2026-04-03 daily 0.8 https://phrma.org/blog/a-new-kind-of-chart-pack 2026-04-03 daily 0.8 https://phrma.org/blog/a-new-way-to-picture-progress-against-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/a-price-control-by-any-other-name-would-still-put-patients-at-risk-and-threaten-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/a-renewed-commitment-to-safety 2026-04-03 daily 0.8 https://phrma.org/blog/a-shared-commitment-to-value 2026-04-03 daily 0.8 https://phrma.org/blog/a-state-by-state-look-at-coverage-and-access-hurdles-in-2016-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/a-voice-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/a-year-and-a-half-later-the-biopharmaceutical-industry-remains-committed-to-beating-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/a-year-later-reflections-on-the-meaning-of-equity 2026-04-03 daily 0.8 https://phrma.org/blog/aarps-latest-misleading-report 2026-04-03 daily 0.8 https://phrma.org/blog/access-to-combination-therapies-may-be-limited-with-exchange-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/accumulator-adjustment-programs-lead-to-surprise-out-of-pocket-costs-and-nonadherence-analysis-finds 2026-04-03 daily 0.8 https://phrma.org/blog/action-needed-to-preserve-the-six-protected-classes 2026-04-03 daily 0.8 https://phrma.org/blog/addressing-mental-health-a-conversation-with-barry-greene-ceo-of-sage-therapeutics 2026-04-03 daily 0.8 https://phrma.org/blog/addressing-the-mounting-threat-of-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/addressing-barriers-that-inhibit-value-based-contracts 2026-04-03 daily 0.8 https://phrma.org/blog/addressing-challenges-in-rare-disease-drug-development-together 2026-04-03 daily 0.8 https://phrma.org/blog/addressing-data-challenges-to-improve-health-equity 2026-04-03 daily 0.8 https://phrma.org/blog/addressing-health-care-challenges-through-unique-ideas-and-perspectives 2026-04-03 daily 0.8 https://phrma.org/blog/addressing-social-determinants-of-health-to-improve-equitable-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/advance-price-notification-a-transparency-measure-that-fails-patients 2026-04-03 daily 0.8 https://phrma.org/blog/advancing-the-science-for-patients-with-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/advancing-the-science-of-hope 2026-04-03 daily 0.8 https://phrma.org/blog/ahips-latest-misinformation-campaign-and-what-its-trying-to-hide 2026-04-03 daily 0.8 https://phrma.org/blog/alzheimers-and-brain-awareness-month-a-conversation-with-biogen 2026-04-03 daily 0.8 https://phrma.org/blog/alzheimers-and-brain-awareness-month-a-conversation-with-eisai 2026-04-03 daily 0.8 https://phrma.org/blog/alzheimers-and-brain-awareness-month-a-conversation-with-eli-lilly-and-company 2026-04-03 daily 0.8 https://phrma.org/blog/american-heart-month-a-nurses-perspective 2026-04-03 daily 0.8 https://phrma.org/blog/american-biopharmaceutical-manufacturing-fueling-economic-growth-now-and-for-years-to-come 2026-04-03 daily 0.8 https://phrma.org/blog/americans-want-state-policymakers-to-lower-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/blog/americans-12-years-of-age-and-older-are-eligible-for-covid-19-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/americans-want-to-know-more-than-just-the-list-price-of-a-medicineand-were-answering-their-call 2026-04-03 daily 0.8 https://phrma.org/blog/americas-biopharmaceutical-companies-are-working-around-the-clock-to-beat-coronavirus 2026-04-03 daily 0.8 https://phrma.org/blog/americas-biopharmaceutical-companies-to-congress-government-negotiation-is-the-wrong-approach 2026-04-03 daily 0.8 https://phrma.org/blog/americas-biopharmaceutical-industry-is-central-to-diverse-randd-ecosystem 2026-04-03 daily 0.8 https://phrma.org/blog/americas-biopharmaceutical-researchers-advance-the-science-of-hope-in-new-from-hope-to-cures-ads 2026-04-03 daily 0.8 https://phrma.org/blog/americas-global-leadership-in-biopharmaceutical-manufacturing 2026-04-03 daily 0.8 https://phrma.org/blog/an-open-letter-to-congress-stand-with-patients-and-future-cures 2026-04-03 daily 0.8 https://phrma.org/blog/an-unprecedented-year-and-the-road-ahead-a-conversation-with-giovanni-caforio-phrma-chairman-and-ceo-of-bristol-myers-squibb 2026-04-03 daily 0.8 https://phrma.org/blog/analysis-states-can-help-patients-save-nearly-1000-annually-on-their-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/announcing-cares-grant-round-4 2026-04-03 daily 0.8 https://phrma.org/blog/annual-projections-from-nhe-compared-to-actual-health-care-spending 2026-04-03 daily 0.8 https://phrma.org/blog/are-the-iras-part-b-inflation-rebates-lowering-costs-for-medicare-patients 2026-04-03 daily 0.8 https://phrma.org/blog/are-health-insurance-exchange-cost-sharing-reductions-really-helping-low-income-patients-access-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/are-insurers-exaggerating-medicine-costs-to-justify-premium-increases-consumers-think-so 2026-04-03 daily 0.8 https://phrma.org/blog/are-new-hep-c-treatments-cost-effective-doctors-say-answer-is-a-resounding-yes 2026-04-03 daily 0.8 https://phrma.org/blog/arkansas-puts-patients-first-with-new-share-the-savings-law 2026-04-03 daily 0.8 https://phrma.org/blog/as-the-administration-continues-to-falsely-claim-that-this-a-negotiation-here-are-things-to-keep-in-mind 2026-04-03 daily 0.8 https://phrma.org/blog/as-u-s-looks-to-modernize-nafta-strong-enforcement-of-existing-obligations-should-be-a-top-priority 2026-04-03 daily 0.8 https://phrma.org/blog/asco-2023-protecting-our-progress-in-the-fight-against-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/asco-2024-showcasing-the-promise-of-biopharmaceutical-randd 2026-04-03 daily 0.8 https://phrma.org/blog/ascos-framework-value-at-the-crossroads 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-discussion-on-medication-adherence-as-national-priority 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-hepatitis-c-cures-will-save-medicaid-12-billion-by-2022 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-how-poorly-managed-blood-pressure-is-placing-older-americans-at-risk-for-heart-disease-and-stroke 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-improving-adherence-among-osteoporosis-patients-could-save-up-to-6-52-billion 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-new-article-looks-at-addressing-medication-nonadherence-in-the-united-states 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-new-resources-from-the-medication-adherence-alliance 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-new-study-examines-effects-of-synchronized-prescription-refill-program-on-medication-adherence 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-new-study-finds-one-third-of-newly-diagnosed-diabetic-patients-arent-starting-treatment 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-new-study-shows-impact-on-preventable-hospital-visits 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-oig-proposed-rule-to-reform-the-rebate-system-could-improve-adherence 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-one-tool-for-synchronizing-and-simplifying-your-medication-routine 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-phrma-foundation-young-investigator-adherence-grant-program 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-poor-medication-adherence-leads-to-negative-health-outcomes-and-increased-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-prescriptions-for-a-healthy-america 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-private-sector-collaboration-can-lead-to-savings-and-care-improvement 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-dr-helaine-resnick-on-diabetes-care 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-on-appointment-based-medication-synchronization 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-christiana-care-health-systems-value-institute 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-national-consumers-league 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-pharmacy-quality-alliance 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-phrma-foundation-grant-awardee-marisa-schauerhamer 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-phrma-foundation-young-investigator-adherence-grantee-sujit-s-sansgiry 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-phrma-foundation-young-investigator-adherence-grantee-xian-shen 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-rxeconomics-llc 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-qanda-with-the-peter-lamy-center-for-drug-therapy-and-aging 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-taking-adherence-research-to-a-global-level 2026-04-03 daily 0.8 https://phrma.org/blog/aspen-spotlight-health-discussing-the-forefront-of-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/assessing-value-top-of-mind-at-ispor-2019 2026-04-03 daily 0.8 https://phrma.org/blog/assistance-is-one-step-toward-adherence 2026-04-03 daily 0.8 https://phrma.org/blog/avalere-insights-on-latest-evidence-communication-research 2026-04-03 daily 0.8 https://phrma.org/blog/balancing-innovation-and-competition-in-the-biologics-marketplace 2026-04-03 daily 0.8 https://phrma.org/blog/because-one-day-isnt-enough 2026-04-03 daily 0.8 https://phrma.org/blog/between-hope-and-despair-improving-cancer-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/beyond-output-and-employment-the-impact-of-americas-biopharmaceutical-industry 2026-04-03 daily 0.8 https://phrma.org/blog/biden-administration-report-debunks-myths-around-patents 2026-04-03 daily 0.8 https://phrma.org/blog/biden-administration-should-prioritize-innovation-in-u-s-taiwan-initiative-on-21st-century-trade 2026-04-03 daily 0.8 https://phrma.org/blog/biden-administrations-indo-pacific-trade-dialogue-is-a-missed-opportunity-to-bolster-american-exports-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/biden-administration-details-inadequate-protection-of-american-intellectual-property-and-foreign-barriers-to-innovation-abroad 2026-04-03 daily 0.8 https://phrma.org/blog/word-of-the-month-biomarkers-and-surrogate-endpoints 2026-04-03 daily 0.8 https://phrma.org/blog/biopharma-leads-sustained-economic-growth-driven-by-ip-intensive-industries 2026-04-03 daily 0.8 https://phrma.org/blog/colorado-is-proof-too-many-unanswered-questions-remain-on-state-government-price-settings-impact-on-patients-and-providers 2026-04-03 daily 0.8 https://phrma.org/blog/commercial-health-plans-transition-from-copays-to-coinsurance-and-deductibles-has-increased-patient-out-of-pocket-costs-for-brand-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-increase-in-drug-resistant-superbugs-during-covid-19-highlights-need-for-policy-reforms-to-address-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/in-comments-to-federal-agency-phrma-warns-of-the-growing-influence-of-middlemen-over-patient-access-and-out-of-pocket-costs-for-prescription-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/incremental-innovation-development-of-biopharmaceuticals 2026-04-03 daily 0.8 https://phrma.org/blog/its-pbms-not-patents-blocking-competition 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-how-the-inflation-reduction-act-stifles-innovation-for-small-molecule-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/a-conversation-with-ron-busby-sr-president-and-ceo-of-the-u-s-black-chambers-inc-on-improving-vaccine-confidence-in-communities-of-color 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-3-factors-impacting-medication-adherence-for-patients-with-diabetes-and-how-our-proactive-affordability-solutions-can-help 2026-04-03 daily 0.8 https://phrma.org/blog/new-50-state-poll-americans-want-to-hold-health-insurers-and-pbms-accountable 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-report-shows-nearly-90-medicines-in-development-to-fight-drug-resistant-infections-but-future-pipeline-remains-challenging 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-to-drive-up-profits-hospitals-continue-unnecessary-medicine-mark-ups-burdening-patients-employers-and-the-health-system 2026-04-03 daily 0.8 https://phrma.org/blog/part-d-101-three-charts-show-how-the-medicare-part-d-program-could-be-improved-to-work-better-for-seniors-and-people-with-disabilities 2026-04-03 daily 0.8 https://phrma.org/blog/putting-2018-medicine-approvals-in-context 2026-04-03 daily 0.8 https://phrma.org/blog/rd-leaders-to-biden-administration-your-policies-are-undermining-the-cancer-moonshot 2026-04-03 daily 0.8 https://phrma.org/blog/rd-focus-5-things-to-know-about-the-biopharmaceutical-research-ecosystem 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-americas-veterans 2026-04-03 daily 0.8 https://phrma.org/blog/report-finds-pbms-are-increasingly-restricting-patient-access-to-their-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/research-shows-gene-therapies-can-offer-cost-savings-potential-of-up-to-18m-over-five-years-for-patients-with-certain-blood-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/retail-pharmacies-continue-to-expand-the-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/setting-the-record-straight-comparing-us-drug-prices-to-those-in-foreign-countries-hurts-patients 2026-04-03 daily 0.8 https://phrma.org/blog/sharing-rebates-can-save-americans-with-diabetes-500-each-year-and-improve-adherence-especially-for-black-and-hispanic-americans 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-important-health-outcomes-are-not-included-in-cost-effectiveness-analyses-for-sickle-cell-alzheimers-and-ms-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/study-hospital-and-outpatient-care-are-biggest-drivers-of-health-care-spending-differences-between-the-united-states-and-other-countries 2026-04-03 daily 0.8 https://phrma.org/blog/the-340b-program-is-interfering-with-the-us-biosimilars-market-and-impacting-patient-costs 2026-04-03 daily 0.8 https://phrma.org/blog/the-future-of-oncology-r-and-d-lies-in-policymakers-hands 2026-04-03 daily 0.8 https://phrma.org/blog/the-iras-pill-penalty-threatens-the-future-of-oncology-randd 2026-04-03 daily 0.8 https://phrma.org/blog/the-importance-of-bayh-dole-act 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-you-should-know-about-the-latest-rx-savings-solutions-analysis 2026-04-03 daily 0.8 https://phrma.org/blog/us-biopharmaceutical-exports-support-jobs-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/ustr-remembers-three-years-later-that-it-announced-a-trade-initiative-with-europe 2026-04-03 daily 0.8 https://phrma.org/blog/watch-putting-patients-front-and-center-on-world-aids-day 2026-04-03 daily 0.8 https://phrma.org/blog/what-is-the-low-income-subsidy-program-how-is-it-changing 2026-04-03 daily 0.8 https://phrma.org/blog/what-to-know-about-the-latest-effort-to-break-patents-using-a-legally-dubious-avenue 2026-04-03 daily 0.8 https://phrma.org/blog/with-the-first-list-of-medicines-coming-let-us-not-forget-why-government-price-setting-is-bad-policy 2026-04-03 daily 0.8 https://phrma.org/blog/wtas-inflation-reduction-act-already-impacting-randd-decisions 2026-04-03 daily 0.8 https://phrma.org/blog/prioritize-innovative-care 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-sheds-light-on-payment-flows-in-the-pharmaceutical-supply-chain-including-the-role-of-340b-and-vertical-integration 2026-04-03 daily 0.8 https://phrma.org/blog/the-real-cost-of-denying-access-to-medicines-in-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/cms-dont-fall-behind-the-rest-of-the-medical-community-on-obesity 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-industry-sponsored-clinical-trials-contribute-billions-to-state-economies 2026-04-03 daily 0.8 https://phrma.org/blog/a-successful-phrma-forum-highlights-our-commitment-to-a-healthier-america 2026-04-03 daily 0.8 https://phrma.org/blog/new-policy-agenda-charts-solutions-for-a-healthier-america 2026-04-03 daily 0.8 https://phrma.org/blog/340b-markup-program-is-a-hidden-tax-increasing-costs-for-employers-straining-state-and-federal-budgets 2026-04-03 daily 0.8 https://phrma.org/blog/congress-keeps-pbms-in-the-hot-seat 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-manufacturing-companies-continue-to-expand-their-economic-footprint-across-the-united-states 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industry-has-made-progress-in-cancer-fight-continues-work-toward-moonshot 2026-04-03 daily 0.8 https://phrma.org/blog/biosimilars-drive-savings-but-the-ira-undermines-their-development 2026-04-03 daily 0.8 https://phrma.org/blog/bringing-innovation-to-clinical-trial-design 2026-04-03 daily 0.8 https://phrma.org/blog/building-a-better-health-care-system-a-conversation-with-mark-reisenauer-president-of-astellas-us 2026-04-03 daily 0.8 https://phrma.org/blog/by-the-numbers-340b-continues-to-climb-in-profits-dwindle-with-patient-support 2026-04-03 daily 0.8 https://phrma.org/blog/cancer-medicines-cost-twice-as-much-at-hospitals-study-finds 2026-04-03 daily 0.8 https://phrma.org/blog/cbo-reaffirms-our-innovation-ecosystem-leads-to-improved-lives-long-term-savings 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-40-years-of-the-orphan-drug-act-on-rare-disease-day 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-the-success-of-the-covid-19-vaccines-and-looking-to-the-future 2026-04-03 daily 0.8 https://phrma.org/blog/changes-to-the-six-protected-class-policy-the-wrong-prescription-for-medicare-and-hiv-patients 2026-04-03 daily 0.8 https://phrma.org/blog/cms-should-rethink-proposed-changes-to-the-medicaid-drug-rebate-program 2026-04-03 daily 0.8 https://phrma.org/blog/coming-soon-clinical-trials-awareness-week-may-2-6 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-albert-bourla-chairman-and-ceo-of-pfizer-inc- 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-alexander-hardy-ceo-of-genentech 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-barry-greene-ceo-of-sage-therapeutics 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-paul-hudson-ceo-of-sanofi 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-paul-perreault-ceo-and-managing-director-of-csl 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-peter-anastasiou-executive-vice-president-of-lundbeck 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-ramona-sequeira-president-of-takeda-pharmaceuticals-u-s-a 2026-04-03 daily 0.8 https://phrma.org/blog/committing-to-diversity-equity-and-inclusion-a-call-to-action-for-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/continued-randd-into-alzheimers-disease-means-hope-for-patients-families-and-caregivers 2026-04-03 daily 0.8 https://phrma.org/blog/critics-repeat-same-misleading-narrative-on-potential-costs-of-new-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/csrxp-proposals-would-undermine-competitive-market-harm-patients-and-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/despite-rhetoric-new-data-shows-medicines-are-not-primary-driver-of-premium-increases 2026-04-03 daily 0.8 https://phrma.org/blog/developing-a-new-drug-is-actually-harder-than-rocket-science 2026-04-03 daily 0.8 https://phrma.org/blog/diabetes-fighting-the-disease-saving-lives 2026-04-03 daily 0.8 https://phrma.org/blog/did-the-administration-consider-the-importance-of-autoimmune-disease-medicines-in-price-setting-process 2026-04-03 daily 0.8 https://phrma.org/blog/dont-take-anti-innovation-activist-funded-academics-at-their-word 2026-04-03 daily 0.8 https://phrma.org/blog/executive-order-threatens-rd-when-we-need-it-most-to-fight-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-biologics-regulatory-data-protection-and-the-united-states-mexico-canada-agreement 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-how-hospitals-continue-to-drive-health-care-spending 2026-04-03 daily 0.8 https://phrma.org/blog/fda-uspto-collaboration-initiatives-should-be-evidence-based-prioritize-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-first-pediatric-patient-to-receive-car-t-cell-therapy-celebrates-10-years-of-being-cancer-free 2026-04-03 daily 0.8 https://phrma.org/blog/floridas-importation-plan-puts-patients-in-danger 2026-04-03 daily 0.8 https://phrma.org/blog/food-allergy-highlights-opportunities-for-inclusive-representative-research-studies 2026-04-03 daily 0.8 https://phrma.org/blog/four-years-later-maryland-board-still-hasnt-delivered-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/fresh-data-show-yet-again-340b-is-growing-while-charity-care-dwindles-at-many-340b-hospitals 2026-04-03 daily 0.8 https://phrma.org/blog/getting-ttip-right-not-rushed 2026-04-03 daily 0.8 https://phrma.org/blog/growth-in-innovative-value-based-contracts-holds-promise-for-the-health-system-and-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-following-my-stroke-having-access-to-ground-breaking-medical-innovation-has-never-been-more-important 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-if-we-truly-want-to-cure-complex-diseases-politicians-should-reject-price-setting 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-the-importance-of-women-diversity-and-inclusion-in-stem 2026-04-03 daily 0.8 https://phrma.org/blog/guest-series-phrma-talks-racial-and-health-equity-with-lauren-powell-vp-us-health-equity-and-community-wellness-takeda 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-phrma-talks-racial-and-health-equity-with-stephanie-dyson-head-of-office-at-biogen 2026-04-03 daily 0.8 https://phrma.org/blog/hidden-markups-at-mail-order-pharmacies-increase-costs-for-employers 2026-04-03 daily 0.8 https://phrma.org/blog/how-modernizing-fda-regulations-can-benefit-patients-providers-and-payers 2026-04-03 daily 0.8 https://phrma.org/blog/how-strengthening-the-biosimilar-marketplace-benefits-patients 2026-04-03 daily 0.8 https://phrma.org/blog/h-r-3-threatens-access-to-medicines-future-innovation-and-american-jobs 2026-04-03 daily 0.8 https://phrma.org/blog/icers-budget-impact-threshold-sounding-a-false-alarm-on-affordability-and-access 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-cancer-death-rate-continues-to-decline-due-to-treatment-advances 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-government-watchdog-report-finds-patients-in-medicare-part-d-paid-billions-more-for-medicines-than-insurers-and-pbms 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-health-care-policy-should-be-driven-by-patients-not-politics 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-innovation-transforms-lives-but-misguided-federal-policies-threaten-patient-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-kicks-off-the-year-at-the-2023-jp-morgan-health-care-conference 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-opaque-industry-secretly-inflating-prices-for-prescription-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-when-middlemen-get-in-the-way-its-the-patients-that-lose 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-a-patient-physician-biotech-investor-and-industry-leaders-warn-about-the-dangers-of-government-price-setting-bill 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-antimicrobial-resistance-spotlighted-as-growing-public-health-threat 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-canadian-government-stakeholders-voice-concerns-with-drug-importation-proposals 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-icer-solicits-feedback-on-its-value-assessment-framework 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-cbo-report-highlights-biopharmaceutical-leadership-in-the-development-of-new-treatments-and-cures 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-report-demonstrates-growing-global-impact-of-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-study-confirms-policies-like-hr-3-could-significantly-reduce-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-patients-saved-nearly-800000-out-of-pocket-through-innovative-contracting-arrangements 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-pharmacy-benefit-managers-increasingly-exclude-medicines-from-formularies-restricting-patient-access 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-research-shows-promise-of-innovative-payment-arrangements-in-reducing-costs-improving-access 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-new-york-times-highlights-how-increasing-cost-sharing-hinders-access-raises-other-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-wall-street-journal-makes-the-case-for-sharing-truthful-non-misleading-information 2026-04-03 daily 0.8 https://phrma.org/blog/if-patients-arent-benefiting-from-the-340b-program-who-is 2026-04-03 daily 0.8 https://phrma.org/blog/if-drug-prices-are-growing-below-the-rate-of-inflation-why-are-patients-still-feeling-the-sting-at-the-pharmacy 2026-04-03 daily 0.8 https://phrma.org/blog/if-washington-isnt-careful-we-might-leave-innovation-behind 2026-04-03 daily 0.8 https://phrma.org/blog/illegal-trade-barriers-discriminate-against-us-innovators 2026-04-03 daily 0.8 https://phrma.org/blog/im-not-average-13-years-later-jamie-is-still-here 2026-04-03 daily 0.8 https://phrma.org/blog/im-not-average-matt-may-have-cancer-but-cancer-doesnt-have-him 2026-04-03 daily 0.8 https://phrma.org/blog/improve-womens-health-by-treating-the-disease-not-the-pain 2026-04-03 daily 0.8 https://phrma.org/blog/in-biopharmaceutical-research-if-at-first-you-dont-succeed-try-again 2026-04-03 daily 0.8 https://phrma.org/blog/in-combating-covid-19-science-is-how-we-get-back-to-normal 2026-04-03 daily 0.8 https://phrma.org/blog/in-survey-phrma-member-companies-highlight-impact-of-ipi-on-randd 2026-04-03 daily 0.8 https://phrma.org/blog/in-the-current-health-care-debate-congress-has-lost-sight-of-what-matters-to-u-s-voters 2026-04-03 daily 0.8 https://phrma.org/blog/increased-use-of-prior-authorization-in-medicaid-is-blocking-access-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/india-denies-patent-on-novel-hiv-aids-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/industry-backed-stem-programs-have-helped-111-million-students-and-nearly-183000-teachers 2026-04-03 daily 0.8 https://phrma.org/blog/innovation-comes-in-many-forms-including-new-and-expanded-uses-of-existing-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/insulin-key-facts-on-access-affordability 2026-04-03 daily 0.8 https://phrma.org/blog/insurers-continue-shifting-more-costs-on-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/insurers-shift-medicine-costs-to-patients-with-severe-chronic-illnesses 2026-04-03 daily 0.8 https://phrma.org/blog/intellectual-property-is-the-key-to-vaccine-development-manufacturing-and-technology-sharing 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-how-does-the-us-patent-process-work 2026-04-03 daily 0.8 https://phrma.org/blog/ira-changes-to-part-d-risk-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/ira-impacts-cancer-treatment-research-and-development 2026-04-03 daily 0.8 https://phrma.org/blog/its-a-new-year-but-sadly-congress-is-still-pursuing-flawed-price-setting-policies 2026-04-03 daily 0.8 https://phrma.org/blog/johnson-and-johnson-pfizer-walgreens-and-other-ceos-discuss-value-in-the-future-of-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/join-im-not-average-a-community-for-patients-and-supporters 2026-04-03 daily 0.8 https://phrma.org/blog/keep-the-six-protected-classes-protected 2026-04-03 daily 0.8 https://phrma.org/blog/key-takeaways-from-acips-recent-meeting 2026-04-03 daily 0.8 https://phrma.org/blog/leveraging-the-power-of-vaccines-to-prevent-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/lilly-merck-and-pfizer-empower-team-members-to-volunteer-on-covid-19-frontlines 2026-04-03 daily 0.8 https://phrma.org/blog/local-impact-hepatitis-c-and-medicaid-spending 2026-04-03 daily 0.8 https://phrma.org/blog/making-coupons-count-for-patients-at-the-pharmacy-counter 2026-04-03 daily 0.8 https://phrma.org/blog/making-medicines-more-affordable-modernizing-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/manufacturers-provided-42-billion-in-medicaid-discounts-in-2021-alone 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-10-years-later-3-reasons-why-part-d-is-a-success-story 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-cms-withdraws-part-b-demo-takes-positive-step-forward-on-cmmi 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-goodbye-2015-hello-2016 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-happy-early-birthday-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-government-price-setting-in-part-d-could-reduce-innovation-shorten-life-expectancy-for-beneficiaries 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-part-d-helps-patients-with-heart-disease-live-longer-healthier-lives 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-its-important-to-shop-around-even-if-your-premium-is-decreasing-next-year 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-medicare-part-d-helps-reduce-spending-in-parts-a-and-b-too 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-moran-finds-part-b-medicine-prices-are-stable-not-a-key-driver-of-medicare-costs 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-more-medicines-in-development-for-heart-disease-stroke-and-other-cardiovascular-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-research-finds-drugs-not-a-key-driver-of-medicare-part-b-costs 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-research-reveals-part-d-coverage-is-more-robust-than-va-coverage-for-new-innovative-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-part-b-and-biosimilars-part-2 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-part-d-premiums-remain-steady-3-things-to-know 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-resources-for-understanding-medicare-part-b-and-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-is-asp 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-is-in-the-2016-medicare-trustees-report 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-is-ipab-and-why-is-it-bad-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-part-d-continues-to-hold-down-costs-maintain-high-level-of-patient-satisfaction 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-and-resources-put-cancer-in-context-showing-more-than-1100-medicines-and-vaccines-in-development 2026-04-03 daily 0.8 https://phrma.org/blog/minnesota-lawmakers-are-letting-pbms-off-the-hook-and-threatening-patients-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/more-oversight-needed-of-unapproved-medicines-that-threaten-patients-health 2026-04-03 daily 0.8 https://phrma.org/blog/more-than-50-medicines-and-vaccines-in-development-for-hiv-infection-treatment-and-prevention 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-flawed-assessments-of-a-medicines-value-jeopardize-patient-access 2026-04-03 daily 0.8 https://phrma.org/blog/new-calculator-demonstrates-how-improved-adherence-to-anti-diabetic-medicines-can-benefit-people-in-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-america-is-an-api-powerhouse 2026-04-03 daily 0.8 https://phrma.org/blog/new-global-analysis-shows-patient-access-challenges-around-the-world 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-1600-cancer-treatments-and-vaccines-in-clinical-development 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-more-than-400-medicines-in-development-for-leading-chronic-conditions-affecting-older-americans 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-high-impact-rd-happens-after-cancer-medicines-are-first-approved 2026-04-03 daily 0.8 https://phrma.org/blog/new-resource-underscores-the-importance-of-small-molecule-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/new-year-same-exploitation-of-the-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-shows-820000-prescriptions-would-be-in-jeopardy-if-icers-value-framework-is-used-in-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-shows-that-more-medicines-worldwide-are-available-to-us-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-insurers-and-pbms-increase-barriers-to-care 2026-04-03 daily 0.8 https://phrma.org/blog/new-insulin-report-highlights-how-incentives-benefit-middlemen-harm-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-nhe-data-medicine-prices-declined-and-hospitals-were-biggest-driver-of-health-care-spending-in-2018 2026-04-03 daily 0.8 https://phrma.org/blog/patients-showcase-longer-healthier-lives-in-new-from-hope-to-cures-ads 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-report-nearly-200-medicines-in-development-for-heart-disease-stroke-and-other-cardiovascular-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-report-more-than-170-medicines-in-development-for-diabetes-offer-patients-longer-healthier-lives 2026-04-03 daily 0.8 https://phrma.org/blog/new-polling-when-it-comes-to-health-insurance-coverage-what-most-concerns-you 2026-04-03 daily 0.8 https://phrma.org/blog/new-pwc-report-finds-medicine-spending-still-small-share-of-health-spending-concerns-may-trigger-false-alarms 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-highlights-importance-of-ip-intensive-manufacturing-industries-to-the-us-economy 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-3-in-10-americans-that-have-insurance-still-face-a-financial-barrier-to-care 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-more-than-400-medicines-and-vaccines-in-development-to-tackle-infectious-diseases-including-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-nearly-260-vaccines-in-development-including-dozens-for-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-shows-competition-driven-by-biosimilars-helps-control-costs-in-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/new-rule-makes-it-harder-for-patients-to-lower-their-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-finds-hospitals-prescribe-more-medicines-and-more-expensive-medicines-after-joining-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-patient-cost-sharing-rising-as-plans-push-more-costs-to-patients-through-deductibles-coinsurance 2026-04-03 daily 0.8 https://phrma.org/blog/new-treatments-could-save-396-billion-over-10-years-lead-to-better-quality-of-life-for-migraine-sufferers 2026-04-03 daily 0.8 https://phrma.org/blog/new-world-of-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/no-matter-how-you-look-at-it-the-most-favored-nation-rule-is-bad-policy 2026-04-03 daily 0.8 https://phrma.org/blog/no-matter-how-you-structure-it-government-arbitration-is-wrong-for-medicare-drug-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/coming-together-to-fight-covid-19-a-conversation-with-kabir-k-nath-president-and-ceo-of-otsuka-north-america-pharmaceutical-business 2026-04-03 daily 0.8 https://phrma.org/blog/nonprofit-hospitals-fall-short-on-community-benefit-studies-show 2026-04-03 daily 0.8 https://phrma.org/blog/novel-medicines-approved-in-2022-offer-increased-treatment-options-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/novel-treatments-and-vaccines-approved-for-us-patients-in-2023-reach-five-year-high 2026-04-03 daily 0.8 https://phrma.org/blog/on-manufacturing-day-a-closer-look-at-the-biopharmaceutical-sectors-contributions 2026-04-03 daily 0.8 https://phrma.org/blog/out-of-pocket-trends-in-medicare-part-d-show-rising-costs-for-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/part-d-cliff-looms-for-seniors-as-program-stability-could-be-in-jeopardy 2026-04-03 daily 0.8 https://phrma.org/blog/pass4prostate-tackling-prostate-cancer-through-awareness-research 2026-04-03 daily 0.8 https://phrma.org/blog/patience-hope-and-survival-progress-on-the-cancer-front 2026-04-03 daily 0.8 https://phrma.org/blog/patient-experience-survey-americans-speak-out-on-health-insurance-barriers-and-need-for-policy-change 2026-04-03 daily 0.8 https://phrma.org/blog/patient-assistance-site-relaunched-to-better-help-patients-caregivers 2026-04-03 daily 0.8 https://phrma.org/blog/patient-groups-members-of-congress-and-other-state-based-stakeholders-agree-stop-the-abuse-of-biopharmaceutical-patents 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-2024-special-301-submission-ustr-needs-to-support-american-innovation-global-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-awards-250000-to-community-based-projects-to-improve-equitable-cancer-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-launches-new-ad-calling-for-congress-to-make-sure-savings-go-to-patients-not-pbms 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-reiterates-concerns-with-ira-price-setting-program-urges-cms-to-mitigate-harm 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submission-calls-for-ustr-to-correct-course-on-trade-policy-enforcement 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-warns-federal-agencies 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-awards-100000-to-fund-projects-that-address-health-inequalities 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-awards-75000-to-fund-initiatives-to-reduce-health-inequities 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-cares-grant-request-for-proposals-addressing-inequities-in-access-to-covid-19-testing-therapeutics-and-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-ceo-raises-concerns-with-florida-importation-proposal-highlights-reforms-needed-to-lower-costs-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-ceo-talks-white-house-meeting-innovation-and-jobs-with-politicos-pulse-check 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-and-nih-create-public-private-partnership-for-immuno-oncology 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-rd-investments-reach-record-high-of-1023-billion-in-2021 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-rd-investments-reach-record-high-of-91-1-billion-in-2020 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-salutes-outgoing-fda-commissioners-leadership-looks-forward-to-continued-collaboration 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submission-to-2022-national-trade-estimate-report-underscores-need-for-pro-innovation-u-s-trade-policy-to-combat-covid-19-and-other-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submission-to-the-2019-national-trade-estimate-report-urges-action-to-protect-u-s-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/progress-to-improve-patient-lives-a-review 2026-04-03 daily 0.8 https://phrma.org/blog/promoting-global-vaccine-equity-while-protecting-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/proposed-march-in-draft-framework-would-chill-american-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/protecting-against-influenza-a-conversation-with-david-ross-vice-president-commercial-operations-north-america-csl-seqirus 2026-04-03 daily 0.8 https://phrma.org/blog/putting-patients-first-at-the-state-level-a-conversation-with-mark-reisenauer-president-of-astellas-pharma-us 2026-04-03 daily 0.8 https://phrma.org/blog/remembering-harrison-cook-vice-president-for-international-government-affairs-at-eli-lilly-and-company 2026-04-03 daily 0.8 https://phrma.org/blog/report-more-than-1300-medicines-and-vaccines-in-development-to-help-fight-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/research-and-development-continues-long-after-a-medicine-is-initially-approved 2026-04-03 daily 0.8 https://phrma.org/blog/safe-drug-disposal-is-a-viable-sustainable-option 2026-04-03 daily 0.8 https://phrma.org/blog/second-annual-phrma-survey-how-americans-view-their-health-three-important-new-health-trends-to-watch 2026-04-03 daily 0.8 https://phrma.org/blog/special-edition-medicare-monday-more-context-on-medpacs-analysis-of-drug-costs-part-ii 2026-04-03 daily 0.8 https://phrma.org/blog/state-policymakers-can-protect-american-innovation-and-help-americans-live-longer-healthier-lives 2026-04-03 daily 0.8 https://phrma.org/blog/strengthening-a-culture-dedicated-to-patients-and-equity-a-conversation-with-percival-barretto-ko-president-of-astellas-us 2026-04-03 daily 0.8 https://phrma.org/blog/strengthening-a-culture-dedicated-to-patients-and-equity-a-conversation-with-vas-narasimhan-ceo-of-novartis 2026-04-03 daily 0.8 https://phrma.org/blog/systemic-racism-is-as-real-as-any-disease-and-our-industry-is-not-immune 2026-04-03 daily 0.8 https://phrma.org/blog/targeting-the-immune-system-not-the-tumor 2026-04-03 daily 0.8 https://phrma.org/blog/the-biden-administration-has-failed-to-advance-an-inclusive-worker-centered-trade-agenda 2026-04-03 daily 0.8 https://phrma.org/blog/the-inflation-reduction-act-could-increase-costs-and-reduce-access-for-millions-of-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/the-biopharmaceutical-industry-leads-in-helping-women-achieve-new-heights-according-to-iams-diversity-100 2026-04-03 daily 0.8 https://phrma.org/blog/the-importance-of-timely-pdufa-and-bsufa-reauthorization 2026-04-03 daily 0.8 https://phrma.org/blog/the-latest-what-they-are-saying-intellectual-property-protections-vital-to-covid-19-research-development-and-manufacturing 2026-04-03 daily 0.8 https://phrma.org/blog/the-patient-experience-insurance-barriers-continue-to-impede-access-to-health-care-especially-among-the-countrys-underserved 2026-04-03 daily 0.8 https://phrma.org/blog/the-patient-experience-insurance-design-hurdles-lead-to-access-issues-for-too-many-americans-including-communities-of-color-and-the-chronically-ill 2026-04-03 daily 0.8 https://phrma.org/blog/the-value-collaborative-advancing-private-market-solutions-to-achieve-better-health-lower-costs 2026-04-03 daily 0.8 https://phrma.org/blog/this-weeks-reading-list-all-the-reasons-the-senate-passed-drug-pricing-bill-is-bad-policy 2026-04-03 daily 0.8 https://phrma.org/blog/three-facts-about-health-care-spending 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-economists-are-saying-about-the-inflation-reduction-act 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-about-the-accelerated-approval-pathway 2026-04-03 daily 0.8 https://phrma.org/blog/three-ways-state-drug-price-setting-boards-fail-patients 2026-04-03 daily 0.8 https://phrma.org/blog/time-to-enforce-the-rules-that-protect-american-ideas-brands-and-inventions 2026-04-03 daily 0.8 https://phrma.org/blog/to-continue-to-drive-the-innovation-economy-and-exports-american-biopharmaceutical-sector-depends-on-fair-trade-agreements 2026-04-03 daily 0.8 https://phrma.org/blog/together-raising-awareness-of-the-toll-of-chronic-disease 2026-04-03 daily 0.8 https://phrma.org/blog/understanding-the-emergency-use-authorization-process-for-covid-19-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/value-at-the-crossroads-part-ii 2026-04-03 daily 0.8 https://phrma.org/blog/watch-a-conversation-with-dr-mike-ybarra-on-rare-disease-day 2026-04-03 daily 0.8 https://phrma.org/blog/we-work-for-health-discovering-champions-even-amid-challenging-times 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-access-patients-part-d-oh-my 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-florida-drug-importation-program-is-unfeasible-and-dangerous 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-covid-19-public-health-emergency-is-over-but-ideological-attacks-on-ip-remain 2026-04-03 daily 0.8 https://phrma.org/blog/when-it-comes-to-the-future-of-innovation-the-ball-is-in-policymakers-court 2026-04-03 daily 0.8 https://phrma.org/blog/when-it-comes-to-getting-your-meds-are-you-covered 2026-04-03 daily 0.8 https://phrma.org/blog/wtas-voters-voice-concerns-about-pbm-abuses-call-on-policymakers-to-act 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-hospitals-mark-up-medicine-prices-500-percent 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-explores-setbacks-that-bring-future-cancer-success-stories 2026-04-03 daily 0.8 https://phrma.org/blog/new-340b-report-from-minnesota-exposes-steep-hospital-markups-on-medicines-how-patients-benefit-remains-murky 2026-04-03 daily 0.8 https://phrma.org/blog/michigan-hospitals-using-federal-program-to-markup-cost-of-medicines-gouging-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-entities-that-don-t-make-medicines-get-half-of-what-is-spent-on-those-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-a-new-administration-poses-new-opportunities-for-patient-access 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-the-value-of-disease-prevention-with-dr-len-friedland-from-gsk 2026-04-03 daily 0.8 https://phrma.org/blog/congratulations-to-our-2024-working-for-cures-employee-champions 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-advances-in-diabetes-research 2026-04-03 daily 0.8 https://phrma.org/blog/post-approval-r-and-d-is-critical-for-fighting-cancer-the-ira-makes-it-more-difficult 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-ceos-tee-up-next-weeks-health-care-conference 2026-04-03 daily 0.8 https://phrma.org/blog/ftc-finds-pbms-make-billions-in-profit-from-marking-up-cancer-other-critical-generic-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/nyt-exposes-hospitals-middlemen-make-millions-off-a-hospital-markup-program 2026-04-03 daily 0.8 https://phrma.org/blog/wrapping-up-the-jp-morgan-healthcare-conference 2026-04-03 daily 0.8 https://phrma.org/blog/patients-are-losing-as-government-price-setting-continues 2026-04-03 daily 0.8 https://phrma.org/blog/preventing-and-fighting-disease-a-look-at-the-biopharmaceutical-progress-made-for-patients-in-2024 2026-04-03 daily 0.8 https://phrma.org/blog/major-drug-compounder-is-spending-millions-on-misleading-super-bowl-ad 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industry-supports-jobs-and-drives-economic-growth-across-the-united-states 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-science-powered-by-pride 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-companies-face-restrictions-in-sharing-scientific-information-to-improve-patient-care 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-companies-recognized-as-meaningful-places-to-work 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industry-drives-economic-growth-in-all-50-states 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industry-is-essential-to-development-of-alzheimers-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industry-leads-manufacturing-sector-in-randd-spending 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industry-policies-aim-to-increase-access-to-clinical-trial-data 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industry-strongly-committed-to-responsible-clinical-trial-data-sharing-to-improve-public-health 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-industrys-success-reducing-disparities-for-african-americans 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-innovation-antibody-drug-conjugates 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-innovation-benefits-many-sectors-of-industry 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-research-and-development-has-ushered-in-a-decade-of-innovation-in-rare-disease 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-research-companies-developing-92-medicines-to-treat-arthritis-and-musculoskeletal-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-researchers-to-discuss-the-value-of-randd-with-congress 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-sector-leads-the-way-in-clinical-trial-data-sharing 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-venture-capital-is-spurring-innovation-and-economic-growth 2026-04-03 daily 0.8 https://phrma.org/blog/biosimilar-uptake-is-increasing-and-so-are-health-savings 2026-04-03 daily 0.8 https://phrma.org/blog/biosimilar-user-fee-act-iii-performance-goals-letter-will-help-increase-options-for-patients-and-promote-competition 2026-04-03 daily 0.8 https://phrma.org/blog/biosimilars-continue-to-drive-market-competition-and-increase-savings-for-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/bipartisan-lawmakers-urge-administration-to-rethink-proposed-changes-to-six-protected-classes-policy 2026-04-03 daily 0.8 https://phrma.org/blog/bmj-clinical-trial-report-misleading 2026-04-03 daily 0.8 https://phrma.org/blog/breaking-a-link-in-the-value-chain 2026-04-03 daily 0.8 https://phrma.org/blog/bringing-innovation-to-light-during-lung-cancer-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/building-confidence-in-the-covid-19-vaccine-through-education 2026-04-03 daily 0.8 https://phrma.org/blog/building-on-the-promise-of-personalized-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-5-questions-on-access-to-asthma-medicines-in-health-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-5-questions-on-access-to-diabetes-medicines-in-health-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-5-questions-on-access-to-hivaids-medicines-in-health-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-5-questions-on-access-to-mental-health-medicines-in-health-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-5-questions-on-access-to-multiple-sclerosis-medicines-in-health-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-5-questions-on-access-to-rheumatoid-arthritis-medicines-in-health-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-access-to-asthma-medicine-and-the-risk-of-going-without 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-access-to-medicines-in-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-access-to-medicines-in-health-insurance-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-insurance-benefit-designs-impact-on-patient-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-limiting-access-to-necessary-medicines-threatens-hope-for-oncology-patients 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-looking-ahead 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-mental-health-disorders-can-affect-anyone-and-health-insurance-exchanges-must-provide-needed-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-one-size-fits-all-approach-to-treating-multiple-sclerosis-hurts-patients 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-prescription-management-is-critical-for-diabetes-patients 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-preserving-the-new-normal-for-patients-with-rheumatoid-arthritis 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-questions-on-access-to-cancer-medicines-in-health-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/blog/burden-on-patients-two-steps-forward-and-one-step-back-for-hivaids-patients 2026-04-03 daily 0.8 https://phrma.org/blog/busting-3-myths-about-copay-coupons 2026-04-03 daily 0.8 https://phrma.org/blog/by-the-numbers-a-look-at-the-part-b-international-pricing-index-model 2026-04-03 daily 0.8 https://phrma.org/blog/by-the-numbers-a-look-at-the-sourcing-of-api-used-in-medicines-consumed-in-the-united-states 2026-04-03 daily 0.8 https://phrma.org/blog/by-the-numbers-contract-pharmacy-participation-in-the-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/by-the-numbers-patients-lose-when-the-government-sets-prices 2026-04-03 daily 0.8 https://phrma.org/blog/by-the-numbers-pelosis-radical-plan-puts-americas-economy-and-jobs-at-risk 2026-04-03 daily 0.8 https://phrma.org/blog/canadas-chance-to-reform-its-approach-to-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/canadas-innovation-challenge 2026-04-03 daily 0.8 https://phrma.org/blog/canadas-innovation-opportunity 2026-04-03 daily 0.8 https://phrma.org/blog/canadas-promise-doctrine-strikes-again 2026-04-03 daily 0.8 https://phrma.org/blog/cancer-victims-try-cancer-survivors 2026-04-03 daily 0.8 https://phrma.org/blog/case-study-how-seniors-could-face-access-disruptions-because-of-the-iras-price-setting-provisions 2026-04-03 daily 0.8 https://phrma.org/blog/case-study-how-one-online-pharmacy-knowingly-endangered-u-s-consumers 2026-04-03 daily 0.8 https://phrma.org/blog/castellani-and-molineaux-oped-in-patriot-news 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-hispanic-heritage-month-at-phrma 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-anniversaries-americans-with-disabilities-act 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-brighter-futures-and-healthier-hearts-during-american-heart-month 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-cardiovascular-health-on-world-heart-day-2015 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-clinical-trials-awareness-week-may-4-8 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-diversity-in-the-biopharmaceutical-industry 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-hope-for-patients-and-families-on-world-heart-day-2016 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-medicares-56th-anniversary 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-medicares-57th-anniversary 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-pride-in-biopharmaceutical-science 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-tremendous-advances-in-hivaids-on-national-youth-hivaids-awareness-day 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-u-s-innovation-as-uspto-issues-the-10-millionth-patent 2026-04-03 daily 0.8 https://phrma.org/blog/challenges-and-opportunities-in-an-era-of-personalized-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/championing-cancer-equity-our-drive-for-healthier-aanhpi-communities 2026-04-03 daily 0.8 https://phrma.org/blog/cheering-the-biosciences-in-west-virginia 2026-04-03 daily 0.8 https://phrma.org/blog/clarity-around-anti-kickback-statute-needed-to-promote-innovative-payment-arrangements 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trial-data-transparency-is-the-right-thing-to-do 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-awareness-week-celebrating-innovation-in-clinical-research 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-awareness-week-celebrating-the-impact-of-clinical-research 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-awareness-week-recognizing-unsung-heroes-in-medical-research 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-qanda-a-patients-perspective 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-qanda-examining-clinical-trial-design 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-qanda-how-does-collaboration-increase-clinical-trial-awareness-and-access 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-qanda-improving-the-recruitment-process-by-listening-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-so-necessary-but-more-complex-than-ever 2026-04-03 daily 0.8 https://phrma.org/blog/cms-coverage-policies-restrict-patient-access-to-important-treatment-options-for-alzheimers-disease 2026-04-03 daily 0.8 https://phrma.org/blog/cms-coverage-policy-is-detrimental-to-alzheimers-patients 2026-04-03 daily 0.8 https://phrma.org/blog/cms-guidance-on-ira-price-setting-process-doubles-down-on-bad-policy 2026-04-03 daily 0.8 https://phrma.org/blog/cms-needs-to-do-better 2026-04-03 daily 0.8 https://phrma.org/blog/cms-coverage-decision-restricts-access-to-treatments-for-alzheimers-disease 2026-04-03 daily 0.8 https://phrma.org/blog/video-phrma-ceo-discusses-goboldly-campaign-and-white-house-meeting-with-cnnmoneys-maggie-lake 2026-04-03 daily 0.8 https://phrma.org/blog/collaboration-between-phrma-and-scientific-american-highlights-biomedical-science 2026-04-03 daily 0.8 https://phrma.org/blog/how-biopharmaceutical-collaboration-is-driving-a-new-era-of-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/collaboration-for-cures-teaming-up-to-advance-science-and-save-lives 2026-04-03 daily 0.8 https://phrma.org/blog/collaboration-is-what-will-help-drive-new-successes-for-the-rare-disease-community 2026-04-03 daily 0.8 https://phrma.org/blog/combatting-a-lack-of-transparency-in-health-insurance-exchanges 2026-04-03 daily 0.8 https://phrma.org/blog/combatting-opioid-abuse-joint-partnership-with-the-rx-abuse-leadership-initiative-and-the-national-sheriffs-association 2026-04-03 daily 0.8 https://phrma.org/blog/commercial-health-plans-have-increased-patients-out-of-pocket-costs-by-over-50-in-some-therapeutic-areas 2026-04-03 daily 0.8 https://phrma.org/blog/compulsory-licensing-a-misused-and-abused-international-trade-law 2026-04-03 daily 0.8 https://phrma.org/blog/congratulations-to-our-2022-working-for-cures-employee-champions 2026-04-03 daily 0.8 https://phrma.org/blog/congratulations-to-our-2023-working-for-cures-employee-champions 2026-04-03 daily 0.8 https://phrma.org/blog/connecting-some-dots-on-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/continuing-and-expanding-the-georgetown-phrma-fellowship-program 2026-04-03 daily 0.8 https://phrma.org/blog/continuing-the-search-for-new-alzheimers-therapies 2026-04-03 daily 0.8 https://phrma.org/blog/copay-assistance-is-a-lifeline-for-patients-so-why-are-insurers-blocking-it 2026-04-03 daily 0.8 https://phrma.org/blog/copay-coupons-can-help-ease-patients-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/blog/correcting-the-record-iras-government-price-setting-provisions-are-unconstitutional 2026-04-03 daily 0.8 https://phrma.org/blog/correcting-the-record-biopharmaceutical-companies-remain-committed-to-the-340b-program-and-helping-patients 2026-04-03 daily 0.8 https://phrma.org/blog/correcting-the-record-putting-medicine-costs-and-spending-in-context 2026-04-03 daily 0.8 https://phrma.org/blog/cost-of-mental-illness-underscores-need-for-new-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/costs-and-consequences-of-not-treating-diabetes 2026-04-03 daily 0.8 https://phrma.org/blog/costs-and-consequences-of-not-treating-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/costs-and-consequences-of-not-treating-high-cholesterol 2026-04-03 daily 0.8 https://phrma.org/blog/coupons-allow-patients-to-remain-on-medicines-in-spite-of-high-cost-sharing-and-deductibles 2026-04-03 daily 0.8 https://phrma.org/blog/covid-19-response-supporting-the-frontline 2026-04-03 daily 0.8 https://phrma.org/blog/covid-19-vaccines-and-treatments-helped-save-millions-of-lives-and-billions-in-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/creating-a-new-patient-risk-paradigm-in-american-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/critics-proven-wrong-again-on-medicine-spending 2026-04-03 daily 0.8 https://phrma.org/blog/cross-country-comparisons-of-medicine-prices-are-like-comparing-apples-to-oranges 2026-04-03 daily 0.8 https://phrma.org/blog/csc-survey-finds-discrepancy-in-definition-of-value-in-cancer-care 2026-04-03 daily 0.8 https://phrma.org/blog/dangers-of-drug-importation-a-case-of-counterfeit-cancer-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/data-show-voters-want-bipartisan-approach-to-tackling-health-care-affordability-and-coverage-issues 2026-04-03 daily 0.8 https://phrma.org/blog/data-shows-covid-19-vaccines-are-creating-a-pathway-to-a-strong-u-s-recovery 2026-04-03 daily 0.8 https://phrma.org/blog/data-shows-that-americans-are-relying-on-vaccines-to-get-us-through-the-pandemic 2026-04-03 daily 0.8 https://phrma.org/blog/data-shows-that-keeping-a-strong-biopharmaceutical-industry-is-important-to-americans 2026-04-03 daily 0.8 https://phrma.org/blog/data-shows-voters-strongly-support-protecting-access-to-their-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/debunking-common-myths-about-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/debunking-the-myths-of-treating-hepatitis-c 2026-04-03 daily 0.8 https://phrma.org/blog/decentralized-clinical-trials-and-the-future-of-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/deep-dive-the-issues-that-drove-the-2020-vote 2026-04-03 daily 0.8 https://phrma.org/blog/diabetes-in-the-news 2026-04-03 daily 0.8 https://phrma.org/blog/five-facts-about-the-value-of-innovative-cancer-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/did-the-administration-consider-the-importance-of-blood-cancer-medicines-to-patients-in-price-setting-process 2026-04-03 daily 0.8 https://phrma.org/blog/did-the-administration-consider-the-importance-of-blood-clot-medicines-to-patients-in-the-price-setting-process 2026-04-03 daily 0.8 https://phrma.org/blog/did-the-administration-consider-the-value-of-innovative-diabetes-medicines-in-price-setting-process 2026-04-03 daily 0.8 https://phrma.org/blog/direct-to-consumer-advertising-makes-doctors-and-patients-stronger-partners 2026-04-03 daily 0.8 https://phrma.org/blog/discovery-of-counterfeit-hepatitis-c-drug-is-another-example-of-why-importation-is-bad-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/disease-modifying-therapies-for-the-management-of-multiple-sclerosis-save-money-and-improve-patient-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/disparities-in-health-coverage-not-all-services-are-created-equal 2026-04-03 daily 0.8 https://phrma.org/blog/disrupting-alzheimers 2026-04-03 daily 0.8 https://phrma.org/blog/diversifying-clinical-trials-and-fighting-disease-requires-equity-and-trust 2026-04-03 daily 0.8 https://phrma.org/blog/diversity-of-thought-fuels-next-generation-of-breakthroughs 2026-04-03 daily 0.8 https://phrma.org/blog/do-you-know-how-insurance-covers-your-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/dont-close-the-door-on-rare-disease-research 2026-04-03 daily 0.8 https://phrma.org/blog/dont-put-the-government-between-patients-and-their-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/dont-lie-down 2026-04-03 daily 0.8 https://phrma.org/blog/dose-sharing-as-a-part-of-the-covid-19-global-vaccine-equity-strategy 2026-04-03 daily 0.8 https://phrma.org/blog/dr-george-scangos-not-just-science-for-sciences-sake 2026-04-03 daily 0.8 https://phrma.org/blog/driving-further-innovation-is-critical-to-global-vaccine-equity 2026-04-03 daily 0.8 https://phrma.org/blog/driving-innovation-through-collaboration 2026-04-03 daily 0.8 https://phrma.org/blog/drug-importation-an-old-idea-that-is-still-a-bad-idea 2026-04-03 daily 0.8 https://phrma.org/blog/drug-of-the-week-one-patients-story 2026-04-03 daily 0.8 https://phrma.org/blog/earth-day-2015-green-initiatives-are-good-for-business-and-the-environment 2026-04-03 daily 0.8 https://phrma.org/blog/efpia-phrma-principles-successfully-enable-responsible-clinical-trial-data-sharing 2026-04-03 daily 0.8 https://phrma.org/blog/election-insights-common-ground-areas-to-address-americans-health-care-concerns 2026-04-03 daily 0.8 https://phrma.org/blog/election-insights-voter-priorities-in-the-states 2026-04-03 daily 0.8 https://phrma.org/blog/empowering-consumers-and-improving-access-to-important-clinical-information 2026-04-03 daily 0.8 https://phrma.org/blog/empowering-consumers-and-improving-access-to-out-of-pocket-cost-information 2026-04-03 daily 0.8 https://phrma.org/blog/empowering-patients-to-be-active-participants-in-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/end-of-year-part-d-reading-list 2026-04-03 daily 0.8 https://phrma.org/blog/enforcing-unmet-trade-obligations-protects-u-s-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/ensuring-access-for-hispanic-americans 2026-04-03 daily 0.8 https://phrma.org/blog/ensuring-global-vaccine-equity-requires-eliminating-trade-and-regulatory-barriers 2026-04-03 daily 0.8 https://phrma.org/blog/ensuring-personalized-medicines-reach-patients 2026-04-03 daily 0.8 https://phrma.org/blog/ensuring-timely-reauthorization-of-pdufa-and-bsufa 2026-04-03 daily 0.8 https://phrma.org/blog/eradication-of-measles-highlights-the-promise-of-vaccines-in-development 2026-04-03 daily 0.8 https://phrma.org/blog/event-new-era-of-medicine-comes-to-capitol-hill 2026-04-03 daily 0.8 https://phrma.org/blog/event-next-week-supporting-the-next-generation-of-lifesaving-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/event-tomorrow-improving-access-and-affordability-for-americas-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/event-tomorrow-improving-patient-access-to-lifesaving-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/event-tomorrow-leaders-convene-to-discuss-solutions-to-advance-value-driven-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/event-tomorrow-maintaining-americas-leadership-in-access-and-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/event-tomorrow-making-the-biopharmaceutical-supply-chain-work-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/examining-the-brain-in-the-new-era-of-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/examining-the-truth-behind-clinical-trial-costs 2026-04-03 daily 0.8 https://phrma.org/blog/excerpts-from-testimony-by-phrmas-lori-reilly 2026-04-03 daily 0.8 https://phrma.org/blog/expanding-the-wto-intellectual-property-waiver-will-hurt-american-jobs 2026-04-03 daily 0.8 https://phrma.org/blog/expanding-trips-waiver-would-jeopardize-biopharmaceutical-research-and-development 2026-04-03 daily 0.8 https://phrma.org/blog/experts-discuss-the-value-of-ip-at-senate-judiciary-committee-hearing 2026-04-03 daily 0.8 https://phrma.org/blog/experts-agree-the-bipartisan-budget-act-changes-to-medicare-part-d-jeopardize-the-program 2026-04-03 daily 0.8 https://phrma.org/blog/exploring-the-new-era-of-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-do-contract-pharmacies-help-patients-access-340b-medicines-no 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-biopharmaceutical-company-communications-with-payers 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-getting-the-facts-straight-about-negotiation-in-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-ipr-and-biopharmaceutical-patents 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-medicaid-spending-on-prescription-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-biopharmaceutical-patents 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-drug-importation-and-patient-safety 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-industrys-role-in-randd 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-ipab 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-negotiation-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-spending-on-cancer-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-friday-the-truth-about-the-cost-of-340b-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-hcci-analysis-overstates-medicine-spending-and-prices 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-how-the-part-b-international-pricing-index-model-replaces-market-competition-with-government-set-prices 2026-04-03 daily 0.8 https://phrma.org/blog/fact-check-how-the-part-b-international-pricing-index-model-threatens-patient-access 2026-04-03 daily 0.8 https://phrma.org/blog/fda-should-remain-the-authority-on-the-safety-and-effectiveness-of-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/fda-approves-a-record-45-new-medicines-in-2015 2026-04-03 daily 0.8 https://phrma.org/blog/fda-issues-draft-biosimilars-labeling-guidance 2026-04-03 daily 0.8 https://phrma.org/blog/fda-needs-best-and-brightest-to-advance-a-new-era-of-medicine-with-americas-biopharmaceutical-companies 2026-04-03 daily 0.8 https://phrma.org/blog/fighting-blood-cancers-together-at-the-2016-leukemia-ball 2026-04-03 daily 0.8 https://phrma.org/blog/fighting-high-cholesterol 2026-04-03 daily 0.8 https://phrma.org/blog/fighting-multiple-sclerosis-new-together-ad-illuminates-the-journey-of-patient-and-scientist 2026-04-03 daily 0.8 https://phrma.org/blog/fighting-the-zika-virus-a-lesson-for-defending-against-emerging-pathogens 2026-04-03 daily 0.8 https://phrma.org/blog/fighting-variants-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/final-rebate-rule-represents-right-way-to-change-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/finding-cures-for-incurable-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/five-key-facts-about-the-market-for-insulins 2026-04-03 daily 0.8 https://phrma.org/blog/five-myths-about-global-efforts-to-combat-tuberculosis 2026-04-03 daily 0.8 https://phrma.org/blog/five-reasons-tying-va-prices-to-medicare-part-d-misses-the-mark 2026-04-03 daily 0.8 https://phrma.org/blog/five-things-you-might-not-know-about-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/flu-season-2020-why-its-time-to-talk-to-your-doctor-today-about-getting-a-flu-shot 2026-04-03 daily 0.8 https://phrma.org/blog/focusing-on-only-1-of-spending-will-not-solve-nations-health-care-challenges 2026-04-03 daily 0.8 https://phrma.org/blog/focusing-on-patients-and-progress-on-world-hepatitis-day 2026-04-03 daily 0.8 https://phrma.org/blog/focusing-payment-and-delivery-on-patients 2026-04-03 daily 0.8 https://phrma.org/blog/forced-pharmaceutical-localization-fails-to-deliver 2026-04-03 daily 0.8 https://phrma.org/blog/foreign-government-price-setting-by-any-name-harms-innovation-and-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/foreign-sourced-active-pharmaceutical-ingredients-vs-imported-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/former-law-enforcement-officials-raise-concerns-with-drug-importation-proposals 2026-04-03 daily 0.8 https://phrma.org/blog/four-things-for-cms-to-keep-in-mind-as-they-implement-changes-to-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/four-ways-that-americas-biopharmaceutical-industry-supports-jobs-and-fuels-economic-growth 2026-04-03 daily 0.8 https://phrma.org/blog/four-facts-value-and-cost-of-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-four-key-takeaways-from-new-bayh-dole-white-paper 2026-04-03 daily 0.8 https://phrma.org/blog/four-solutions-americans-support-to-make-health-care-more-affordable 2026-04-03 daily 0.8 https://phrma.org/blog/four-states-adopt-first-in-the-nation-laws-to-protect-patients-from-surprise-insurer-practices 2026-04-03 daily 0.8 https://phrma.org/blog/four-things-to-know-about-the-iqvia-medicine-spending-and-affordability-in-the-u-s-report 2026-04-03 daily 0.8 https://phrma.org/blog/four-things-to-know-from-iqvias-latest-report 2026-04-03 daily 0.8 https://phrma.org/blog/four-things-you-should-know-about-aarp 2026-04-03 daily 0.8 https://phrma.org/blog/frazier-phrma-scholarship-awarded-to-four-college-bound-students-in-philadelphia-and-dc 2026-04-03 daily 0.8 https://phrma.org/blog/free-trade-agreements-may-be-good-for-your-health 2026-04-03 daily 0.8 https://phrma.org/blog/from-hope-to-cures-the-value-of-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/ftc-report-confirms-pbms-profit-at-the-expense-of-patients 2026-04-03 daily 0.8 https://phrma.org/blog/gao-again-recommends-improvements-to-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/gao-prescription-drugs-are-just-2-of-medicaid-spending 2026-04-03 daily 0.8 https://phrma.org/blog/gao-report-finds-drug-prices-increasing-at-lower-rate-than-medical-inflation 2026-04-03 daily 0.8 https://phrma.org/blog/gene-therapies-can-reduce-treatment-burden-and-costs-for-patients-with-blood-disorders 2026-04-03 daily 0.8 https://phrma.org/blog/get-the-facts-on-pcmas-newest-attempt-to-avoid-accountability 2026-04-03 daily 0.8 https://phrma.org/blog/get-involved-to-protect-womens-health-during-cervical-health-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/getting-the-340b-program-back-on-track-in-2021 2026-04-03 daily 0.8 https://phrma.org/blog/getting-the-most-out-of-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/giving-patients-a-voice-phrma-launches-voters-for-cures-to-support-the-next-generation-of-treatments-and-cures 2026-04-03 daily 0.8 https://phrma.org/blog/global-covid-19-vaccination-matters-now-and-for-the-future 2026-04-03 daily 0.8 https://phrma.org/blog/goboldly-ad-showcases-need-to-foster-americas-leadership-in-medical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/going-boldly-together-new-advancements-and-new-anniversaries 2026-04-03 daily 0.8 https://phrma.org/blog/government-price-setting-wont-help-patients-in-illinois 2026-04-03 daily 0.8 https://phrma.org/blog/government-price-setting-boards-why-minnesota-needs-to-take-a-better-approach 2026-04-03 daily 0.8 https://phrma.org/blog/government-imposed-price-controls-threaten-innovation-and-access 2026-04-03 daily 0.8 https://phrma.org/blog/government-negotiation-could-have-devastating-consequences-for-medicare-enrollees 2026-04-03 daily 0.8 https://phrma.org/blog/government-price-setting-leaves-behind-families-counting-on-new-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/government-price-setting-wont-stop-insurers-from-shifting-costs-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/greatest-hit-for-the-week 2026-04-03 daily 0.8 https://phrma.org/blog/groups-sound-the-alarm-on-administrations-new-part-b-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/growing-consensus-on-the-need-to-improve-communications-with-health-care-professionals 2026-04-03 daily 0.8 https://phrma.org/blog/growing-trend-increased-vaccine-confidence 2026-04-03 daily 0.8 https://phrma.org/blog/growth-in-340b-program-has-not-translated-to-improvements-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/guess-what-part-b-drug-spending-remains-stable-share-of-medicare-spending 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-my-health-care-vote 2026-04-03 daily 0.8 https://phrma.org/blog/what-new-cures-would-mean-to-families 2026-04-03 daily 0.8 https://phrma.org/blog/guest-blog-covid-19-vaccines-are-the-key-to-keeping-kids-healthy 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-debra-of-america-on-epidermolysis-bullosa 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-a-cure-for-ellie-on-leukodystrophy-lbsl 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-a-patients-story-of-the-long-term-health-impacts-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-a-post-pandemic-crisis-the-mental-toll-on-america 2026-04-03 daily 0.8 https://phrma.org/blog/stephanie-dyson-of-bms-on-reducing-health-disparities 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-advancing-healthy-hearts-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-advancing-oncology-research-through-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-amgen-foundation-stands-for-equal-opportunities-in-stem-learning 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-bringing-our-best-to-the-fight-against-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-congress-should-not-put-future-innovation-at-risk 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-continued-research-and-development-is-critical-for-als-patients-and-families 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-developing-new-payment-models-to-ensure-patients-have-access-to-high-investment-therapies 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-driving-towards-a-healthy-heart 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-ensuring-communities-have-a-seat-at-the-table-the-importance-of-diversity-in-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-epilepsy-foundation-on-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-excellent-care-for-lgbtq-patients-requires-cultural-humility-and-specific-medical-knowledge 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-film-chronicles-clinical-trials-paying-it-forward 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-from-lab-to-jab-vaccine-development-to-prevent-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-hearing-from-patients-on-rare-disease-day 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-honoring-asian-and-pacific-islander-heritage-in-the-age-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-how-covid-19-underscores-the-importance-of-public-confidence-in-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-how-proactivity-and-planning-helped-novartis-ensure-a-stable-supply-of-medicines-during-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-h-r-3-is-the-wrong-approach-to-help-patients-like-me 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-johnson-and-johnson-is-celebrating-outstanding-scientists-who-will-be-next 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-joining-forces-to-combat-the-covid-19-mental-health-crisis 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-looking-out-for-the-invisibly-vulnerable-in-the-time-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-new-bioethical-points-to-consider-on-truthful-and-non-misleading-product-communication 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-new-threats-could-fundamentally-alter-innovation-in-drug-manufacturing 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-patients-as-research-partners-rethinking-patient-access-to-clinical-trial-data 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-preserving-clinical-research-sites-during-the-coronavirus-pandemic 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-pride-started-with-protest-combatting-the-dual-pandemics-of-covid-19-and-racism-this-pride-month 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-recognizing-national-disability-employment-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-retired-medics-return-to-the-field-to-take-on-vaccine-delivery-and-disaster-relief 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-room-for-optimism-in-als-research 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-securing-the-health-care-supply-chain-during-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-sharing-discounts-and-rebates-is-the-right-thing-to-do 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-spotlighting-the-heroes-in-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-takeda-seeks-new-normal-for-cancer-research-during-the-covid-19-pandemic 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-takedas-efforts-to-address-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-the-clinical-trial-experience-from-a-patient-and-researcher-perspective 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-value-based-agreements-can-improve-outcomes-and-even-save-patients-money-at-the-pharmacy-counter 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-what-will-we-learn-from-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/happy-50th-anniversary-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/harnessing-the-power-of-real-world-evidence-to-benefit-patients-through-pdufa-vi 2026-04-03 daily 0.8 https://phrma.org/blog/health-affairs-study-misses-the-mark-on-medicine-costs 2026-04-03 daily 0.8 https://phrma.org/blog/health-coverage-101-back-to-basics 2026-04-03 daily 0.8 https://phrma.org/blog/health-coverage-resources-in-spanish 2026-04-03 daily 0.8 https://phrma.org/blog/health-insurance-exchange-plans-increasingly-putting-needed-medicines-out-of-reach 2026-04-03 daily 0.8 https://phrma.org/blog/healthy-outlook-conquering-cancer-in-the-21st-century 2026-04-03 daily 0.8 https://phrma.org/blog/helping-medicare-patients-manage-chronic-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/helping-patients-in-times-of-need 2026-04-03 daily 0.8 https://phrma.org/blog/helping-those-affected-by-the-2017-hurricane-season 2026-04-03 daily 0.8 https://phrma.org/blog/helping-those-affected-by-the-coronavirus 2026-04-03 daily 0.8 https://phrma.org/blog/heres-how-americas-biopharmaceutical-companies-lead-the-way-in-development-of-innovative-new-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/high-cost-of-medicines-in-health-insurance-exchange-plans-is-harming-patients 2026-04-03 daily 0.8 https://phrma.org/blog/highlighting-innovation-during-mental-illness-awareness-week-2015 2026-04-03 daily 0.8 https://phrma.org/blog/highlights-from-asco-2023 2026-04-03 daily 0.8 https://phrma.org/blog/hispanic-heritage-month-fighting-for-hispanic-patients 2026-04-03 daily 0.8 https://phrma.org/blog/holding-pharmacy-benefit-managers-accountable 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-honoring-hispanic-heritage-month-by-taking-action-on-health-equity 2026-04-03 daily 0.8 https://phrma.org/blog/honoring-veterans-serving-in-the-biopharmaceutical-industry 2026-04-03 daily 0.8 https://phrma.org/blog/hospitals-make-9-times-more-than-physicians-offices-on-provider-administered-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/how-fdas-modernization-strategy-could-improve-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/how-government-price-setting-fails-to-address-systemic-health-care-inequities 2026-04-03 daily 0.8 https://phrma.org/blog/how-hta-based-price-controls-could-worsen-health-outcomes-and-health-disparities 2026-04-03 daily 0.8 https://phrma.org/blog/how-part-bs-asp-system-helps-control-costs-for-the-government-and-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/how-the-340b-program-became-a-pbm-giveaway 2026-04-03 daily 0.8 https://phrma.org/blog/how-the-ira-is-more-coercive-than-any-european-government-price-setting-scheme 2026-04-03 daily 0.8 https://phrma.org/blog/how-to-protect-your-childrens-health-this-school-year 2026-04-03 daily 0.8 https://phrma.org/blog/how-340b-discounts-work 2026-04-03 daily 0.8 https://phrma.org/blog/how-a-competitive-biopharmaceutical-marketplace-helps-to-control-costs 2026-04-03 daily 0.8 https://phrma.org/blog/how-biopharmaceutical-researchers-are-ensuring-covid-19-vaccines-will-be-safe-and-effective 2026-04-03 daily 0.8 https://phrma.org/blog/how-do-multiple-sclerosis-patients-define-value 2026-04-03 daily 0.8 https://phrma.org/blog/how-does-medicare-part-d-impact-you 2026-04-03 daily 0.8 https://phrma.org/blog/how-drug-importation-schemes-could-increase-u-s-law-enforcement-burdens 2026-04-03 daily 0.8 https://phrma.org/blog/how-icers-assessment-of-a-new-class-of-migraine-treatments-fails-patients 2026-04-03 daily 0.8 https://phrma.org/blog/how-innovative-medicines-are-benefiting-countries-across-the-globe 2026-04-03 daily 0.8 https://phrma.org/blog/how-manufacturing-advances-can-help-make-medicines-more-effective 2026-04-03 daily 0.8 https://phrma.org/blog/how-many-americans-could-potentially-be-treated-with-new-pcsk9-inhibitors-hint-it-wont-be-as-many-as-critics-claim 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-medicare-helps-beneficiaries-access-needed-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/how-medicare-part-d-supports-patients 2026-04-03 daily 0.8 https://phrma.org/blog/how-much-are-hospitals-marking-up-the-price-of-medicines-the-answer-may-surprise-you 2026-04-03 daily 0.8 https://phrma.org/blog/how-much-do-you-know-about-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-part-b-has-evolved-over-the-years 2026-04-03 daily 0.8 https://phrma.org/blog/how-research-evolves-and-brings-new-hope-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/how-standardized-plans-can-improve-patients-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/how-the-rebate-rule-would-help-reduce-patients-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/blog/how-to-get-value-assessment-frameworks-right 2026-04-03 daily 0.8 https://phrma.org/blog/how-were-curing-the-incurable 2026-04-03 daily 0.8 https://phrma.org/blog/icer-framework-threatens-to-halt-continued-progress-against-multiple-myeloma 2026-04-03 daily 0.8 https://phrma.org/blog/icer-glosses-over-significant-progress-in-ms-treatment 2026-04-03 daily 0.8 https://phrma.org/blog/icer-puts-hard-fought-progress-in-non-small-cell-lung-cancer-treatment-at-risk 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-3-takeaways-on-the-iras-unintended-consequences-from-americas-physician-groups-2023-annual-fall-conference 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-grounding-policy-reforms-in-real-lived-patient-experiences-is-key-to-improving-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-misaligned-policies-undermine-patient-access 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-more-evidence-of-the-iras-harmful-consequences-on-post-approval-research-and-development 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-research-builds-upon-growing-body-of-evidence-on-value-of-covid-19-treatments-and-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-pbm-exec-admits-choosing-profits-over-patients 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-cmo-dr-michael-ybarra-speaks-with-dr-fabian-sandoval-about-clinical-trial-diversity 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-coo-lori-reilly-esq-speaks-with-jacob-van-naarden-about-the-future-of-cancer-research 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-coo-lori-reilly-speaks-about-the-health-care-agenda-for-the-next-congress 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-president-and-ceo-stephen-j-ubl-discusses-patient-affordability 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrmas-4th-annual-pathways-to-success-virtual-stem-career-expo 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-scott-laganga-and-matt-salo-deliver-a-state-of-the-industry-report 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-powerful-companies-driving-local-drugstores-out-of-business 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-voter-priorities-this-election-season 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-what-patients-care-about-this-election-year 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-why-2017-medicine-approvals-matter 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-2019-brings-innovative-medicines-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-340b-program-raises-eyebrows-in-north-carolina 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-a-broad-coalition-of-stakeholders-continue-to-raise-concerns-about-patent-litigation-reform 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-american-society-for-clinical-oncology-statement-on-clinical-pathways 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-americas-biopharmaceutical-companies-are-taking-on-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-americas-biopharmaceutical-companies-are-working-around-the-clock-to-beat-coronavirus 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-avalere-and-fastercures-develop-new-value-framework-from-patient-perspective 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-bipartisan-lawmakers-urge-new-administration-to-oppose-changes-to-six-protected-classes-policy 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-cancer-death-rate-continues-decline-due-to-advances-in-treatment 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-community-oncologists-speak-out-against-hospital-cancer-doctors-drug-price-control-proposals 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-continued-biopharmaceutical-action-on-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-coverage-of-expensive-drugs-tops-patients-concerns 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-data-find-provider-consolidation-increases-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-debunking-myths-about-cancer-care-in-the-united-states 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-event-spotlights-how-we-can-make-medicare-work-better-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-fighting-for-a-cure-to-als 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-has-the-340b-program-lost-its-way 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-innovative-payment-models-helping-provide-patient-access-to-new-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-more-evidence-that-increased-use-of-medicines-helps-reduce-spending-on-other-medical-care 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-more-than-60-phrma-company-scientists-visit-capitol-hill 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-multi-stakeholder-group-recommended-changes-to-support-value-driven-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-analysis-shows-u-s-brand-name-medicines-rose-just-0-7-percent-in-second-quarter 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-approvals-by-the-fda-in-2021-offer-greater-treatment-options-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-cholesterol-lowering-medicines-will-not-be-budget-busters 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-era-of-medicine-initiative-kicks-off-in-boston 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-oncology-trend-report-highlights-the-future-promise-of-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-report-on-benefits-of-cancer-medicines-that-emerge-after-fda-approval 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-report-outlines-steps-for-greater-transparency-in-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-resource-catalogs-biopharmaceutical-industry-lessons-learned-from-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-study-highlights-often-high-out-of-pocket-costs-in-exchanges 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-study-reinforces-dangers-of-proposed-ipi-model 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-study-shows-medicines-advance-life-expectancy-for-hiv-patients 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-study-underscores-access-challenges-in-essential-health-benefit-plans 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-survey-finds-most-patients-unaware-of-clinical-pathways 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-next-generation-cures 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-nyt-explores-how-immunotherapy-is-revolutionizing-cancer-care 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-orphan-drug-development-brings-unique-challenges 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-patients-across-the-country-are-sharing-concerns-about-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-ceo-in-stat-pelosis-drug-pricing-plan-puts-medical-innovation-at-risk 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-ceo-speaks-at-stat-summit-about-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-ceo-stephen-j-ubl-spotlights-lessons-learned-during-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-coo-lori-reilly-spotlights-efforts-to-improve-health-care-in-2022-and-beyond 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-president-and-ceo-stephen-j-ubl-joins-other-industry-leaders-for-a-conversation-on-covid-19-vaccines-with-axios 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrmas-ubl-pens-op-ed-on-ip-waiver-for-covid-19-technologies 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-physicians-want-better-information-sharing-with-biopharmaceutical-companies 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-policy-solutions-for-delivering-innovative-treatments-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-recent-survey-adds-to-growing-body-of-research-on-barriers-to-innovative-payment-approaches 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-regulators-urge-broader-health-networks 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-report-highlights-overall-decrease-in-cancer-death-rates 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-report-provides-actionable-recommendations-to-strengthen-americas-preparedness-and-future-health-crises-response 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-survey-highlights-key-barriers-limiting-number-and-scale-of-new-approaches-to-paying-for-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-importance-of-enrolling-in-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-latest-as-americas-biopharmaceutical-companies-work-to-beat-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-new-era-of-medicine-initiative-spotlights-genomics-in-nyc 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-ubl-weighs-in-on-how-fair-trade-protects-us-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-wall-street-journal-highlights-dangers-of-counterfeit-medicines-entering-the-united-states-through-drug-importation 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-what-the-experts-are-saying-about-importation 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-wsj-and-nyt-highlight-concerns-with-part-b-international-pricing-index-model 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-wall-street-journal-and-washington-post-say-tpp-should-protect-medical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-wsj-showcases-breakthrough-science-of-covid-19-vaccines-and-implications-for-future-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/identifying-and-addressing-health-disparities-phrmas-first-chart-pack-on-health-equity 2026-04-03 daily 0.8 https://phrma.org/blog/illegal-abuse-of-340b-hurts-us-all 2026-04-03 daily 0.8 https://phrma.org/blog/im-not-average-campaign-hits-close-to-home 2026-04-03 daily 0.8 https://phrma.org/blog/im-not-average-doreens-struggle-with-cholesterol-video 2026-04-03 daily 0.8 https://phrma.org/blog/im-not-average-jacks-journey-battling-rare-blood-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/im-not-average-marina-is-living-well-in-spite-of-stomach-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/im-not-average-pancreatic-cancer-survivor-who-defies-the-odds 2026-04-03 daily 0.8 https://phrma.org/blog/impact-of-deductibles-in-health-plans 2026-04-03 daily 0.8 https://phrma.org/blog/improving-care-quality-by-engaging-patients-in-shared-decision-making 2026-04-03 daily 0.8 https://phrma.org/blog/improving-fdas-combination-product-review-process-could-increase-epinephrine-auto-injector-competition 2026-04-03 daily 0.8 https://phrma.org/blog/improving-pdmps-strengthening-state-tools-to-prevent-prescription-drug-abuse 2026-04-03 daily 0.8 https://phrma.org/blog/in-their-own-words-financial-barriers-exacerbate-access-challenges-for-insured-americans 2026-04-03 daily 0.8 https://phrma.org/blog/in-their-own-words-insured-americans-struggle-to-navigate-complex-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/in-their-own-words-insured-americans-support-policy-reforms-that-address-access-and-affordability-concerns 2026-04-03 daily 0.8 https://phrma.org/blog/in-case-you-missed-it-progress-and-promise-in-alzheimers-research 2026-04-03 daily 0.8 https://phrma.org/blog/in-the-oecd-other-health-care-services-will-be-ten-times-prescription-medicine-spending-growth-over-next-decade 2026-04-03 daily 0.8 https://phrma.org/blog/incomplete-evaluations-undermine-patient-access-to-transformational-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/increasing-diversity-at-investigator-sites-could-increase-minority-participation-in-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/increasing-global-access-to-vaccines-by-optimizing-production 2026-04-03 daily 0.8 https://phrma.org/blog/incubators-of-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/indiaseizing-the-opportunity 2026-04-03 daily 0.8 https://phrma.org/blog/indias-ip-policies-still-much-room-for-improvement 2026-04-03 daily 0.8 https://phrma.org/blog/industry-leaders-discuss-the-impact-of-the-drug-pricing-debate 2026-04-03 daily 0.8 https://phrma.org/blog/innovation-comes-from-companies-of-all-sizes 2026-04-03 daily 0.8 https://phrma.org/blog/innovative-contracts-continue-to-gain-traction-and-improve-quality-of-care 2026-04-03 daily 0.8 https://phrma.org/blog/innovative-contracts-drive-access-for-patients-and-value-for-the-system 2026-04-03 daily 0.8 https://phrma.org/blog/insulin-and-reconciliation 2026-04-03 daily 0.8 https://phrma.org/blog/insurance-data-pbm-reform-has-no-material-impact-on-premiums 2026-04-03 daily 0.8 https://phrma.org/blog/insurance-coverage-101 2026-04-03 daily 0.8 https://phrma.org/blog/insurance-design-barriers-can-impact-patient-adherence-and-can-lead-to-poor-health-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/insurer-and-pbm-tactics-are-shifting-higher-costs-to-patients-with-chronic-and-complex-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/intellectual-property-waiver-on-covid-19-innovation-is-unnecessary-and-harmful 2026-04-03 daily 0.8 https://phrma.org/blog/introducing-clinical-research-participation-to-the-everyday-person 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-by-the-numbers-how-reliable-ip-protections-promote-a-strong-u-s-economy 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-fact-check-march-in-authority-and-the-bayh-dole-act 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-four-things-to-know-about-the-bayh-dole-act 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-how-hatch-waxman-successfully-balances-affordability-and-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-how-patents-support-innovation-throughout-the-biopharmaceutical-lifecycle 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-intellectual-property-system-working-to-combat-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-myth-vs-fact-about-strong-patent-protections-in-the-biopharmaceutical-industry 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-three-forms-of-ip-protections-for-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-understanding-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-what-is-section-101-and-why-reforms-are-needed 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-what-they-are-saying-on-the-importance-of-strong-intellectual-property-protections 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-why-ip-protections-are-important-for-biologic-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/ip-explained-why-patents-are-so-critical-to-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/ip-protections-found-to-be-critical-to-life-science-innovation-and-investment 2026-04-03 daily 0.8 https://phrma.org/blog/ira-is-already-negatively-impacting-access-to-medicines-in-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/the-ira-could-lead-to-higher-out-of-pocket-costs-for-3-5-million-medicare-patients-in-2026 2026-04-03 daily 0.8 https://phrma.org/blog/ira-threatens-seniors-access-to-robust-treatment-options 2026-04-03 daily 0.8 https://phrma.org/blog/is-cms-paying-attention-to-the-growing-access-barriers-for-medicare-patients-under-the-ira 2026-04-03 daily 0.8 https://phrma.org/blog/itif-report-shows-how-canadas-ip-system-is-falling-behind 2026-04-03 daily 0.8 https://phrma.org/blog/its-a-good-thing-pharmaceutical-manufacturing-supply-chains-are-spread-out-around-the-world 2026-04-03 daily 0.8 https://phrma.org/blog/just-released-phrma-members-new-clinical-trial-diversity-principles 2026-04-03 daily 0.8 https://phrma.org/blog/keeping-the-wheels-turning-on-patent-reform 2026-04-03 daily 0.8 https://phrma.org/blog/key-considerations-as-congress-works-towards-pahpa-reauthorization 2026-04-03 daily 0.8 https://phrma.org/blog/key-election-year-voter-insights 2026-04-03 daily 0.8 https://phrma.org/blog/key-trends-patient-experience-data-reveal-how-insurers-and-middlemen-impose-barriers-in-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/key-voter-insights-two-months-from-election-day 2026-04-03 daily 0.8 https://phrma.org/blog/key-excerpts-phrma-submits-comments-to-keep-the-six-protected-classes-protected 2026-04-03 daily 0.8 https://phrma.org/blog/key-excerpts-phrma-submits-comments-to-nist-in-effort-to-safeguard-intellectual-property-protections 2026-04-03 daily 0.8 https://phrma.org/blog/key-facts-the-final-rebate-rule-will-be-a-positive-change-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/key-takeaways-from-ascos-annual-meeting 2026-04-03 daily 0.8 https://phrma.org/blog/insights-from-the-election-meeting-voters-where-they-are-on-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/key-takeaways-phrma-comments-to-uspto-on-how-to-make-the-innovation-ecosystem-more-diverse-and-inclusive 2026-04-03 daily 0.8 https://phrma.org/blog/know-the-signs-of-stroke-and-act-quickly 2026-04-03 daily 0.8 https://phrma.org/blog/labeling-your-health 2026-04-03 daily 0.8 https://phrma.org/blog/leading-efforts-to-better-understand-amyloidosis-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/leading-researchers-to-spotlight-the-critical-role-of-biopharmaceutical-randd 2026-04-03 daily 0.8 https://phrma.org/blog/learning-from-history-how-government-price-setting-and-other-anti-innovation-policies-negatively-impact-biopharmaceutical-randd 2026-04-03 daily 0.8 https://phrma.org/blog/legislation-threatens-patent-protections-and-future-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/legislative-and-legal-action-seeks-to-improve-communications-with-health-care-professionals-to-better-inform-patient-care 2026-04-03 daily 0.8 https://phrma.org/blog/lessons-learned-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/lessons-learned-from-covid-19-the-way-we-develop-new-medicines-is-changing 2026-04-03 daily 0.8 https://phrma.org/blog/local-impact-improving-diabetes-care-for-children-in-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/local-impact-state-by-state-medicaid-spending-on-prescription-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/long-awaited-fda-guidance-addresses-one-key-obstacle-to-value-based-contracting 2026-04-03 daily 0.8 https://phrma.org/blog/look-at-the-facts-drug-importation-is-dangerous 2026-04-03 daily 0.8 https://phrma.org/blog/looking-ahead-to-pdufa-vi 2026-04-03 daily 0.8 https://phrma.org/blog/looking-back-at-a-decade-of-advancements-in-ms-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-looking-back-at-the-success-of-part-d-in-its-first-10-years 2026-04-03 daily 0.8 https://phrma.org/blog/loretta-shares-a-story-of-hope-in-the-face-of-her-cancer-diagnosis 2026-04-03 daily 0.8 https://phrma.org/blog/low-value-health-care-costs-345b-each-year-and-provides-little-benefit 2026-04-03 daily 0.8 https://phrma.org/blog/lung-map-demonstrates-real-change-in-cancer-research-and-care-possible-through-collaboration 2026-04-03 daily 0.8 https://phrma.org/blog/lupus-foundation-of-america-event-calls-for-more-progress-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/maintaining-appropriate-incentives-for-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/making-coupons-count-for-patients-with-hiv 2026-04-03 daily 0.8 https://phrma.org/blog/making-drug-formulary-search-tools-better-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/making-medicines-more-affordable-making-coupons-count 2026-04-03 daily 0.8 https://phrma.org/blog/making-medicines-more-affordable-making-insurance-work-like-insurance 2026-04-03 daily 0.8 https://phrma.org/blog/making-medicines-more-affordable-phrmas-solutions 2026-04-03 daily 0.8 https://phrma.org/blog/making-medicines-more-affordable-preserving-safety-net-programs-like-340b 2026-04-03 daily 0.8 https://phrma.org/blog/making-medicines-more-affordable-sharing-savings-at-the-pharmacy-counter 2026-04-03 daily 0.8 https://phrma.org/blog/highlighting-advances-in-science-during-breast-cancer-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-shows-why-insurers-should-share-rebates-with-medicare-part-d-beneficiaries-on-a-mandatory-basis 2026-04-03 daily 0.8 https://phrma.org/blog/manufacturer-cost-sharing-assistance-programs-can-save-chronically-ill-patients-hundreds-to-thousands-of-dollars-annually 2026-04-03 daily 0.8 https://phrma.org/blog/manufacturing-day-2020-a-closer-look-at-the-biopharmaceutical-industrys-contributions 2026-04-03 daily 0.8 https://phrma.org/blog/many-seniors-are-paying-more-for-part-d-medicines-than-their-insurer 2026-04-03 daily 0.8 https://phrma.org/blog/many-consumers-still-face-confusion-around-health-insurance-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/matt-and-jamie-share-their-stories-in-new-from-hope-to-cures-ads 2026-04-03 daily 0.8 https://phrma.org/blog/medicaid-by-the-numbers 2026-04-03 daily 0.8 https://phrma.org/blog/medicaid-101-three-charts-on-access-and-spending 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-part-b-spending-in-four-points 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-part-d-open-enrollment-and-what-recent-changes-mean-for-beneficiaries 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-prescription-payment-plan-will-benefit-patients-if-implemented-correctly 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-3-medicare-videos 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-3-reasons-why-repealing-part-ds-noninterference-clause-is-a-bad-idea 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-3-things-to-know-about-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-3-things-to-know-about-the-governments-medicare-payment-change 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-3-tips-for-choosing-a-medicare-part-d-plan 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-4-things-you-may-not-know-about-competition-in-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-closer-look-at-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-closer-look-at-part-b-spending 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-discussion-on-affordability-and-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-guide-to-medpacs-part-b-vote-this-week 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-guide-to-medpacs-part-d-vote-this-week 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-medicare-open-enrollment-checklist 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-medicare-part-d-reading-list 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-refresh-on-private-negotiation-in-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-access-to-medicines-for-veterans 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-access-to-vaccines-for-older-americans 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-adherence-in-medicare-and-medicaid-saves-money 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-advancing-treatments-for-osteoporosis-with-medicines-in-development 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-another-example-of-the-competitive-market-at-work-in-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-beware-scary-proposed-changes-to-medicare-are-out-there 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-billing-code-basics-for-biologics-in-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-call-for-repeal-of-ipab-intensifies 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-catch-up-on-medpac-and-its-part-b-recommendations 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-celebrating-presidents-day-with-a-brief-medicare-history 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-concerns-still-abound-about-part-b-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-congestive-heart-failure-patients-benefit-from-taking-advantage-of-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-did-you-know- 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-did-you-know-medicare-part-b-uses-a-market-based-system-to-pay-for-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-dont-forget-medicare-open-enrollment-ends-wednesday 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-drug-coverage-before-and-after-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-fact-checking 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-gaining-part-d-coverage-reduces-hospitalizations-and-overall-spending-in-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-growing-body-of-research-finds-reduced-mortality-after-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-happy-memorial-day 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-have-you-heard-of-cmmi 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-helping-beneficiaries-access-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-helping-hypertensive-patients-live-healthier-lives 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-existing-cmmi-models-affect-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-finding-an-alzheimers-treatment-could-lower-medicare-spending 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-medpac-recommendations-would-actually-increase-beneficiary-costs 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-part-d-extra-help-works-for-katie 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-part-d-helps-parkinsons-patients 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-successful-negotiation-takes-place-in-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-to-switch-plans-during-open-enrollment 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-increased-rebate-levels-in-part-d-show-robust-negotiation-continues 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-it-is-medicares-birthday-month 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-majority-of-part-d-prescriptions-are-generics 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-managing-diabetes-thanks-to-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-medicare-part-b-and-biosimilars 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-medicare-part-d-by-the-numbers 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-medicare-reading-list 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-medicare-turns-52 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-negotiation-in-medicare-part-d-works 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-hepatitis-c-treatments-in-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-part-d-study-highlights-benefit-of-switching-plans 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-report-highlights-progress-in-fighting-cancer-with-new-physician-administered-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-research-finds-beneficiaries-live-longer-after-implementation-of-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-research-finds-trends-in-average-sales-price-of-part-b-drugs-remains-stable 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-study-further-confirms-increased-use-of-generics-after-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-study-highlights-impact-of-variability-in-medication-therapy-management-programs 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-xcenda-white-paper-looks-at-four-strengths-of-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-one-size-fits-all-treatments-are-wrong-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-open-enrollment-ends-december-7-last-call-to-shop-around 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-open-enrollment-ends-today 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-open-enrollment-is-here-again 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-open-enrollment-starts-this-weekend 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-part-b-proposal-lacks-essential-patient-protections 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-part-d-competition-then-and-now 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-part-d-coverage-then-and-now 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-part-d-then-and-now 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-phrmas-comments-on-new-direction-for-cmmi 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-positive-impact-of-part-d-on-americas-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-progress-in-fight-against-diabetes-is-one-more-thing-to-be-thankful-for-this-year 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-protecting-beneficiaries-who-receive-extra-help 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-provider-consolidation-drives-up-costs-for-patients-and-government 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-providing-value-to-beneficiaries 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-putting-medpacs-19-in-context 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-same-bad-ideas-continue-to-threaten-part-d-and-beneficiary-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-a-short-video-on-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-stakeholders-raise-concern-with-medpacs-proposed-changes-to-drug-purchasing-program 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-strengthening-access-to-vaccines-for-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-study-finds-mortality-rates-for-elderly-have-decreased-every-year-since-creation-of-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-tampering-with-the-successful-structure-of-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-the-downside-of-one-size-fits-all-treatment-for-patients-managing-mental-health-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-the-importance-of-shopping-around-for-your-part-d-plan-this-thanksgiving 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-theres-an-agency-called-medpac 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-upcoming-on-the-medicare-calendar 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-a-one-size-fits-all-treatment-means-for-arthritis-patients-and-quality-of-life 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-actually-happened-with-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-does-medicare-part-b-cover 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-goes-into-part-d-premiums 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-is-the-extra-help-program 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-part-d-extra-help-means-to-patients-like-diane 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-the-experts-are-saying-about-the-independent-payment-advisory-board 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-they-are-saying-about-medpacs-part-b-recommendations 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-they-are-saying-about-medpacs-recommendations 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-they-are-saying-about-negotiation-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-theyre-saying-about-the-cms-proposed-part-b-payment-model 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-you-need-to-know-about-part-d-appeals 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-who-benefits-from-part-d-extra-help 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-who-qualifies-for-part-d-extra-help 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-why-average-sales-price-works 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-why-changing-the-structure-of-part-d-could-hurt-beneficiary-access 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-why-imposing-medicaid-style-rebates-in-part-d-is-a-bad-idea 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-why-medicaid-style-rebates-arent-good-for-part-d-beneficiaries-or-the-program 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-why-part-d-extra-help-matters-for-patients-like-mateo 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-negotiation-proposals-threaten-americans-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-part-d-cliff-ahead 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-part-d-continues-to-be-a-success 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-part-ds-six-protected-classes 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-celebrating-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-did-you-know-four-out-of-five-part-d-prescriptions-are-generic 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-how-part-d-helps-save-lives 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-managing-chronic-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-medicare-part-d-and-adherence-help-high-cholesterol-patients-save 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-medication-therapy-management-in-part-d-another-potential-opportunity-for-savings 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-more-medicines-in-development-for-older-americans 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-research-on-how-successfully-managing-diabetes-helps-patients-and-part-d-save 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-new-video-how-patients-benefit-from-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-is-cmmi 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-why-the-independent-payment-advisory-board-is-bad-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/medicares-55th-anniversary-celebrating-the-success-of-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/medicine-spending-relatively-stable-following-increased-regulatory-data-protection-in-canada-and-japan 2026-04-03 daily 0.8 https://phrma.org/blog/medicines-are-part-of-the-solution 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-nearly-300-cell-and-gene-therapies-in-development 2026-04-03 daily 0.8 https://phrma.org/blog/medpac-proposal-threatens-access-to-medicines-in-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/meet-mat-5-things-to-know-about-phrmas-new-medicine-assistance-tool 2026-04-03 daily 0.8 https://phrma.org/blog/meet-the-chart-pack 2026-04-03 daily 0.8 https://phrma.org/blog/meeting-tomorrow-looking-ahead-to-pdufa-vii 2026-04-03 daily 0.8 https://phrma.org/blog/mental-health-awareness-month-fighting-the-growing-mental-health-crisis-and-supporting-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/mental-health-awareness-month-supporting-loved-ones-and-improving-mental-health-in-america 2026-04-03 daily 0.8 https://phrma.org/blog/mental-illness-awareness-week-a-time-for-reflection 2026-04-03 daily 0.8 https://phrma.org/blog/mental-health-in-the-new-era-of-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/mercks-dr-julie-gerberding-on-the-threat-of-antimicrobial-resistance-and-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/michigan-proposal-jeopardizes-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/minority-health-matters 2026-04-03 daily 0.8 https://phrma.org/blog/misuse-of-march-in-could-stifle-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/modernizing-fda-regulations-to-advance-a-value-driven-health-care-system 2026-04-03 daily 0.8 https://phrma.org/blog/more-than-60-researchers-advocate-on-capitol-hill 2026-04-03 daily 0.8 https://phrma.org/blog/more-than-60-researchers-ask-congress-to-support-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-more-attention-to-adequacy-of-health-insurance-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/more-counterfeit-medicines-follow-up 2026-04-03 daily 0.8 https://phrma.org/blog/more-evidence-that-medicine-prices-are-growing-at-slowest-rate-in-decades 2026-04-03 daily 0.8 https://phrma.org/blog/more-than-240-immuno-oncology-treatments-in-development-to-fight-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/more-than-430-medicines-in-development-to-treat-chronic-diseases-affecting-older-americans 2026-04-03 daily 0.8 https://phrma.org/blog/more-than-800-medicines-are-in-development-for-diseases-that-disproportionately-affect-racial-and-ethnic-communities 2026-04-03 daily 0.8 https://phrma.org/blog/myth-vs-fact-polling-and-medicare-negotiation 2026-04-03 daily 0.8 https://phrma.org/blog/myth-vs-fact-the-senates-latest-price-setting-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/nafta-tribunal-fails-to-rule-on-canadas-patent-utility-doctrine 2026-04-03 daily 0.8 https://phrma.org/blog/national-drug-take-back-day 2026-04-03 daily 0.8 https://phrma.org/blog/national-medicare-education-week-the-history-of-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/navigating-the-patient-experience-burdens-and-barriers-standing-between-patients-and-their-care 2026-04-03 daily 0.8 https://phrma.org/blog/navigating-the-patient-experience-survey-protecting-lifelines-to-access-and-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/navigating-the-patient-experience-in-the-time-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/nearly-140-medicines-in-development-to-treat-mental-illness 2026-04-03 daily 0.8 https://phrma.org/blog/nearly-40-of-commercially-insured-patients-face-half-their-annual-out-of-pocket-expenses-from-just-one-health-care-encounter 2026-04-03 daily 0.8 https://phrma.org/blog/nearly-400-cell-and-gene-therapies-in-development-to-target-a-broad-range-of-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/nearly-50-of-brand-medicine-spending-goes-to-the-supply-chain-and-others 2026-04-03 daily 0.8 https://phrma.org/blog/nearly-60-biopharmaceutical-researchers-goboldly-on-capitol-hill 2026-04-03 daily 0.8 https://phrma.org/blog/negotiators-must-say-aloha-to-a-21st-century-trade-deal 2026-04-03 daily 0.8 https://phrma.org/blog/never-too-late-to-plan-for-retirement 2026-04-03 daily 0.8 https://phrma.org/blog/new-340b-mega-guidance 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-accelerated-approval-pathway-is-changing-lives-in-underserved-communities 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-of-patient-access-restrictions-in-the-united-kingdom 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-shows-pbms-use-fees-as-a-profit-center 2026-04-03 daily 0.8 https://phrma.org/blog/new-comments-outline-ways-to-protect-patients-from-health-plans-and-pbms-who-profit-from-patient-assistance 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-how-insurers-and-middlemen-shift-rx-costs-onto-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-the-340b-program-is-driving-up-costs-for-patients-and-our-health-care-system 2026-04-03 daily 0.8 https://phrma.org/blog/new-government-price-setting-policy-threatens-post-approval-research 2026-04-03 daily 0.8 https://phrma.org/blog/new-paper-addressing-the-growing-crisis-of-mental-health-and-substance-use-disorders 2026-04-03 daily 0.8 https://phrma.org/blog/new-pes-survey-out-of-pocket-costs-lead-key-health-care-priorities-ahead-of-the-november-election 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-ad-campaign-sheds-light-on-pbm-abuses 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-ad-exposes-yet-another-way-pbms-get-between-patients-and-their-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-site-demonstrates-how-a-technology-driven-health-care-system-brings-benefits-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-poll-shows-strong-bipartisan-support-for-pbm-reform 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-adds-to-questions-about-nonprofit-status-of-340b-hospitals 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-ignores-benefits-of-patent-system-to-innovation-and-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-more-than-160-medicines-in-development-for-mental-illness 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-nearly-800-medicines-in-development-to-treat-chronic-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/read-more 2026-04-03 daily 0.8 https://phrma.org/blog/new-social-determinants-of-health-simulation-explores-structural-barriers-patients-face-accessing-and-affording-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/new-studies-add-to-body-of-evidence-questioning-340b-efficacy 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-finds-insurers-and-pbms-increasing-access-restrictions-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/new-survey-insurers-confirm-ira-will-reduce-patient-treatment-options 2026-04-03 daily 0.8 https://phrma.org/blog/new-2010-randd-numbers-demonstrate-our-commitment 2026-04-03 daily 0.8 https://phrma.org/blog/new-340b-analysis-hospitals-raking-in-billions-while-uncompensated-care-drops-by-billions 2026-04-03 daily 0.8 https://phrma.org/blog/new-academic-initiative-aims-to-inform-approaches-to-value-assessment-frameworks 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-adds-to-research-questioning-whether-340b-is-working-as-congress-intended 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-confirms-hospitals-markup-prices-for-oncology-therapies 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-finds-340b-medicine-sales-hit-record-high-in-2017-and-continue-to-grow-as-a-share-of-total-drug-spending 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-finds-average-sales-price-system-has-led-to-significant-cost-savings-for-medicare-and-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-finds-deeper-impact-of-drug-pricing-bill-on-biopharmaceutical-researchers 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-finds-stark-difference-in-coverage-of-breast-cancer-medicines-for-seniors-in-the-united-states-and-england 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-government-intervention-in-part-b-threatens-patient-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-in-health-affairs-reinforces-one-third-of-medicine-list-price-rebated-back-to-supply-chain 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-midyear-formulary-changes-in-marketplace-plans-can-significantly-reduce-access-to-needed-medications-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-more-than-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-full-list-price 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-shows-negative-impact-of-icers-value-framework-on-patient-access-in-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-shows-that-hta-organizations-may-frequently-restrict-access-to-cancer-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/new-avalere-study-health-plan-formularies-continue-to-suggest-bias-against-individuals-with-certain-health-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/new-chart-pack-advancing-innovative-treatment-options-for-patients-through-personalized-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/new-chart-pack-big-strides-in-fight-against-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/new-chart-pack-biopharmaceuticals-in-government-programs 2026-04-03 daily 0.8 https://phrma.org/blog/new-comments-outline-ways-to-counteract-cost-shifting-insurance-trends 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-commonwealth-fund-study-shows-health-insurance-does-not-always-translate-to-affordable-care 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-covid-19-vaccine-global-production-capacity-projected-to-exceed-20-billion-doses-this-year 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-from-insurers-show-detriments-of-copay-accumulator-adjustment-programs 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-on-health-insurance-exchange-plans-shows-cost-sharing-increasing-for-some-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-put-medicine-costs-and-spending-in-context 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-commercially-insured-patients-face-increasingly-high-cost-sharing-for-brand-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-continued-decline-in-death-rates-for-cancer-patients-related-to-treatment-advances 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-how-icers-value-framework-could-prevent-or-delay-access-to-treatments-for-medicaid-patients-across-the-country 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-how-sharing-negotiated-discounts-could-save-certain-patients-hundreds-of-dollars-at-the-pharmacy-counter 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-patients-out-of-pocket-costs-are-rising-faster-than-their-insurers-costs 2026-04-03 daily 0.8 https://phrma.org/blog/new-data-show-retail-medicine-prices-fell-in-2019 2026-04-03 daily 0.8 https://phrma.org/blog/new-documentary-highlights-tremendous-advances-in-cancer-treatment 2026-04-03 daily 0.8 https://phrma.org/blog/new-efforts-to-spur-needed-civil-justice-reform 2026-04-03 daily 0.8 https://phrma.org/blog/new-evidence-of-discrimination-in-essential-health-benefit-plans 2026-04-03 daily 0.8 https://phrma.org/blog/new-gao-report-some-hospitals-participating-in-340b-may-not-be-eligible-for-the-program 2026-04-03 daily 0.8 https://phrma.org/blog/new-graphic-public-private-collaboration-fuels-the-u-s-biopharmaceutical-ecosystem 2026-04-03 daily 0.8 https://phrma.org/blog/new-infographic-how-we-are-fighting-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/new-infographic-medicines-cut-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/new-initiative-to-bridge-the-gap-on-antimicrobial-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/new-iqvia-data-show-medicine-prices-grew-just-1-5-percent-in-2018 2026-04-03 daily 0.8 https://phrma.org/blog/new-law-overrules-state-supreme-courts-innovator-liability-decision 2026-04-03 daily 0.8 https://phrma.org/blog/new-lets-talk-about-cost-ads-highlight-how-copay-accumulator-programs-could-leave-patients-financially-exposed 2026-04-03 daily 0.8 https://phrma.org/blog/new-lets-talk-about-cost-campaign-convenes-national-dialogue-on-medicine-costs 2026-04-03 daily 0.8 https://phrma.org/blog/new-lets-talk-about-cost-tv-ad-asks-why-arent-patients-sharing-in-savings-at-the-pharmacy-counter 2026-04-03 daily 0.8 https://phrma.org/blog/new-lets-talk-about-medicare-campaign-focuses-on-solutions-to-improve-affordability-and-predictability-for-seniors-in-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/new-medicines-are-part-of-the-solution-to-hold-down-future-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/new-medicines-the-long-path-to-approval 2026-04-03 daily 0.8 https://phrma.org/blog/new-nhe-data-show-the-true-picture-of-health-care-spending 2026-04-03 daily 0.8 https://phrma.org/blog/new-non-discrimination-rule-neglects-to-define-discriminatory-benefits 2026-04-03 daily 0.8 https://phrma.org/blog/new-nonprofit-i-act-for-children-launches-to-promote-innovative-medicines-development-for-young-patients-in-need 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-and-epilepsy-foundation-report-420-medicines-in-development-for-neurological-disorders 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-report-836-medicines-and-vaccines-in-development-to-treat-cancers 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-report-medicines-in-development-offer-hope-for-osteoporosis-patients-and-families 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-resources-chock-full-of-biopharma-industry-facts 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-scholars-program-provides-support-to-exceptional-college-bound-dc-students 2026-04-03 daily 0.8 https://phrma.org/blog/higher-deductibles-and-more-dissatisfaction-with-health-plans-according-to-new-poll 2026-04-03 daily 0.8 https://phrma.org/blog/new-poll-finds-majority-of-voters-oppose-government-price-setting-for-prescription-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/new-poll-of-all-50-states-and-435-congressional-districts-shows-perils-of-so-called-medicare-negotiation 2026-04-03 daily 0.8 https://phrma.org/blog/new-poll-shows-americans-reject-medicare-negotiation-once-they-learn-more-about-the-policy 2026-04-03 daily 0.8 https://phrma.org/blog/new-poll-shows-voters-sounding-the-alarm-on-health-insurance-companies-and-pbms 2026-04-03 daily 0.8 https://phrma.org/blog/new-poll-76-of-voters-concerned-speaker-pelosis-plan-would-result-in-fewer-new-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/new-polling-shows-americans-are-sounding-the-alarm-on-the-trips-ip-waiver 2026-04-03 daily 0.8 https://phrma.org/blog/new-prescription-for-medicare-campaign-focuses-on-impacts-of-wrong-and-right-solutions-for-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-advanced-manufacturing-powering-innovative-biopharmaceuticals 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-and-event-examine-the-new-era-of-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-biopharmaceutical-industry-supports-over-4-million-jobs-and-1-1-trillion-in-u-s-economic-output 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-celebrates-a-decade-of-progress-in-chronic-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-clinical-trials-and-the-impact-on-state-economies 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-confirms-competitive-market-works-net-prices-for-medicines-increased-just-2-8-percent-in-2015 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-decade-of-breakthroughs-in-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-demonstrates-development-of-new-medicines-relies-on-private-sector-expertise-and-investment 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-demonstrates-the-growing-importance-of-partnerships-in-advancing-biomedical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-details-the-promise-of-the-biopharmaceutical-pipeline 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-details-the-setbacks-and-challenges-to-alzheimers-research 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-eliminating-hepatitis-c-today-could-reduce-future-u-s-health-care-spending-by-115-billion-over-the-next-decade 2026-04-03 daily 0.8 https://phrma.org/blog/medicines-have-significantly-increased-chances-of-cancer-survival-around-the-globe 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-finds-15-new-oncology-therapies-launched-last-year 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-forecasts-for-specialty-medicines-have-been-overstated 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-highlights-a-decade-of-innovation-in-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/report-highlights-biopharmaceutical-industrys-commitment-to-dandi 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-highlights-impact-of-intellectual-property-on-u-s-economy 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-highlights-more-than-250-vaccines-in-development 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-highlights-need-to-speed-patent-examination 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-innovation-in-the-biopharmaceutical-randd-process-adapting-to-a-changing-environment 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-nearly-800-new-medicines-in-development-to-treat-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-part-b-proposal-is-more-aggressive-than-previous-efforts 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-portrays-flourishing-pipeline 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-provides-recommendations-for-securing-and-protecting-ip 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-nearly-20-innovative-medicines-in-development-for-sickle-cell-disease 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-200-medicines-in-development-for-heart-disease-and-stroke 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-better-diabetes-management-saves-money-and-improves-patient-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-more-than-160-medicines-in-development-for-diabetes-and-related-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-more-than-260-medicines-in-development-to-fight-neurodegenerative-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-more-than-300-skin-disease-medicines-in-development 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-over-500-medicines-in-development-for-neurological-disorders 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-past-drug-failures-aid-in-the-fight-against-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-the-biopharmaceutical-industrys-sustained-commitment-to-inspiring-and-advancing-tomorrows-stem-workforce 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-using-march-in-authority-would-jeopardize-u-s-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/new-reports-shed-light-on-key-facts-about-medicines-and-affordability 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-access-and-quality-implications-of-cms-proposed-part-b-model 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-shows-changes-to-the-six-protected-classes-would-harm-most-vulnerable-patients-and-are-unnecessary 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-finds-gaps-in-charity-care-provided-by-340b-hospitals 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-highlights-gaps-in-quality-measures-for-cancer-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-insurance-plan-structure-can-have-discriminatory-effect 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-shows-hotspots-of-inequity-relate-to-increased-covid-19-hospitalizations 2026-04-03 daily 0.8 https://phrma.org/blog/new-spanish-language-resources-added-to-abcs-en-espanol 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-finds-hospitals-continue-to-push-patients-to-costlier-outpatient-settings 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-finds-more-than-half-of-brand-medicine-spending-goes-to-the-supply-chain-and-others 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-finds-some-hospitals-mark-up-medicine-prices-at-least-700-percent 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-illustrates-biopharmaceutical-industrys-commitment-to-personalized-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-policy-environment-has-a-significant-impact-on-biopharmaceutical-investment 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-substantial-rebates-negotiated-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/new-survey-patients-share-of-health-care-costs-continues-to-grow 2026-04-03 daily 0.8 https://phrma.org/blog/new-survey-voters-seriously-concerned-about-fine-print-in-reconciliation-bill 2026-04-03 daily 0.8 https://phrma.org/blog/new-surveys-find-payers-and-providers-want-more-data-from-biopharmaceutical-companies 2026-04-03 daily 0.8 https://phrma.org/blog/new-video-clinical-trials-serve-as-engine-for-local-economic-growth 2026-04-03 daily 0.8 https://phrma.org/blog/new-video-how-medicines-can-curb-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/new-video-patient-and-researcher-fight-jra-together 2026-04-03 daily 0.8 https://phrma.org/blog/new-video-saving-lives-and-building-for-the-future 2026-04-03 daily 0.8 https://phrma.org/blog/new-video-see-how-strong-ip-protections-lead-to-stronger-treatments-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-video-why-changes-to-the-340b-program-are-essential-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-white-paper-recognizing-emerging-value-in-oncology-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/new-whitepaper-identifies-limitations-in-using-icers-potential-budget-impact-work-to-guide-private-payer-budget-decisions 2026-04-03 daily 0.8 https://phrma.org/blog/new-whitepaper-identifies-reasons-why-icers-cost-effectiveness-analyses-are-not-useful-for-payers 2026-04-03 daily 0.8 https://phrma.org/blog/newly-implemented-expanded-access-principles-support-commitment-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/nhe-data-medicine-spending-grew-just-1-3-percent-in-2016 2026-04-03 daily 0.8 https://phrma.org/blog/no-region-left-behind-ustr-expands-its-unambitious-trade-agenda-to-the-western-hemisphere 2026-04-03 daily 0.8 https://phrma.org/blog/340b-spotlight-new-study-raises-questions-about-whether-non-profit-hospitals-are-meeting-charity-care-requirements-in-affordable-care-act 2026-04-03 daily 0.8 https://phrma.org/blog/no-two-patients-with-high-cholesterol-are-the-same-meet-sheryl-and-bill 2026-04-03 daily 0.8 https://phrma.org/blog/nord-on-the-need-for-more-collaboration-to-drive-progress-for-rare-disease-patients 2026-04-03 daily 0.8 https://phrma.org/blog/number-of-value-based-contracts-continues-to-rise 2026-04-03 daily 0.8 https://phrma.org/blog/observing-national-minority-health-month-in-the-age-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/oig-proposed-rule-could-help-strengthen-the-part-d-market 2026-04-03 daily 0.8 https://phrma.org/blog/one-year-later-iras-unintended-consequences-are-becoming-reality 2026-04-03 daily 0.8 https://phrma.org/blog/one-year-to-election-day-four-voter-priorities-to-watch 2026-04-03 daily 0.8 https://phrma.org/blog/ongoing-federal-probes-shed-light-on-pbm-and-insurer-practices 2026-04-03 daily 0.8 https://phrma.org/blog/open-enrollment-how-to-find-a-medicare-plan-that-meets-your-needs 2026-04-03 daily 0.8 https://phrma.org/blog/opening-the-conversation-around-mental-health-treatment-with-advocates-and-industry-leaders 2026-04-03 daily 0.8 https://phrma.org/blog/opportunities-to-build-upon-enhanced-competition-for-medicines-in-the-marketplace 2026-04-03 daily 0.8 https://phrma.org/blog/optumrx-sharing-rebates-with-patients-is-worth-it 2026-04-03 daily 0.8 https://phrma.org/blog/oregons-hb-4005-fails-to-deliver-savings-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/our-commitment-to-advancing-patient-centered-payment-models 2026-04-03 daily 0.8 https://phrma.org/blog/our-commitment-to-turning-the-tide-against-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/our-continued-commitment-to-combating-ebola 2026-04-03 daily 0.8 https://phrma.org/blog/our-three-part-approach-to-build-a-better-health-care-system 2026-04-03 daily 0.8 https://phrma.org/blog/ours-is-a-global-community 2026-04-03 daily 0.8 https://phrma.org/blog/outdated-fda-regulations-discourage-development-and-dissemination-of-healthcare-economic-data-to-support-value-based-healthcare 2026-04-03 daily 0.8 https://phrma.org/blog/over-500-billion-invested-in-randd-by-phrma-member-companies-since-2000 2026-04-03 daily 0.8 https://phrma.org/blog/pacira-settlement-important-step-towards-ensuring-clinicians-have-access-to-the-best-available-data-on-fda-approved-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/panel-releases-best-practices-in-cost-effectiveness-analysis 2026-04-03 daily 0.8 https://phrma.org/blog/paper-finds-gaps-in-health-data-are-a-barrier-to-health-equity 2026-04-03 daily 0.8 https://phrma.org/blog/part-b-101-three-charts-show-the-program-helps-control-costs-for-health-care-system-and-enrollees 2026-04-03 daily 0.8 https://phrma.org/blog/part-d-101-three-charts-show-how-the-program-provides-comprehensive-prescription-drug-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/partnership-for-prescription-assistance-celebrates-10th-anniversary 2026-04-03 daily 0.8 https://phrma.org/blog/partnerships-are-driving-global-covid-19-treatment-access 2026-04-03 daily 0.8 https://phrma.org/blog/pass-through-rebates-do-not-violate-non-interference-clause-but-they-do-increase-savings-for-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/past-free-trade-agreements-provide-valuable-lessons-for-future-success 2026-04-03 daily 0.8 https://phrma.org/blog/patent-policy-changes-proposed-by-uspto-and-fda-would-leave-patients-behind 2026-04-03 daily 0.8 https://phrma.org/blog/patent-settlements-benefit-consumers 2026-04-03 daily 0.8 https://phrma.org/blog/patents-more-important-to-biopharmaceutical-sector-than-other-industries 2026-04-03 daily 0.8 https://phrma.org/blog/patient-priorities-in-the-2024-election 2026-04-03 daily 0.8 https://phrma.org/blog/patient-profile-out-of-pocket-cost-burden-for-patients-treating-hivaids 2026-04-03 daily 0.8 https://phrma.org/blog/patient-profile-out-of-pocket-cost-burden-for-patients-treating-mental-health-conditions 2026-04-03 daily 0.8 https://phrma.org/blog/patient-profile-out-of-pocket-cost-burden-for-rheumatoid-arthritis-patient 2026-04-03 daily 0.8 https://phrma.org/blog/patient-safety-demands-that-drug-compounders-comply-with-law 2026-04-03 daily 0.8 https://phrma.org/blog/patient-safety-is-at-the-heart-of-covid-19-vaccine-randd 2026-04-03 daily 0.8 https://phrma.org/blog/patient-voices-missing-from-media-conversation-about-prescription-drug-abuse 2026-04-03 daily 0.8 https://phrma.org/blog/patients-and-innovators-lose-if-the-government-pursues-march-in 2026-04-03 daily 0.8 https://phrma.org/blog/patients-and-researchers-say-were-fighting-back-in-new-from-hope-to-cures-ads 2026-04-03 daily 0.8 https://phrma.org/blog/patients-need-to-pay-less-for-their-medicines-states-can-help 2026-04-03 daily 0.8 https://phrma.org/blog/patients-pay-the-price-when-hospitals-mark-up-cancer-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/patients-support-state-action-requiring-pbms-and-insurers-to-share-savings-and-cap-costs-for-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/patients-theyre-at-the-table-its-about-time-to-ask-them-what-should-be-served 2026-04-03 daily 0.8 https://phrma.org/blog/patients-win-as-west-virginia-implements-first-in-nation-share-the-savings-policy 2026-04-03 daily 0.8 https://phrma.org/blog/patients-with-a-deductible-have-seen-their-out-of-pocket-costs-for-brand-medicines-increase-50-percent-since-2014 2026-04-03 daily 0.8 https://phrma.org/blog/paving-the-way-for-better-cancer-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/payers-subject-80-of-new-ra-and-ms-patients-to-utilization-management-restrictions 2026-04-03 daily 0.8 https://phrma.org/blog/paying-for-personalized-medicine-protecting-the-future-of-patient-centered-cancer-care 2026-04-03 daily 0.8 https://phrma.org/blog/pbms-and-insurers-off-the-hook-sen-sanders-selective-hearing-on-drug-costs 2026-04-03 daily 0.8 https://phrma.org/blog/pbms-using-340b-program-to-drive-profits-at-patients-expense 2026-04-03 daily 0.8 https://phrma.org/blog/pdufa-and-bsufa-reauthorizations-are-wins-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/pdufa-101 2026-04-03 daily 0.8 https://phrma.org/blog/pdufa-still-a-weird-word-worth-knowing 2026-04-03 daily 0.8 https://phrma.org/blog/pdufa-vii-is-critical-for-future-biopharmaceutical-innovation-and-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/pelosis-radical-plan-leaves-lung-cancer-patients-behind 2026-04-03 daily 0.8 https://phrma.org/blog/pelosis-radical-plan-would-leave-als-patients-behind 2026-04-03 daily 0.8 https://phrma.org/blog/pelosis-radical-plan-would-leave-alzheimers-patients-behind 2026-04-03 daily 0.8 https://phrma.org/blog/pelosis-radical-plan-would-leave-patients-with-rare-pediatric-diseases-behind 2026-04-03 daily 0.8 https://phrma.org/blog/pelosis-radical-plan-would-leave-patients-with-sickle-cell-disease-behind 2026-04-03 daily 0.8 https://phrma.org/blog/personalized-medicine-the-next-health-frontier 2026-04-03 daily 0.8 https://phrma.org/blog/pharmaceutical-industry-increases-investment-in-neglected-tropical-diseases-by-28 2026-04-03 daily 0.8 https://phrma.org/blog/phased-in-approach-offers-best-hope-for-fdas-proposed-quality-metrics-program 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-awards-grant-to-emerson-diversity-health-foundation 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-awards-grants-to-2023-annual-pathways-to-success-graduate-summit-partners 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-awards-grants-to-2024-annual-pathways-to-success-virtual-stem-career-expo-partners 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-launches-education-campaign-on-the-benefits-of-americas-ip-system 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-launches-new-ad-in-campaign-exposing-ways-middlemen-drive-up-costs 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-otorga-beca-a-la-emerson-diversity-health-foundation 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-provides-comments-and-testimony-to-usitc-investigation-on-covid-19-medicines-and-the-trips-agreement 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-provides-grant-funding-to-support-the-morehouse-school-of-medicine-satcher-health-leadership-institutes-health-equity-tracker 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-responds-to-senate-todays-340b-program-leaves-patients-behind-phrma 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submission-to-ustr-calls-for-urgent-defense-of-american-innovation-abroad 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submission-ustr-needs-more-ambition-to-combat-unfair-trade-barriers 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-to-ostp-on-enhancing-clinical-trial-diversity 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-to-uspto-highlighting-important-role-of-patent-system-in-medicine-development 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-urges-hrsa-not-to-impede-new-340b-pricing-approaches-to-improve-transparency-and-integrity 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-and-bio-citizen-petition-to-fda-calls-for-biosimilar-labeling-guidance 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-and-bio-release-joint-principles-on-communications-with-health-care-professionals-and-payers 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-cares-grant-request-for-proposals-addressing-racial-disparities-in-medication-utilization-and-adherence 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-ceo-discusses-industrys-new-approach-to-dtc-television-advertising 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-ceo-in-forbes-how-to-negotiate-better-deals-for-prescription-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-ceo-statement-following-meeting-with-president-trump 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-comments-in-response-to-request-for-information-on-competitive-bidding-program-in-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-comments-on-hhs-proposed-rule-on-manufacturer-cost-sharing-assistance-and-accumulator-adjustment-programs 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-comments-on-oig-proposed-rule-to-reform-the-rebate-system 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-comments-to-administration-on-international-pricing-index-model 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-comments-to-administration-on-medicare-part-d-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-comments-to-congress-on-cures-2-0-call-to-action 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-encourages-biden-administration-to-pursue-ambitious-indo-pacific-economic-framework 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-foundation-2015-in-review 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-foundation-celebrates-50-years-launching-scientific-careers 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-foundation-launches-new-web-platform 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-foundation-recognizes-inaugural-challenge-award-recipients 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-honors-research-and-hope-award-recipients 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-hosts-first-stakeholder-workshop-on-clinical-trial-diversity 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-launches-biologics-and-biosimilars-online-resources 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-launches-new-consumer-facing-lets-talk-about-cost-website 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-and-lls-more-than-240-medicines-in-development-for-blood-cancers 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-invested-51-2-billion-in-randd-in-2014 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-invested-58-8-billion-in-randd-in-2015 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-invested-83-billion-in-research-and-development-last-year 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-invested-nearly-80-billion-in-randd-last-year 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-randd-investments-hit-record-high-in-2017-71-4-billion 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-member-companies-share-how-they-are-improving-clinical-trial-diversity 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-presents-research-at-ispor-2022 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-releases-2021-industry-profile 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-responds-to-floridas-request-for-information-on-drug-importation 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-response-to-washington-post-and-60-minutes-stories 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-statement-on-energy-and-commerce-health-subcommittee-340b-hearing 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-statement-on-medicare-drug-spending-dashboard 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-statement-on-presidents-fy2017-budget 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submission-to-hhs-on-blueprint-to-lower-drug-prices-and-reduce-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submission-to-2020-national-trade-estimate-report-urgent-action-required-to-protect-u-s-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-on-cmss-part-d-specialty-tier-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-on-fdas-proposed-rule-on-drug-importation 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-on-ways-to-refocus-the-340b-program-on-americas-vulnerable-patients 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-to-cms-on-medicaid-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-to-cms-on-policy-changes-for-in-home-care-under-part-b-during-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-submits-comments-urging-cms-to-withdraw-coverage-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-supports-presidents-commissions-holistic-approach-on-opioid-crisis 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-urges-cms-to-share-the-savings-with-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-urges-ustr-to-protect-american-innovators-abroad 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-webcast-to-examine-progress-and-promise-of-alzheimers-research 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-will-continue-to-advocate-for-equity-within-our-industry 2026-04-03 daily 0.8 https://phrma.org/blog/phrmas-change-agents-bring-awareness-and-value-of-hbcus-and-their-impact-to-stem 2026-04-03 daily 0.8 https://phrma.org/blog/phrmas-john-castellani-gives-attendees-a-2015-leukemia-ball-sneak-peek 2026-04-03 daily 0.8 https://phrma.org/blog/phrmas-lori-reilly-joined-csg-to-discuss-the-industrys-response-to-covid-19-and-what-it-means-for-states 2026-04-03 daily 0.8 https://phrma.org/blog/physicians-deserve-timely-authoritative-risk-information-for-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/placing-innovation-at-the-forefront-of-the-u-s-trade-agenda 2026-04-03 daily 0.8 https://phrma.org/blog/policies-need-to-address-the-growing-threat-of-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/policies-to-combat-prescription-drug-abuse-and-misuse 2026-04-03 daily 0.8 https://phrma.org/blog/poll-respondents-appreciate-economic-benefits-of-innovation-and-call-for-more-protections 2026-04-03 daily 0.8 https://phrma.org/blog/polling-continues-to-show-voters-reject-so-called-medicare-negotiation-once-they-learn-about-consequences-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/post-approval-research-save-lives-why-is-congress-trying-disincentivize-it 2026-04-03 daily 0.8 https://phrma.org/blog/potential-gene-therapies-bring-hope-to-patients-with-sickle-cell-disease 2026-04-03 daily 0.8 https://phrma.org/blog/powering-the-next-generation-of-therapies-a-conversation-with-astellas-us-president-mark-reisenauer 2026-04-03 daily 0.8 https://phrma.org/blog/ppa-2016-in-review 2026-04-03 daily 0.8 https://phrma.org/blog/ppa-connects-nearly-10-million-people-celebrates-11th-anniversary-and-launches-mobile-app 2026-04-03 daily 0.8 https://phrma.org/blog/ppa-celebrates-13-years-of-helping-patients-access-their-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/ppa-more-than-just-prescription-assistance 2026-04-03 daily 0.8 https://phrma.org/blog/ppa-spread-the-word 2026-04-03 daily 0.8 https://phrma.org/blog/prescription-drug-lifecycle-helps-health-care-spending-hit-record-low 2026-04-03 daily 0.8 https://phrma.org/blog/prescription-drug-prices-are-not-fueling-inflation 2026-04-03 daily 0.8 https://phrma.org/blog/preserving-u-s-innovation-worldwide-is-more-important-than-ever 2026-04-03 daily 0.8 https://phrma.org/blog/preventing-the-next-public-health-emergency-new-evidence-demonstrates-need-to-address-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/prime-minister-abes-visit-is-an-important-step-toward-strengthening-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/prime-minister-modis-u-s-visit-a-prime-opportunity-to-strengthen-u-s-india-ties 2026-04-03 daily 0.8 https://phrma.org/blog/profiles-in-courage-latinos-in-the-fight-against-alzheimers 2026-04-03 daily 0.8 https://phrma.org/blog/proposed-change-to-medicaid-line-extension-definition-ignores-importance-of-critical-improvements-in-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/proposed-quality-metrics-program-raises-operability-questions 2026-04-03 daily 0.8 https://phrma.org/blog/protect-your-health-important-disaster-preparedness-tips-for-harvey-and-irma 2026-04-03 daily 0.8 https://phrma.org/blog/protecting-treatment-advances-for-breast-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/protecting-medicare-from-government-interference 2026-04-03 daily 0.8 https://phrma.org/blog/protecting-medicare-part-ds-extra-help-program 2026-04-03 daily 0.8 https://phrma.org/blog/protecting-patients-from-dangerous-counterfeit-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/protecting-u-s-innovation-abroad-to-support-economic-and-pandemic-recovery 2026-04-03 daily 0.8 https://phrma.org/blog/providing-affordable-access-to-medicines-in-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/putting-delaware-patients-first-protecting-patient-assistance-programs 2026-04-03 daily 0.8 https://phrma.org/blog/putting-2014-figures-on-prescription-drug-spending-in-context 2026-04-03 daily 0.8 https://phrma.org/blog/putting-patients-at-the-center-of-the-clinical-pathways-debate 2026-04-03 daily 0.8 https://phrma.org/blog/putting-the-bio-in-biotech-how-bay-area-minds-are-powering-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/putting-the-cost-of-medicines-in-context 2026-04-03 daily 0.8 https://phrma.org/blog/putting-the-ims-health-global-forecast-on-prescription-medicines-in-perspective 2026-04-03 daily 0.8 https://phrma.org/blog/putting-your-health-first-for-the-greater-good 2026-04-03 daily 0.8 https://phrma.org/blog/ra-medicines-often-demonstrate-far-greater-benefits-to-patients-than-initially-understood 2026-04-03 daily 0.8 https://phrma.org/blog/rare-but-equal 2026-04-03 daily 0.8 https://phrma.org/blog/rare-disease-community-loses-a-champion 2026-04-03 daily 0.8 https://phrma.org/blog/rare-disease-day-2020-progress-toward-cures 2026-04-03 daily 0.8 https://phrma.org/blog/rare-disease-day-accelerating-innovation-for-patients-in-need 2026-04-03 daily 0.8 https://phrma.org/blog/rare-disease-day-should-last-all-year 2026-04-03 daily 0.8 https://phrma.org/blog/rare-disease-day-unmet-medical-need-inspires-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/rare-disease-day-unmet-need-inspires-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/rarepov-conversation-generates-strong-enthusiasm-for-rare-disease-day-on-february-28th 2026-04-03 daily 0.8 https://phrma.org/blog/randd-focus-four-ways-the-biopharmaceutical-industry-leads-in-delivering-new-treatments-and-cures 2026-04-03 daily 0.8 https://phrma.org/blog/randd-focus-it-takes-an-ecosystem-to-deliver-innovative-new-therapies 2026-04-03 daily 0.8 https://phrma.org/blog/continuing-progress-and-promise-in-pediatric-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/the-biopharmaceutical-industrys-unique-role-in-responding-to-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/real-change-for-patients-with-gi-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/real-world-evidence-not-just-big-data 2026-04-03 daily 0.8 https://phrma.org/blog/reality-check-value-based-contracts-are-good-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/rebate-rule-would-help-ensure-seniors-with-diabetes-dont-pay-more-for-their-medicine-than-their-insurer 2026-04-03 daily 0.8 https://phrma.org/blog/recap-our-inaugural-graduate-summit-and-career-expo 2026-04-03 daily 0.8 https://phrma.org/blog/recent-events-highlight-progress-on-health-equity 2026-04-03 daily 0.8 https://phrma.org/blog/recent-administration-actions-undermine-patient-assistance-programs 2026-04-03 daily 0.8 https://phrma.org/blog/recent-polling-misrepresents-public-support-for-medicare-negotiation 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-national-glaucoma-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-national-sickle-cell-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-hepatitis-randd-on-world-hepatitis-day 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-lgbtq-pride-in-biopharmaceutical-science 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-national-immunization-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/record-number-of-personalized-medicines-approved-in-2017 2026-04-03 daily 0.8 https://phrma.org/blog/reflecting-on-mental-health-awareness-month 2026-04-03 daily 0.8 https://phrma.org/blog/reflecting-on-terrific-progress-in-treating-diabetes 2026-04-03 daily 0.8 https://phrma.org/blog/reimagining-patient-access-through-meaningful-policy-reform 2026-04-03 daily 0.8 https://phrma.org/blog/reject-efforts-to-undermine-americas-randd-ecosystem 2026-04-03 daily 0.8 https://phrma.org/blog/rejecting-icers-bad-advice 2026-04-03 daily 0.8 https://phrma.org/blog/repealing-part-d-noninterference-clause-threatens-access-and-choice-for-americas-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/report-corporate-venture-capital-is-catalyzing-groundbreaking-biomedical-innovation-in-the-united-states 2026-04-03 daily 0.8 https://phrma.org/blog/report-more-than-500-medicines-in-development-to-treat-disorders-of-the-blood 2026-04-03 daily 0.8 https://phrma.org/blog/report-more-than-600-medicines-in-development-for-diseases-affecting-women 2026-04-03 daily 0.8 https://phrma.org/blog/research-doesnt-end-on-a-medicines-approval 2026-04-03 daily 0.8 https://phrma.org/blog/researchers-bring-focus-on-science-and-medicine-to-californias-capital-city 2026-04-03 daily 0.8 https://phrma.org/blog/researchers-to-shine-light-on-biopharmaceutical-randd-with-policymakers 2026-04-03 daily 0.8 https://phrma.org/blog/resources-for-understanding-the-dangers-of-drug-importation 2026-04-03 daily 0.8 https://phrma.org/blog/responsible-clinical-trial-data-sharing-is-enhancing-science-and-improving-patient-health 2026-04-03 daily 0.8 https://phrma.org/blog/retail-medicine-spending-to-remain-stable-share-of-overall-health-care-spending-through-next-decade 2026-04-03 daily 0.8 https://phrma.org/blog/riyb-event-in-pennsylvania-spreads-awareness-of-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/blog/safe-and-effective-prescribing-a-new-and-important-initiative-from-the-phrma-foundation 2026-04-03 daily 0.8 https://phrma.org/blog/safe-drug-disposal-national-prescription-drug-take-back-days-and-other-year-round-opportunities 2026-04-03 daily 0.8 https://phrma.org/blog/saving-kids-and-dogs-from-shared-cancers 2026-04-03 daily 0.8 https://phrma.org/blog/sb-17-doesnt-address-pressing-prescription-drug-transparency-issues-for-ca-voters 2026-04-03 daily 0.8 https://phrma.org/blog/science-of-hope-incorporating-the-patient-perspective 2026-04-03 daily 0.8 https://phrma.org/blog/science-of-hope-learning-from-setbacks 2026-04-03 daily 0.8 https://phrma.org/blog/searching-for-success-in-als 2026-04-03 daily 0.8 https://phrma.org/blog/second-guessing-your-doctor-possible-barriers-to-access 2026-04-03 daily 0.8 https://phrma.org/blog/secretary-clintons-proposal-would-turn-back-the-clock-on-medical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/securely-dispose-of-your-unwanted-medicines-on-national-take-back-day 2026-04-03 daily 0.8 https://phrma.org/blog/seizing-the-opportunity-to-rebuild-u-s-leadership-in-stem 2026-04-03 daily 0.8 https://phrma.org/blog/senate-hearing-to-examine-bipartisan-reforms-to-rein-in-middlemen 2026-04-03 daily 0.8 https://phrma.org/blog/setting-the-record-straight-on-accelerated-approval 2026-04-03 daily 0.8 https://phrma.org/blog/setting-the-record-straight-on-the-bayh-dole-act-and-march-in 2026-04-03 daily 0.8 https://phrma.org/blog/setting-the-record-straight-addressing-common-misconceptions-about-the-covid-19-vaccine 2026-04-03 daily 0.8 https://phrma.org/blog/setting-the-record-straight-on-international-reference-pricing 2026-04-03 daily 0.8 https://phrma.org/blog/setting-the-story-straight-on-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/setting-up-a-pharmaceutical-manufacturing-supply-chain-is-a-complex-and-lengthy-process 2026-04-03 daily 0.8 https://phrma.org/blog/six-key-facts-about-the-market-for-insulins 2026-04-03 daily 0.8 https://phrma.org/blog/sharing-a-story-of-hope 2026-04-03 daily 0.8 https://phrma.org/blog/sharing-negotiated-discounts-at-the-pharmacy-counter-could-save-seniors-with-diabetes-more-than-350-annually 2026-04-03 daily 0.8 https://phrma.org/blog/sharing-rebates-can-improve-access-to-medicines-and-increase-health-equity 2026-04-03 daily 0.8 https://phrma.org/blog/shining-a-spotlight-on-mental-illness 2026-04-03 daily 0.8 https://phrma.org/blog/significant-progress-fighting-cancer-death-rate-has-dropped-25-percent 2026-04-03 daily 0.8 https://phrma.org/blog/six-ways-i-mak-is-lying-about-biopharma-patents 2026-04-03 daily 0.8 https://phrma.org/blog/six-policy-solutions-to-help-patients-afford-their-insulin 2026-04-03 daily 0.8 https://phrma.org/blog/some-health-insurance-exchange-plans-put-all-treatments-for-certain-diseases-on-top-cost-sharing-tier 2026-04-03 daily 0.8 https://phrma.org/blog/sparking-conversations-and-careers-at-the-2nd-annual-pathways-to-success-summit 2026-04-03 daily 0.8 https://phrma.org/blog/speaker-pelosis-drug-pricing-plan-could-result-in-56-fewer-new-medicines-over-10-years 2026-04-03 daily 0.8 https://phrma.org/blog/special-301-submission-calls-for-a-level-playing-field-for-american-innovators 2026-04-03 daily 0.8 https://phrma.org/blog/special-edition-medicare-monday-new-report-looks-at-medicare-negotiation-proposals 2026-04-03 daily 0.8 https://phrma.org/blog/spending-on-medicines-grew-less-than-one-percent-in-2017 2026-04-03 daily 0.8 https://phrma.org/blog/spending-on-medicines-the-big-picture 2026-04-03 daily 0.8 https://phrma.org/blog/spotlighting-a-growing-mental-health-challenge 2026-04-03 daily 0.8 https://phrma.org/blog/stakeholders-agree-modernize-the-legal-framework-to-support-move-to-value-driven-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/stakeholders-raise-concerns-about-icers-evidence-report-for-non-small-cell-lung-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/stakeholders-raise-concerns-with-proposed-drastic-changes-to-the-pharmaceutical-supply-chain 2026-04-03 daily 0.8 https://phrma.org/blog/state-leaders-see-bioscience-as-jobs-engine 2026-04-03 daily 0.8 https://phrma.org/blog/states-can-support-access-to-medicine-as-covid-19-public-health-emergency-ends 2026-04-03 daily 0.8 https://phrma.org/blog/stemming-the-tide 2026-04-03 daily 0.8 https://phrma.org/blog/stopping-pharmacy-benefit-managers-from-gaming-the-system 2026-04-03 daily 0.8 https://phrma.org/blog/stopping-opioid-abuse 2026-04-03 daily 0.8 https://phrma.org/blog/stories-from-the-lab-researchers-discuss-innovative-treatments-for-cancers-of-the-blood 2026-04-03 daily 0.8 https://phrma.org/blog/strength-in-numbers-to-strengthen-the-system 2026-04-03 daily 0.8 https://phrma.org/blog/strengthening-ip-would-significantly-boost-indias-economy 2026-04-03 daily 0.8 https://phrma.org/blog/strengthening-the-wtos-global-trade-and-health-agenda 2026-04-03 daily 0.8 https://phrma.org/blog/strong-ip-is-propelling-innovation-and-saving-lives 2026-04-03 daily 0.8 https://phrma.org/blog/strong-randd-investment-the-best-bet-to-slow-alzheimers-growing-threat 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-hepatitis-c-cure-saved-medicaid-15-billion 2026-04-03 daily 0.8 https://phrma.org/blog/study-after-study-after-study-contract-pharmacy-expansion-not-aligned-in-communities-340b-is-meant-to-serve 2026-04-03 daily 0.8 https://phrma.org/blog/study-better-use-of-prescription-drugs-by-medicaid-beneficiaries-can-yield-significant-savings 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-actual-cost-of-14-new-medicines-is-billions-less-than-predicted 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-biopharmaceutical-innovation-is-responsible-for-35-of-the-increase-in-life-expectancy-from-1990-to-2015 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-hospitals-continue-to-mark-up-medicines-up-to-500-of-their-cost 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-insurance-barriers-disproportionately-burden-patients-with-chronic-illness 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-middlemen-excluded-nearly-850-medicines-from-formularies-this-year 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-nearly-half-of-payers-believe-innovative-contracts-can-lead-to-lower-patient-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/blog/study-finds-the-pharmaceutical-industry-retains-a-smaller-share-of-revenue-than-research-intensive-industries 2026-04-03 daily 0.8 https://phrma.org/blog/study-highlights-negative-impact-of-canadas-promise-doctrine-on-r-and-d-investment 2026-04-03 daily 0.8 https://phrma.org/blog/summer-reading-in-the-age-of-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/support-for-continued-progress-is-critical-for-pediatric-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/supporting-access-to-vaccines-for-part-d-beneficiaries 2026-04-03 daily 0.8 https://phrma.org/blog/supporting-better-patient-outcomes-through-reform 2026-04-03 daily 0.8 https://phrma.org/blog/supporting-country-readiness-to-boost-global-vaccine-access 2026-04-03 daily 0.8 https://phrma.org/blog/supporting-india-during-the-devastating-coronavirus-surge 2026-04-03 daily 0.8 https://phrma.org/blog/supporting-opportunities-for-enhanced-competition-in-the-marketplace 2026-04-03 daily 0.8 https://phrma.org/blog/supporting-our-colleagues-national-service 2026-04-03 daily 0.8 https://phrma.org/blog/supreme-court-decisions-in-two-cases-pave-way-for-ipr-reforms 2026-04-03 daily 0.8 https://phrma.org/blog/survey-aarp-members-support-sharing-medicine-discounts-with-seniors 2026-04-03 daily 0.8 https://phrma.org/blog/survey-found-insurance-premiums-grew-faster-than-inflation-in-2020 2026-04-03 daily 0.8 https://phrma.org/blog/survey-says-prescription-drug-prices-are-not-fueling-inflation-concerns-for-americans 2026-04-03 daily 0.8 https://phrma.org/blog/survey-shows-out-of-pocket-costs-top-health-care-concern-for-voters 2026-04-03 daily 0.8 https://phrma.org/blog/tactic-to-exploit-patient-assistance-likely-to-increase-despite-harm-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/taking-stock-of-obesity-and-its-costly-effects 2026-04-03 daily 0.8 https://phrma.org/blog/tearing-down-barriers-to-cooperation-with-strengthened-intellectual-property-protections 2026-04-03 daily 0.8 https://phrma.org/blog/tedmed-great-challenges-google-hangout-on-balancing-the-costs-of-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/teen-ods-on-drugs-purchased-online-without-prescription 2026-04-03 daily 0.8 https://phrma.org/blog/tennessees-medicaid-demonstration-fails-patients 2026-04-03 daily 0.8 https://phrma.org/blog/thanking-research-and-hope-honorees-for-their-efforts-fighting-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/the-biopharmaceutical-industry-still-needs-clarity-from-the-fda-on-orange-book-listings 2026-04-03 daily 0.8 https://phrma.org/blog/the-dangers-of-expanding-the-trips-waiver 2026-04-03 daily 0.8 https://phrma.org/blog/the-hidden-bill-patients-dont-know-they-are-paying 2026-04-03 daily 0.8 https://phrma.org/blog/the-impact-of-innovative-medicines-a-caregivers-perspective 2026-04-03 daily 0.8 https://phrma.org/blog/the-importance-of-partnership-a-conversation-with-takeda 2026-04-03 daily 0.8 https://phrma.org/blog/the-law-driving-technology-transfer-and-fostering-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/the-patient-perspective-vaccines 2026-04-03 daily 0.8 https://phrma.org/blog/the-pbm-industrys-desperate-attempt-to-stop-reform 2026-04-03 daily 0.8 https://phrma.org/blog/the-truth-about-nebraskas-price-setting-push 2026-04-03 daily 0.8 https://phrma.org/blog/the-unintended-consequences-of-government-price-setting-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/the-use-of-real-world-data-in-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/the-white-house-continues-to-attack-american-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/the-20-year-journey-yielding-a-new-weapon-against-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/the-2020-we-work-for-health-champion-awards-showcase-the-best-of-our-industry 2026-04-03 daily 0.8 https://phrma.org/blog/the-abcs-and-ds-of-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/the-abcs-of-health-coverage 2026-04-03 daily 0.8 https://phrma.org/blog/the-accelerated-approval-pathway-helping-patients-with-serious-or-life-threatening-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/the-best-kind-of-progress-cancer-medicines-and-the-value-they-bring-to-us-all 2026-04-03 daily 0.8 https://phrma.org/blog/the-biden-administration-allows-politics-to-upend-a-pragmatic-pandemic-response 2026-04-03 daily 0.8 https://phrma.org/blog/the-big-picture-in-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/the-biopharmaceutical-industrys-commitment-to-quality 2026-04-03 daily 0.8 https://phrma.org/blog/the-challenge-of-diagnosing-alzheimers-disease 2026-04-03 daily 0.8 https://phrma.org/blog/the-coming-alzheimers-catastrophe 2026-04-03 daily 0.8 https://phrma.org/blog/the-continued-imperative-to-protect-u-s-innovation-worldwide 2026-04-03 daily 0.8 https://phrma.org/blog/the-cost-of-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/the-drug-development-and-approval-process-is-about-much-more-than-the-final-okay 2026-04-03 daily 0.8 https://phrma.org/blog/the-earthquake-in-japan-reminds-us-all-to-be-prepared 2026-04-03 daily 0.8 https://phrma.org/blog/the-fda-office-of-minority-health-and-health-equity-working-to-advance-health-equity-through-diversity-in-research 2026-04-03 daily 0.8 https://phrma.org/blog/the-five-essential-truths-about-prescription-drug-spending 2026-04-03 daily 0.8 https://phrma.org/blog/the-flood-of-counterfeit-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/the-future-of-clinical-pathways 2026-04-03 daily 0.8 https://phrma.org/blog/the-future-of-the-rebate-rule-will-policymakers-stand-with-patients 2026-04-03 daily 0.8 https://phrma.org/blog/the-impact-of-monoclonal-antibodies-and-covid-19-recovery 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-the-importance-of-a-modern-fda-in-drug-discovery 2026-04-03 daily 0.8 https://phrma.org/blog/the-important-role-of-antivirals-in-the-fight-against-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/the-industry-labor-partnership-where-biopharmaceutical-innovation-meets-economic-advancement 2026-04-03 daily 0.8 https://phrma.org/blog/the-journey-to-better-health-care-requires-a-holistic-view 2026-04-03 daily 0.8 https://phrma.org/blog/the-latest-misleading-poll-on-drug-pricing 2026-04-03 daily 0.8 https://phrma.org/blog/the-latest-what-they-are-saying-importance-of-intellectual-property-protections-to-combat-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/the-latest-what-they-are-saying-intellectual-property-protections-critical-as-we-work-to-defeat-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/the-new-administration-should-reconsider-a-recent-hhs-rule-that-could-negatively-impact-patient-access-and-affordability 2026-04-03 daily 0.8 https://phrma.org/blog/the-next-five-years-of-pdufa-vi-driving-the-availability-of-innovative-treatments-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/the-next-step-towards-colombias-future 2026-04-03 daily 0.8 https://phrma.org/blog/the-next-threat-combatting-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/the-online-echo-of-the-counterfeit-medicine-story 2026-04-03 daily 0.8 https://phrma.org/blog/the-partnership-for-prescription-assistance-a-history-of-caring 2026-04-03 daily 0.8 https://phrma.org/blog/the-patient-experience-out-of-pocket-costs-are-driving-patients-affordability-and-access-challenges 2026-04-03 daily 0.8 https://phrma.org/blog/the-patient-experience-uncovering-the-barriers-to-care-for-insured-americans 2026-04-03 daily 0.8 https://phrma.org/blog/the-patient-perspective-government-price-setting-harms-patients 2026-04-03 daily 0.8 https://phrma.org/blog/the-pbm-story-you-havent-heard-hidden-fees-quadrupled-in-two-years 2026-04-03 daily 0.8 https://phrma.org/blog/the-personal-side-of-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/the-reality-of-prescription-drug-spending-in-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/the-risks-of-counterfeit-imported-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/the-science-of-hope-understanding-biomarkers 2026-04-03 daily 0.8 https://phrma.org/blog/using-setbacks-as-stepping-stones-in-alzheimers-research 2026-04-03 daily 0.8 https://phrma.org/blog/the-senates-latest-price-setting-proposal-will-undermine-american-medical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/the-senates-latest-price-setting-proposal-will-undermine-our-health-care-system 2026-04-03 daily 0.8 https://phrma.org/blog/the-senates-latest-price-setting-proposal-will-undermine-patient-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/the-senates-latest-price-setting-proposal-will-undermine-u-s-economic-growth 2026-04-03 daily 0.8 https://phrma.org/blog/the-tradeoffs-personalized-treatment-vs-one-size-fits-all-standards 2026-04-03 daily 0.8 https://phrma.org/blog/the-truth-about-the-marketing-and-promotion-of-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/the-u-s-india-relationship-is-full-of-opportunities 2026-04-03 daily 0.8 https://phrma.org/blog/the-vital-role-of-clinical-outcome-assessments-in-patient-centered-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/the-war-on-alzheimers-progress-and-challenges-of-biopharmaceutical-research 2026-04-03 daily 0.8 https://phrma.org/blog/the-washington-post-retracts-phrma-claim-in-opioid-story 2026-04-03 daily 0.8 https://phrma.org/blog/then-and-now-how-prescription-drug-prices-fall-significantly-over-time 2026-04-03 daily 0.8 https://phrma.org/blog/thinking-about-the-sectors-future 2026-04-03 daily 0.8 https://phrma.org/blog/this-is-not-a-special-effect-new-video-shows-the-destruction-of-a-rogue-cell 2026-04-03 daily 0.8 https://phrma.org/blog/this-is-not-a-video-game-new-tv-ad-showcases-the-destruction-of-a-cancer-cell-by-immune-system 2026-04-03 daily 0.8 https://phrma.org/blog/this-week-on-the-blogosphere 2026-04-03 daily 0.8 https://phrma.org/blog/three-concerns-about-colorados-approach-to-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-about-antibody-drug-conjugates 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-about-the-united-nations-new-hivaids-report 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-from-the-latest-patient-experience-survey 2026-04-03 daily 0.8 https://phrma.org/blog/three-ways-340b-is-failing-vulnerable-patients 2026-04-03 daily 0.8 https://phrma.org/blog/three-black-friday-tips-for-choosing-a-health-insurance-plan 2026-04-03 daily 0.8 https://phrma.org/blog/three-reasons-the-administration-should-abandon-its-international-pricing-index-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/three-reasons-the-senate-finance-package-is-the-wrong-approach-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/three-reasons-why-medpacs-latest-part-d-proposal-would-be-bad-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/three-reasons-why-repealing-the-part-d-non-interference-clause-is-a-bad-idea 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-about-so-called-medicare-negotiation-polling 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-about-the-part-d-gao-report 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-you-need-to-know-about-todays-wsj-story-on-medicine-prices 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-you-should-know-about-recent-health-care-polling 2026-04-03 daily 0.8 https://phrma.org/blog/three-ways-the-pharmaceutical-industry-can-positively-impact-health-equity 2026-04-03 daily 0.8 https://phrma.org/blog/time-for-canada-to-catch-up-on-intellectual-property 2026-04-03 daily 0.8 https://phrma.org/blog/timely-reauthorization-of-pdufa-and-bsufa-is-vital-to-the-fdas-review-of-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/to-the-millions-affected-by-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/top-five-issues-voters-want-addressed-in-the-administrations-first-100-days 2026-04-03 daily 0.8 https://phrma.org/blog/trade-facilitation-and-enforcement-act-will-strengthen-ip-enforcement 2026-04-03 daily 0.8 https://phrma.org/blog/trading-fair-means-upholding-the-law-a-focus-on-patents 2026-04-03 daily 0.8 https://phrma.org/blog/traditional-hta-methods-treat-everyone-like-the-average-patient 2026-04-03 daily 0.8 https://phrma.org/blog/traditional-htas-keep-diverse-patients-out-of-the-conversation 2026-04-03 daily 0.8 https://phrma.org/blog/transparency-and-confidentiality-in-fdas-proposed-quality-metrics-proposal-is-key 2026-04-03 daily 0.8 https://phrma.org/blog/trips-waiver-expansion-risks-public-health 2026-04-03 daily 0.8 https://phrma.org/blog/trump-administration-must-defend-and-protect-u-s-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/tune-in-now-to-the-phrma-2016-annual-meeting 2026-04-03 daily 0.8 https://phrma.org/blog/new-government-data-show-medicine-price-growth-continues-to-decline 2026-04-03 daily 0.8 https://phrma.org/blog/understanding-breakthrough-covid-19-infections 2026-04-03 daily 0.8 https://phrma.org/blog/understanding-health-insurance-exchanges-state-by-state 2026-04-03 daily 0.8 https://phrma.org/blog/understanding-long-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/international-meetings-hold-big-implications-for-americans-and-our-innovation-ecosystem 2026-04-03 daily 0.8 https://phrma.org/blog/upcoming-forum-on-improving-critical-tools-for-preventing-prescription-drug-abuse 2026-04-03 daily 0.8 https://phrma.org/blog/upcoming-graduate-student-summit-will-showcase-pathways-to-success-within-the-biopharmaceutical-industry 2026-04-03 daily 0.8 https://phrma.org/blog/upcoming-symposium-building-community-health-and-wellbeing 2026-04-03 daily 0.8 https://phrma.org/blog/u-s-must-address-ip-and-market-access-barriers-abroad-to-protect-american-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/american-leadership-on-innovation-policy-is-essential-to-global-health-progress 2026-04-03 daily 0.8 https://phrma.org/blog/u-s-trade-policy-must-prioritize-american-biopharmaceutical-innovation-and-patient-access 2026-04-03 daily 0.8 https://phrma.org/blog/use-as-directed-adherence-for-a-healthier-future 2026-04-03 daily 0.8 https://phrma.org/blog/using-traditional-htas-to-determine-coverage-threatens-patient-access-to-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/u-s-trade-representative-continues-the-vital-ip-dialogue 2026-04-03 daily 0.8 https://phrma.org/blog/vaccines-a-history-of-improving-health 2026-04-03 daily 0.8 https://phrma.org/blog/value-assessment-should-include-all-aspects-of-value-that-matter-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/value-assessments-should-include-all-the-outcomes-that-matter-to-patients-and-families 2026-04-03 daily 0.8 https://phrma.org/blog/veterans-affairs-101-three-charts-show-how-the-va-system-differs-from-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/video-barriers-to-results-based-contracts 2026-04-03 daily 0.8 https://phrma.org/blog/video-how-can-biomarkers-and-surrogate-endpoints-enhance-randd-of-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/video-how-does-the-supply-chain-shape-brand-name-medicine-prices 2026-04-03 daily 0.8 https://phrma.org/blog/video-phrma-ceo-discusses-biopharmaceutical-supply-chain-at-politico-event 2026-04-03 daily 0.8 https://phrma.org/blog/video-phrma-ceo-discusses-industry-response-to-opioid-crisis-on-mornings-with-maria 2026-04-03 daily 0.8 https://phrma.org/blog/video-phrma-ceo-discusses-medicine-costs-with-cnbcs-squawk-box 2026-04-03 daily 0.8 https://phrma.org/blog/video-phrma-ceo-joins-cnbcs-squawk-on-the-street-to-discuss-industry-campaign-goboldly 2026-04-03 daily 0.8 https://phrma.org/blog/video-translating-science-into-new-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/video-what-is-a-results-based-contract 2026-04-03 daily 0.8 https://phrma.org/blog/visualizing-our-scope 2026-04-03 daily 0.8 https://phrma.org/blog/voter-insights-four-things-to-know 2026-04-03 daily 0.8 https://phrma.org/blog/voters-across-all-50-states-want-state-policymakers-to-focus-on-health-insurance-and-pbm-practices 2026-04-03 daily 0.8 https://phrma.org/blog/voters-agree-congress-should-protect-patents 2026-04-03 daily 0.8 https://phrma.org/blog/voters-want-to-address-the-real-drivers-of-health-care-costs-for-patients-and-the-system 2026-04-03 daily 0.8 https://phrma.org/blog/wanted-a-balanced-discussion-on-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/blog/watch-new-video-series-spotlights-advances-in-biopharmaceutical-science 2026-04-03 daily 0.8 https://phrma.org/blog/watch-biomarkers-in-drug-development-with-dr-bernie-zeiher 2026-04-03 daily 0.8 https://phrma.org/blog/watch-building-trust-and-enhancing-clinical-trial-diversity 2026-04-03 daily 0.8 https://phrma.org/blog/the-patient-perspective-navigating-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/we-must-work-together-to-lessen-the-toll-of-mental-illness 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-building-a-brighter-future-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-collaboration-for-patient-progress 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-commitment-to-patient-well-being 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-continued-progress-for-patient-health 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-keeping-patients-in-the-know 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-planning-ahead-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-the-latest-from-phrma 2026-04-03 daily 0.8 https://phrma.org/blog/week-in-review-vaccine-myth-busters-edition 2026-04-03 daily 0.8 https://phrma.org/blog/welcome-news-in-two-high-profile-cancer-battles 2026-04-03 daily 0.8 https://phrma.org/blog/welcome-to-the-catalyst 2026-04-03 daily 0.8 https://phrma.org/blog/welcome-to-the-new-phrma-org 2026-04-03 daily 0.8 https://phrma.org/blog/west-virginia-becomes-the-first-state-to-lower-patient-costs-by-sharing-the-savings 2026-04-03 daily 0.8 https://phrma.org/blog/what-recent-rhetoric-on-the-cost-of-diabetes-and-anti-obesity-medicines-gets-wrong 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-experts-agree-that-proposed-march-in-framework-would-jeopardize-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-experts-reinforce-that-trips-waiver-expansion-is-harmful-and-unnecessary 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-nonprofit-hospitals-are-gaming-the-system-at-the-expense-of-patients 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-pasteur-act-can-help-fight-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-about-patients-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-should-know-about-protecting-your-health-this-fall 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-should-know-about-real-world-evidence-and-drug-development 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-should-know-about-rsv 2026-04-03 daily 0.8 https://phrma.org/blog/what-60-minutes-missed-on-the-value-and-cost-of-cancer-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/what-access-and-affordability-means-for-chronic-disease-patients 2026-04-03 daily 0.8 https://phrma.org/blog/what-are-health-insurance-exchanges 2026-04-03 daily 0.8 https://phrma.org/blog/what-are-rems-these-extra-steps-are-helping-protect-patient-health 2026-04-03 daily 0.8 https://phrma.org/blog/what-if-a-couple-of-small-fixes-could-protect-seniors-in-the-donut-hole-and-save-them-money-on-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/blog/what-is-inter-partes-review-and-why-does-it-matter 2026-04-03 daily 0.8 https://phrma.org/blog/what-is-kaiser-family-foundation-up-to 2026-04-03 daily 0.8 https://phrma.org/blog/what-makes-valeant-different-than-innovative-biopharmaceutical-companies 2026-04-03 daily 0.8 https://phrma.org/blog/what-scientific-experts-are-saying-about-vaccine-safety 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-about-icers-scoping-document-for-non-small-cell-lung-cancer 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-about-new-hepatitis-c-cure-thats-actually-a-great-deal 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-about-the-value-of-new-innovative-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-close-patent-loopholes-that-threaten-innovation-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-experts-highlight-the-importance-of-ip-in-recent-nist-proposal-comments 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-government-price-setting-for-medicines-is-not-the-answer 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-immunotherapy-is-transforming-cancer-care 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-intellectual-property-protections-are-critical-as-we-work-to-defeat-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-negative-impact-of-pelosis-plan-on-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-phrma-member-executives-on-industrys-new-approach-to-dtc-television-advertising 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-rising-deductibles-and-out-of-pocket-costs-in-health-insurance-plans 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-stakeholders-raise-concerns-about-patent-litigation-reform 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-study-on-cancer-randd-costs-is-not-an-accurate-representation-of-marketplace 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-arent-telling-you-about-medicine-prices 2026-04-03 daily 0.8 https://phrma.org/blog/what-theyre-saying-patient-advocates-want-to-protect-medicare-from-government-interference 2026-04-03 daily 0.8 https://phrma.org/blog/what-theyre-saying-safety-is-top-concern-for-recent-drug-importation-proposal 2026-04-03 daily 0.8 https://phrma.org/blog/why-vaccines-work-in-the-fight-against-measles-and-other-infectious-diseases 2026-04-03 daily 0.8 https://phrma.org/blog/what-value-means-to-me 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-dont-know-about-importation-from-canada 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-access-to-innovative-medicines-in-the-u-s 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-h-r-3 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-newly-authorized-covid-19-antiviral-treatments 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-pdufa-vi 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-the-cbo-rebate-rule-score 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-the-federal-governments-health-spending-projections 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-what-you-need-to-know-about-the-latest-medicare-trustees-report 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-the-new-kaiser-poll 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-about-the-new-nhe-health-spending-projections 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-should-know-government-arbitration-is-the-wrong-way-to-change-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/whats-the-340b-program-like-in-your-state 2026-04-03 daily 0.8 https://phrma.org/blog/whats-driving-insurance-premium-increases-hint-its-not-prescription-drugs 2026-04-03 daily 0.8 https://phrma.org/blog/what-is-missing-in-the-current-drug-pricing-plan 2026-04-03 daily 0.8 https://phrma.org/blog/whats-really-happening-when-it-comes-to-prescription-drug-costs 2026-04-03 daily 0.8 https://phrma.org/blog/when-coverage-does-not-equal-access-to-care 2026-04-03 daily 0.8 https://phrma.org/blog/where-voters-stand-ahead-of-the-election 2026-04-03 daily 0.8 https://phrma.org/blog/which-340b-entities-are-getting-most-of-the-savings 2026-04-03 daily 0.8 https://phrma.org/blog/who-pandemic-agreement-offers-opportunities-and-risks-for-american-innovators 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-who-benefits-from-contract-pharmacy-arrangements-in-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/who-benefits-from-the-340b-drug-discount-program 2026-04-03 daily 0.8 https://phrma.org/blog/who-gets-a-seat-at-icers-table-hint-its-not-patients 2026-04-03 daily 0.8 https://phrma.org/blog/who-is-making-decisions-about-your-health-care 2026-04-03 daily 0.8 https://phrma.org/blog/who-is-pushing-for-price-controls-the-answer-may-surprise-you 2026-04-03 daily 0.8 https://phrma.org/blog/why-congress-should-prioritize-fixing-the-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/why-wont-ustr-strengthen-medical-supply-chains-with-americas-allies 2026-04-03 daily 0.8 https://phrma.org/blog/why-are-cancer-medicines-expensive 2026-04-03 daily 0.8 https://phrma.org/blog/why-cross-country-comparisons-on-drug-prices-are-misleading 2026-04-03 daily 0.8 https://phrma.org/blog/why-drug-importation-threatens-patient-safety 2026-04-03 daily 0.8 https://phrma.org/blog/why-incorporating-patients-perspectives-matters 2026-04-03 daily 0.8 https://phrma.org/blog/why-neglected-tropical-disease-and-rare-disease-researchers-need-each-other 2026-04-03 daily 0.8 https://phrma.org/blog/why-reauthorization-of-pdufa-matters 2026-04-03 daily 0.8 https://phrma.org/blog/why-state-drug-importation-pilot-programs-dont-work 2026-04-03 daily 0.8 https://phrma.org/blog/why-the-u-s-biopharmaceutical-industry-is-leading-the-charge-against-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/why-the-world-looks-to-the-u-s-for-the-most-elusive-cures 2026-04-03 daily 0.8 https://phrma.org/blog/why-wont-the-insurance-industry-tell-the-truth-about-medicine-costs 2026-04-03 daily 0.8 https://phrma.org/blog/will-the-administration-capitalize-on-the-indo-pacific-economic-framework-to-drive-medical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/will-life-sciences-be-gone-tomorrow 2026-04-03 daily 0.8 https://phrma.org/blog/winning-the-war-against-counterfeiters 2026-04-03 daily 0.8 https://phrma.org/blog/witnessing-a-historic-moment-in-u-s-japan-relations 2026-04-03 daily 0.8 https://phrma.org/blog/womens-health-month-a-conversation-with-astellas 2026-04-03 daily 0.8 https://phrma.org/blog/womens-health-month-a-conversation-with-sage 2026-04-03 daily 0.8 https://phrma.org/blog/word-of-the-month-340b-covered-entity 2026-04-03 daily 0.8 https://phrma.org/blog/word-of-the-month-amr 2026-04-03 daily 0.8 https://phrma.org/blog/word-of-the-month-long-covid 2026-04-03 daily 0.8 https://phrma.org/blog/word-of-the-month-the-bayh-dole-act 2026-04-03 daily 0.8 https://phrma.org/blog/word-of-the-month-what-is-trips 2026-04-03 daily 0.8 https://phrma.org/blog/working-to-harness-the-power-of-the-bodys-own-immune-system 2026-04-03 daily 0.8 https://phrma.org/blog/working-together-for-the-greater-good-the-current-state-of-the-collaborative-research-ecosystem-in-oncology 2026-04-03 daily 0.8 https://phrma.org/blog/working-together-to-combat-coronavirus 2026-04-03 daily 0.8 https://phrma.org/blog/working-together-to-combat-global-zika-threat 2026-04-03 daily 0.8 https://phrma.org/blog/working-together-to-deliver-hope-to-patients 2026-04-03 daily 0.8 https://phrma.org/blog/working-together-to-stop-ebola-in-its-tracks 2026-04-03 daily 0.8 https://phrma.org/blog/world-ip-day-2023-celebrating-women-leaders-in-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/world-ip-day-2024-supporting-an-innovative-and-sustainable-future 2026-04-03 daily 0.8 https://phrma.org/blog/world-trade-week-2024-time-for-a-more-ambitious-u-s-trade-agenda 2026-04-03 daily 0.8 https://phrma.org/blog/world-aids-day-2014-transforming-the-trajectory-of-disease 2026-04-03 daily 0.8 https://phrma.org/blog/world-aids-day-making-progress 2026-04-03 daily 0.8 https://phrma.org/blog/world-aids-day-2016-a-decade-of-scientific-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/world-aids-day-2017-scientific-breakthroughs-paving-the-way-for-an-aids-free-generation 2026-04-03 daily 0.8 https://phrma.org/blog/world-aids-day-remembering-those-weve-lost-and-exploring-the-continued-fight-against-hivaids 2026-04-03 daily 0.8 https://phrma.org/blog/world-asthma-day-new-hope-for-millions-with-asthma 2026-04-03 daily 0.8 https://phrma.org/blog/world-cancer-day-reflecting-on-progress-and-hope-for-the-future-in-cancer-treatment 2026-04-03 daily 0.8 https://phrma.org/blog/world-cancer-day-revolutionizing-treatment-for-patients-is-not-beyond-us 2026-04-03 daily 0.8 https://phrma.org/blog/world-ip-day-celebrating-the-protections-that-allow-innovation-to-thrive 2026-04-03 daily 0.8 https://phrma.org/blog/world-ip-day-the-foundation-of-modern-life-in-america 2026-04-03 daily 0.8 https://phrma.org/blog/wsj-editorial-scotus-needs-to-hear-alameda-case 2026-04-03 daily 0.8 https://phrma.org/blog/wtas-on-reasonable-pricing-and-public-private-partnerships 2026-04-03 daily 0.8 https://phrma.org/blog/wtas-proposed-unsubstantiated-uspto-rule-change-is-a-threat-to-american-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/wtas-the-consequences-of-consolidation-and-vertical-integration 2026-04-03 daily 0.8 https://phrma.org/blog/what-they-are-saying-broad-opposition-to-pelosis-radical-drug-pricing-plan 2026-04-03 daily 0.8 https://phrma.org/blog/yet-another-misleading-report-on-medicine-prices 2026-04-03 daily 0.8 https://phrma.org/blog/ymca-healthy-kids-day-promoting-childhood-wellness 2026-04-03 daily 0.8 https://phrma.org/blog/you-wont-fix-what-you-dont-value-two-reasons-why-traditional-cost-effective-analyses-can-perpetuate-health-inequities 2026-04-03 daily 0.8 https://phrma.org/blog/no-two-patients-with-high-cholesterol-are-the-same-meet-george-and-betty 2026-04-03 daily 0.8 https://phrma.org/blog/world-trade-month-how-we-can-expand-world-class-pro-innovation-standards 2026-04-03 daily 0.8 https://phrma.org/blog/what-you-need-to-know-measles-and-the-mmr-vaccine 2026-04-03 daily 0.8 https://phrma.org/blog/strong-trade-policies-protect-american-workers-and-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/world-aids-day-2018-hope-for-the-future 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-phrma-submits-comments-to-white-house-on-artificial-intelligence 2026-04-03 daily 0.8 https://phrma.org/blog/the-time-has-arrived-for-patent-reform 2026-04-03 daily 0.8 https://phrma.org/blog/a-closer-look-at-how-health-care-consolidation-drives-up-patient-costs-creates-barriers-to-care 2026-04-03 daily 0.8 https://phrma.org/blog/special-edition-medicare-monday-more-context-on-medpacs-analysis-of-drug-costs 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-survey-underscores-daily-burden-of-migraines 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-3-new-reports-show-dramatic-slowdown-in-medicine-spending-growth 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-addressing-health-inequities-biopharmaceutical-companies-are-rising-to-the-occasion 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-analysis-finds-higher-outpatient-drug-spending-at-340b-hospitals 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-two-pbm-reports-show-dramatic-slowdown-in-medicine-spending-growth 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-cancer-leaders-lay-out-policy-road-map-for-continued-progress 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-ims-institute-branded-net-medicine-price-increases-lowest-in-past-five-years 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-new-york-times-editorial-board-hepatitis-c-medicines-a-high-value-for-patients-and-health-care-system 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-nyt-unable-to-meet-the-deductible-or-the-doctor 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-report-highlights-increasing-prevalence-for-alzheimers-disease 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-economists-voice-are-biopharmaceutical-budget-caps-good-public-policy 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-wsj-commentary-the-folly-of-targeting-big-pharma 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-in-wsj-same-drug-two-prices-why-the-higher-price-prevails 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-wsj-the-arrow-of-u-s-cancer-progress 2026-04-03 daily 0.8 https://phrma.org/blog/health-care-practitioners-sound-the-alarm-on-middlemen-imposed-barriers-to-patient-care-need-for-policy-change 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-finds-more-abuse-of-340b-program-by-hospitals-and-drug-middlemen 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-impact-state-economies 2026-04-03 daily 0.8 https://phrma.org/blog/3-myths-critics-get-wrong-about-intellectual-property 2026-04-03 daily 0.8 https://phrma.org/blog/4-things-to-know-on-rare-disease-day 2026-04-03 daily 0.8 https://phrma.org/blog/improved-treatments-continue-to-lead-to-declining-cancer-mortality-rates-in-the-us 2026-04-03 daily 0.8 https://phrma.org/blog/nearly-4-5-million-jobs-and-counting 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-report-medicines-in-development-for-patients-with-rare-diseases-demonstrate-the-promise-of-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/new-phrma-report-new-medicines-in-development-for-autoimmune-diseases-offer-patients-hope-for-brighter-futures 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-tackling-chronic-conditions-with-preventive-treatment 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-vaccines-continue-to-drive-improved-health-outcomes 2026-04-03 daily 0.8 https://phrma.org/blog/world-vaccine-congress-building-on-vaccine-success 2026-04-03 daily 0.8 https://phrma.org/blog/why-drug-importation-is-bad-for-americans 2026-04-03 daily 0.8 https://phrma.org/blog/new-research-american-biopharmaceutical-investment-in-randd-drives-transformational-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/congress-needs-to-fix-the-iras-pill-penalty 2026-04-03 daily 0.8 https://phrma.org/blog/how-the-ira-is-impacting-the-generic-drug-market 2026-04-03 daily 0.8 https://phrma.org/blog/when-middlemen-own-it-all-patients-pay-the-price 2026-04-03 daily 0.8 https://phrma.org/blog/from-sound-to-science-how-ip-powers-innovation-in-music-and-hearing 2026-04-03 daily 0.8 https://phrma.org/blog/world-immunization-week-highlighting-the-importance-of-vaccines-for-public-health 2026-04-03 daily 0.8 https://phrma.org/blog/ensuring-access-to-affordable-medicines-for-patients-through-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/ustr-2025-special-301-report-corrects-course 2026-04-03 daily 0.8 https://phrma.org/blog/the-biopharmaceutical-industry-is-one-of-the-highest-contributors-to-america-s-economy-among-all-manufacturers 2026-04-03 daily 0.8 https://phrma.org/blog/when-hospitals-have-free-rein-to-mark-up-drug-prices-who-pays-the-price 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-fewer-treatments-and-cures-under-the-ira-s-pill-penalty 2026-04-03 daily 0.8 https://phrma.org/blog/pbms-launch-new-ad-campaign-to-block-reforms 2026-04-03 daily 0.8 https://phrma.org/blog/tariffs-on-medicines-would-harm-american-competitiveness-industry-and-patients 2026-04-03 daily 0.8 https://phrma.org/blog/biopharmaceutical-innovation-for-a-healthier-america-phrma-releases-new-innovation-report 2026-04-03 daily 0.8 https://phrma.org/blog/how-the-340b-hospital-markup-program-and-pbms-drive-up-costs-for-u-s-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-balance-the-scales-campaign-highlights-why-americans-pay-more-for-prescription-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/foreign-first-pricing-schemes-don-t-address-why-americans-pay-more 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-post-approval-innovation-delivers-substantial-patient-benefits 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-foundation-celebrates-60-years-of-investing-in-future-scientific-leaders 2026-04-03 daily 0.8 https://phrma.org/blog/how-the-340b-hospital-markup-program-could-hurt-michigan-patients 2026-04-03 daily 0.8 https://phrma.org/blog/americans-are-paying-a-26-freerider-tax-on-medicines-because-other-countries-don-t-pay-their-fair-share 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-finds-rampant-abuse-of-the-340b-program 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-part-d-plans-initially-denied-medicines-for-more-than-70-of-patients-in-four-chronic-disease-areas 2026-04-03 daily 0.8 https://phrma.org/blog/what-to-know-about-vaccine-ingredients-aluminum-and-thimerosal 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-forget-foreign-price-controls-there-s-a-better-solution-to-lowering-drug-prices 2026-04-03 daily 0.8 https://phrma.org/blog/cms-continues-to-make-a-bad-law-worse 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-how-intellectual-property-drives-u-s-innovation-and-biopharma-s-impact 2026-04-03 daily 0.8 https://phrma.org/blog/latest-analysis-from-ohio-exposes-growing-abuses-of-the-340b-markup-program 2026-04-03 daily 0.8 https://phrma.org/blog/bringing-to-life-the-full-story-of-biopharmaceutical-innovation-and-investments 2026-04-03 daily 0.8 https://phrma.org/blog/answering-common-questions-on-mrna-technology 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-patients-face-higher-drug-costs-despite-ira-promises 2026-04-03 daily 0.8 https://phrma.org/blog/guest-post-using-the-patient-voice-to-go-boldly 2026-04-03 daily 0.8 https://phrma.org/blog/clinical-trials-qanda-income-disparities 2026-04-03 daily 0.8 https://phrma.org/blog/the-hidden-cost-of-340b-a-multi-billion-dollar-burden-on-taxpayers-and-medicaid 2026-04-03 daily 0.8 https://phrma.org/blog/the-ahip-premium-dollar-corrected-again 2026-04-03 daily 0.8 https://phrma.org/blog/ask-about-adherence-cms-finds-medication-adherence-saved-medicare-up-to-46-6b-in-avoided-health-care-costs-between-2013-and-2018 2026-04-03 daily 0.8 https://phrma.org/blog/10-things-you-should-know-about-medicine-spending-and-costs 2026-04-03 daily 0.8 https://phrma.org/blog/10-years-later-lessons-learned-from-katrina 2026-04-03 daily 0.8 https://phrma.org/blog/10-years-of-living-and-managing-type-1-diabetes-lessons-learned 2026-04-03 daily 0.8 https://phrma.org/blog/north-carolina-puts-patients-first-with-rebate-pass-through-law 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-pbms-and-commercial-insurers-are-quietly-blocking-prescription-access 2026-04-03 daily 0.8 https://phrma.org/blog/the-role-of-antidepressants-in-addressing-america-s-mental-health-crisis 2026-04-03 daily 0.8 https://phrma.org/blog/curbing-340b-abuse-and-rising-costs-with-the-rebate-model 2026-04-03 daily 0.8 https://phrma.org/blog/study-340b-hospitals-drive-up-patient-drug-costs 2026-04-03 daily 0.8 https://phrma.org/blog/why-the-vaccine-injury-program-matters 2026-04-03 daily 0.8 https://phrma.org/blog/pbms-are-hiding-hurdles-to-essential-care 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-unmasks-how-big-city-hospitals-exploit-340b-by-posing-as-rural-providers 2026-04-03 daily 0.8 https://phrma.org/blog/medical-innovation-takes-center-stage-in-state-legislatures 2026-04-03 daily 0.8 https://phrma.org/blog/medicare-monday-kicking-off-2017-with-medicare-resources 2026-04-03 daily 0.8 https://phrma.org/blog/new-meet-mark-ad-exposes-how-the-340b-hospital-markup-program-drives-up-costs-for-everyone 2026-04-03 daily 0.8 https://phrma.org/blog/pbms-not-patents-are-blocking-access-to-lower-cost-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/delivering-breakthroughs-and-lower-costs-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-stresses-importance-of-340b-rebate-model-pilot 2026-04-03 daily 0.8 https://phrma.org/blog/cbo-340b-program-costs-taxpayers-no-evidence-patients-benefit 2026-04-03 daily 0.8 https://phrma.org/blog/why-states-struggle-to-deliver-savings-middlemen-and-340b-siphon-dollars-from-patients-and-states 2026-04-03 daily 0.8 https://phrma.org/blog/340b-hospitals-use-scare-tactics-to-evade-accountability 2026-04-03 daily 0.8 https://phrma.org/blog/vaccines-and-autism-decades-of-scientific-evidence-find-no-link 2026-04-03 daily 0.8 https://phrma.org/blog/icymi-the-wall-street-journal-calls-340b-reform-a-good-idea-to-cut-drug-costs 2026-04-03 daily 0.8 https://phrma.org/blog/virginia-dont-let-politicians-take-away-your-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/historic-biopharmaceutical-investments-a-prescription-for-america-s-future 2026-04-03 daily 0.8 https://phrma.org/blog/manufacturing-u-s-jobs-and-breakthroughs 2026-04-03 daily 0.8 https://phrma.org/blog/7-reasons-why-states-shouldnt-copy-the-iras-price-setting-mistake 2026-04-03 daily 0.8 https://phrma.org/blog/pbms-say-they-want-lower-priced-medicines-so-why-don-t-they-cover-them 2026-04-03 daily 0.8 https://phrma.org/blog/part-d-premiums-are-going-up-while-choices-are-going-down 2026-04-03 daily 0.8 https://phrma.org/blog/2015-a-banner-year-for-personalized-medicine 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-about-bayh-dole-innovation-that-pays-off-for-taxpayers 2026-04-03 daily 0.8 https://phrma.org/blog/340b-abuses-are-fueling-higher-medicare-costs-new-brg-report-shows 2026-04-03 daily 0.8 https://phrma.org/blog/what-seniors-can-expect-this-open-enrollment 2026-04-03 daily 0.8 https://phrma.org/blog/world-mental-health-day-supporting-access-to-medicines-that-help-loved-ones 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-60-years-of-medicare 2026-04-03 daily 0.8 https://phrma.org/blog/direct-purchase-programs-can-lower-costs-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/recognizing-the-importance-of-vaccination-for-american-health-and-security 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-measles-setbacks-harm-health-and-america-s-economy 2026-04-03 daily 0.8 https://phrma.org/blog/putting-patients-first-breaking-down-barriers-to-care 2026-04-03 daily 0.8 https://phrma.org/blog/why-the-hepatitis-b-vaccine-matters 2026-04-03 daily 0.8 https://phrma.org/blog/pdufa-essential-to-america-s-edge-in-drug-development-and-patient-access 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-calls-on-ustr-to-ensure-foreign-nations-pay-their-fair-share 2026-04-03 daily 0.8 https://phrma.org/blog/the-administration-approves-manufacturers-340b-rebate-pilot-plans 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-to-know-about-340b-contract-pharmacies 2026-04-03 daily 0.8 https://phrma.org/blog/middlemen-mark-up-drug-prices-and-keep-discounts-meant-for-you 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-stem-day-investing-in-america-s-innovators 2026-04-03 daily 0.8 https://phrma.org/blog/california-s-landmark-pbm-crackdown-a-wake-up-call-for-reform 2026-04-03 daily 0.8 https://phrma.org/blog/stop-collaborate-and-re-evaluate-icer-s-pricing-report 2026-04-03 daily 0.8 https://phrma.org/blog/the-ira-s-price-setting-doesn-t-guarantee-lower-costs-or-better-access 2026-04-03 daily 0.8 https://phrma.org/blog/myth-vs-fact-how-government-price-setting-impacts-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/one-thing-the-senate-can-agree-on-it-s-time-to-fix-340b 2026-04-03 daily 0.8 https://phrma.org/blog/knockoffs-of-fda-approved-drugs-put-patients-at-risk 2026-04-03 daily 0.8 https://phrma.org/blog/new-poll-americans-agree-that-expanding-the-trips-waiver-will-harm-us-global-manufacturing-and-innovation-leadership 2026-04-03 daily 0.8 https://phrma.org/blog/how-post-approval-innovation-keeps-delivering-for-patients 2026-04-03 daily 0.8 https://phrma.org/blog/guest-blog-making-the-most-of-the-medicare-prescription-payment-plan 2026-04-03 daily 0.8 https://phrma.org/blog/new-study-340b-rebate-model-pilot-won-t-hurt-cash-flow-for-providers 2026-04-03 daily 0.8 https://phrma.org/blog/340b-s-billion-dollar-boom-oversight-lags-as-spending-soars 2026-04-03 daily 0.8 https://phrma.org/blog/big-tax-exempt-hospitals-are-charging-cancer-patients-employers-massive-medicine-markups 2026-04-03 daily 0.8 https://phrma.org/blog/data-shows-tax-exempt-hospital-profit-seeking-behavior-not-drug-prices-is-driving-explosive-340b-expansion 2026-04-03 daily 0.8 https://phrma.org/blog/changes-to-america-s-childhood-vaccine-schedule-fail-to-protect-our-nations-kids 2026-04-03 daily 0.8 https://phrma.org/blog/can-t-get-your-medicine-don-t-count-on-your-insurer 2026-04-03 daily 0.8 https://phrma.org/blog/price-setting-policies-put-cancer-gains-in-jeopardy 2026-04-03 daily 0.8 https://phrma.org/blog/new-analysis-finds-340b-hospitals-push-patients-toward-costly-care-to-boost-profits 2026-04-03 daily 0.8 https://phrma.org/blog/top-themes-of-the-2026-j-p-morgan-healthcare-conference 2026-04-03 daily 0.8 https://phrma.org/blog/three-things-you-should-know-from-the-insurer-ceo-congressional-hearings 2026-04-03 daily 0.8 https://phrma.org/blog/50-state-poll-says-americans-are-concerned-that-hospital-markups-hurt-patients 2026-04-03 daily 0.8 https://phrma.org/blog/new-list-of-selected-drugs-highlights-growing-consequences-of-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/blog/congratulations-to-our-2026-working-for-cures-employee-champions 2026-04-03 daily 0.8 https://phrma.org/blog/advancing-patient-care-a-look-at-new-medicines-approved-in-2025 2026-04-03 daily 0.8 https://phrma.org/blog/the-time-is-now-to-address-brazils-notorious-patent-backlog 2026-04-03 daily 0.8 https://phrma.org/blog/cares-2025-supporting-community-based-solutions-that-improve-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/separating-fact-from-fiction-in-the-medicine-supply-chain 2026-04-03 daily 0.8 https://phrma.org/blog/the-federal-trade-commission-ftc-takes-important-action-to-highlight-and-curb-pbm-abuses 2026-04-03 daily 0.8 https://phrma.org/blog/no-hassle-hidden-markups-or-fees-americasmedicines-com 2026-04-03 daily 0.8 https://phrma.org/blog/questions-mount-over-340b-program-and-increased-cost-to-everyone 2026-04-03 daily 0.8 https://phrma.org/blog/why-shifting-childhood-vaccines-to-shared-clinical-decision-making-puts-kids-at-risk 2026-04-03 daily 0.8 https://phrma.org/blog/what-weve-learned-from-three-years-of-fighting-covid-19 2026-04-03 daily 0.8 https://phrma.org/blog/340b-hospital-markup-scheme-is-costing-states-taxpayers-billions 2026-04-03 daily 0.8 https://phrma.org/blog/the-special-301-report-is-foundational-to-ustr-s-trade-policy-agenda 2026-04-03 daily 0.8 https://phrma.org/blog/340b-hospitals-buy-low-and-sell-high-a-new-analysis-shows 2026-04-03 daily 0.8 https://phrma.org/blog/mfn-drug-pricing-risks-reviving-a-harmful-metric-the-u-s-rejected 2026-04-03 daily 0.8 https://phrma.org/blog/insurers-routinely-block-seniors-access-to-medicines-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/blog/congress-should-look-under-the-hood-of-340b-hospitals-don-t-want-them-to 2026-04-03 daily 0.8 https://phrma.org/blog/key-context-is-often-missing-from-the-debate-over-the-patent-trial-and-appeal-board 2026-04-03 daily 0.8 https://phrma.org/blog/16-years-later-how-bpcia-continues-to-expand-competition-and-lower-costs 2026-04-03 daily 0.8 https://phrma.org/blog/hospitals-drive-nearly-80-of-the-u-s-health-spending-gap 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-from-minnesota-340b-is-generating-billions-for-big-hospitals 2026-04-03 daily 0.8 https://phrma.org/blog/argentina-sets-course-to-enable-innovation-by-rejecting-failed-patent-rules 2026-04-03 daily 0.8 https://phrma.org/blog/phrma-forum-2026-highlights-the-importance-of-fostering-the-next-era-of-american-leadership 2026-04-03 daily 0.8 https://phrma.org/blog/america-cures-championing-u-s-leadership-in-medical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/cms-puts-patients-and-innovation-at-risk-with-mfn 2026-04-03 daily 0.8 https://phrma.org/blog/mfn-undermines-u-s-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/americans-believe-u-s-pharma-leadership-needs-to-be-protected 2026-04-03 daily 0.8 https://phrma.org/blog/celebrating-rare-disease-innovation-progress-and-the-path-forward 2026-04-03 daily 0.8 https://phrma.org/blog/harmful-u-s-policies-will-help-drive-china-s-global-leadership-in-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/blog/new-report-shows-promising-pipeline-for-cell-and-gene-therapies-but-access-challenges-persist 2026-04-03 daily 0.8 https://phrma.org/blog/leadership-in-biopharmaceutical-r-d-provides-u-s-patients-the-greatest-access-to-innovative-medicines 2026-04-03 daily 0.8 https://phrma.org/blog/how-ai-is-transforming-the-drug-innovation-lifecycle 2026-04-03 daily 0.8 https://phrma.org/blog/policymakers-shouldn-t-double-down-on-the-ira-s-flaws-with-mfn 2026-04-03 daily 0.8 https://phrma.org/blog/virginia-should-be-cautious-about-importing-federal-price-setting-mechanisms 2026-04-03 daily 0.8 https://phrma.org/blog/author 2026-04-03 daily 0.8 https://phrma.org/blog/author/jocelyn-ulrich 2026-04-03 daily 0.8 https://phrma.org/blog/author/david-korn 2026-04-03 daily 0.8 https://phrma.org/blog/author/jim-stansel 2026-04-03 daily 0.8 https://phrma.org/blog/author/john-corea 2026-04-03 daily 0.8 https://phrma.org/blog/author/kate-sikora 2026-04-03 daily 0.8 https://phrma.org/blog/author/larry-kerr 2026-04-03 daily 0.8 https://phrma.org/blog/author/lauren-olcott 2026-04-03 daily 0.8 https://phrma.org/blog/author/lindsey-seidlitz 2026-04-03 daily 0.8 https://phrma.org/blog/author/megan-van-etten 2026-04-03 daily 0.8 https://phrma.org/blog/author/michelle-nyman 2026-04-03 daily 0.8 https://phrma.org/blog/author/ali-lapidus 2026-04-03 daily 0.8 https://phrma.org/blog/author/drew-voytal 2026-04-03 daily 0.8 https://phrma.org/blog/author/abigail-lore 2026-04-03 daily 0.8 https://phrma.org/blog/author/amber-lyons 2026-04-03 daily 0.8 https://phrma.org/blog/author/amey-sutkowski 2026-04-03 daily 0.8 https://phrma.org/blog/author/anita-roach-ms 2026-04-03 daily 0.8 https://phrma.org/blog/author/anne-mcdonald-pritchett-phd 2026-04-03 daily 0.8 https://phrma.org/blog/author/ashley-czin 2026-04-03 daily 0.8 https://phrma.org/blog/author/ashley-flint 2026-04-03 daily 0.8 https://phrma.org/blog/author/bill-chin-m-d 2026-04-03 daily 0.8 https://phrma.org/blog/author/brian-newell 2026-04-03 daily 0.8 https://phrma.org/blog/author/brooke-ringel 2026-04-03 daily 0.8 https://phrma.org/blog/author/caitlin-carroll 2026-04-03 daily 0.8 https://phrma.org/blog/author/camille-jackson 2026-04-03 daily 0.8 https://phrma.org/blog/author/chris-moore 2026-04-03 daily 0.8 https://phrma.org/blog/author/christian-clymer 2026-04-03 daily 0.8 https://phrma.org/blog/author/eileen-cannon 2026-04-03 daily 0.8 https://phrma.org/blog/author/emma-van-hook 2026-04-03 daily 0.8 https://phrma.org/blog/author/gabriela-lavezzari 2026-04-03 daily 0.8 https://phrma.org/blog/author/hannah-mooney-mack 2026-04-03 daily 0.8 https://phrma.org/blog/author/holly-campbell 2026-04-03 daily 0.8 https://phrma.org/blog/author/jeff-francer 2026-04-03 daily 0.8 https://phrma.org/blog/author/jennifer-bryant 2026-04-03 daily 0.8 https://phrma.org/blog/author/john-castellani 2026-04-03 daily 0.8 https://phrma.org/blog/author/john-tunnell 2026-04-03 daily 0.8 https://phrma.org/blog/author/mark-reisenauer-and-stephen-j-ubl 2026-04-03 daily 0.8 https://phrma.org/blog/author/nicole-longo 2026-04-03 daily 0.8 https://phrma.org/blog/author/tiffany-haverly 2026-04-03 daily 0.8 https://phrma.org/blog/author/saumil-pandya-and-emily-donaldson 2026-04-03 daily 0.8 https://phrma.org/blog/author/samantha-hinkle 2026-04-03 daily 0.8 https://phrma.org/blog/author/ryan-garofalo 2026-04-03 daily 0.8 https://phrma.org/blog/author/richard-moscicki-m-d 2026-04-03 daily 0.8 https://phrma.org/blog/author/myisha-gatson 2026-04-03 daily 0.8 https://phrma.org/blog/author/katie-verb 2026-04-03 daily 0.8 https://phrma.org/blog/author/katie-koziara 2026-04-03 daily 0.8 https://phrma.org/blog/author/juliet-johnson 2026-04-03 daily 0.8 https://phrma.org/blog/author/joseph-havey 2026-04-03 daily 0.8 https://phrma.org/blog/author/joe-vandigo 2026-04-03 daily 0.8 https://phrma.org/blog/author/jasmine-gossett 2026-04-03 daily 0.8 https://phrma.org/blog/author/jackie-mcrae 2026-04-03 daily 0.8 https://phrma.org/blog/author/ieva-m-augstums 2026-04-03 daily 0.8 https://phrma.org/blog/author/guest-contributor 2026-04-03 daily 0.8 https://phrma.org/blog/author/gretta-stone 2026-04-03 daily 0.8 https://phrma.org/blog/author/giovanni-caforio-m-d 2026-04-03 daily 0.8 https://phrma.org/blog/author/ernest-kawka-and-douglas-petersen 2026-04-03 daily 0.8 https://phrma.org/blog/author/emily-donaldson 2026-04-03 daily 0.8 https://phrma.org/blog/author/emilie-signora 2026-04-03 daily 0.8 https://phrma.org/blog/author/dr-steven-thomas 2026-04-03 daily 0.8 https://phrma.org/blog/author/dr-freda-lewis-hall 2026-04-03 daily 0.8 https://phrma.org/blog/author/debra-deshong 2026-04-03 daily 0.8 https://phrma.org/blog/author/allyson-funk 2026-04-03 daily 0.8 https://phrma.org/blog/author/alex-schriver 2026-04-03 daily 0.8 https://phrma.org/blog/author/carolyn-ha 2026-04-03 daily 0.8 https://phrma.org/blog/author/jay-taylor 2026-04-03 daily 0.8 https://phrma.org/blog/author/rebecca-marklund 2026-04-03 daily 0.8 https://phrma.org/blog/author/scott-laganga 2026-04-03 daily 0.8 https://phrma.org/blog/author/sharon-lamberton 2026-04-03 daily 0.8 https://phrma.org/blog/author/matthew-norawong 2026-04-03 daily 0.8 https://phrma.org/blog/author/mark-keida 2026-04-03 daily 0.8 https://phrma.org/blog/author/nick-mcgee 2026-04-03 daily 0.8 https://phrma.org/blog/author/sarah-k-martin 2026-04-03 daily 0.8 https://phrma.org/blog/author/kristin-williams 2026-04-03 daily 0.8 https://phrma.org/blog/author/mike-ybarra 2026-04-03 daily 0.8 https://phrma.org/blog/author/kevin-haninger 2026-04-03 daily 0.8 https://phrma.org/blog/author/douglas-petersen 2026-04-03 daily 0.8 https://phrma.org/blog/author/andrew-powaleny 2026-04-03 daily 0.8 https://phrma.org/blog/author/liz-mahar 2026-04-03 daily 0.8 https://phrma.org/blog/author/rebecca-nebel-phd 2026-04-03 daily 0.8 https://phrma.org/blog/author/sarah-ryan 2026-04-03 daily 0.8 https://phrma.org/blog/author/gabby-migliara 2026-04-03 daily 0.8 https://phrma.org/blog/author/hannah-loiacono 2026-04-03 daily 0.8 https://phrma.org/blog/author/molly-jenkins 2026-04-03 daily 0.8 https://phrma.org/blog/author/ernest-kawka 2026-04-03 daily 0.8 https://phrma.org/blog/author/robert-zirkelbach 2026-04-03 daily 0.8 https://phrma.org/blog/author/lori-reilly 2026-04-03 daily 0.8 https://phrma.org/blog/author/elizabeth-carpenter 2026-04-03 daily 0.8 https://phrma.org/blog/author/rachel-weissman 2026-04-03 daily 0.8 https://phrma.org/blog/author/brian-picone 2026-04-03 daily 0.8 https://phrma.org/blog/author/courtney-christian 2026-04-03 daily 0.8 https://phrma.org/blog/author/cynthia-hicks 2026-04-03 daily 0.8 https://phrma.org/blog/author/richard-kane 2026-04-03 daily 0.8 https://phrma.org/blog/author/samantha-dougherty 2026-04-03 daily 0.8 https://phrma.org/blog/author/stephen-j-ubl 2026-04-03 daily 0.8 https://phrma.org/blog/author/gabby-migliara1 2026-04-03 daily 0.8 https://phrma.org/blog/author/john-corea1 2026-04-03 daily 0.8 https://phrma.org/blog/author/jonathan-kimball 2026-04-03 daily 0.8 https://phrma.org/blog/author/josephine-martin 2026-04-03 daily 0.8 https://phrma.org/blog/author/kelsey-lang 2026-04-03 daily 0.8 https://phrma.org/blog/author/lauren-dipaola 2026-04-03 daily 0.8 https://phrma.org/blog/author/mark-grayson 2026-04-03 daily 0.8 https://phrma.org/blog/author/michelle-drozd 2026-04-03 daily 0.8 https://phrma.org/blog/author/mit-spears 2026-04-03 daily 0.8 https://phrma.org/blog/author/mollymae-metheny 2026-04-03 daily 0.8 https://phrma.org/blog/author/olivia-shopshear 2026-04-03 daily 0.8 https://phrma.org/blog/author/pete-martinez 2026-04-03 daily 0.8 https://phrma.org/blog/author/priscilla-vanderveer 2026-04-03 daily 0.8 https://phrma.org/blog/author/rebecca-davison 2026-04-03 daily 0.8 https://phrma.org/blog/author/rick-smith 2026-04-03 daily 0.8 https://phrma.org/blog/author/sarah-spurgeon 2026-04-03 daily 0.8 https://phrma.org/blog/author/sascha-haverfield 2026-04-03 daily 0.8 https://phrma.org/blog/author/setareh-samii 2026-04-03 daily 0.8 https://phrma.org/blog/author/stephanie-fischer 2026-04-03 daily 0.8 https://phrma.org/blog/author/stephen-j-ubl-and-giovanni-caforio-m-d 2026-04-03 daily 0.8 https://phrma.org/blog/author/tina-stow 2026-04-03 daily 0.8 https://phrma.org/blog/author/emily-ortman 2026-04-03 daily 0.8 https://phrma.org/blog/author/kristen-booze 2026-04-03 daily 0.8 https://phrma.org/blog/author/brianna-allen 2026-04-03 daily 0.8 https://phrma.org/blog/author/elise-shutzer 2026-04-03 daily 0.8 https://phrma.org/blog/author/fabian-lucero-and-nielah-tucker 2026-04-03 daily 0.8 https://phrma.org/blog/author/eliza-maciag 2026-04-03 daily 0.8 https://phrma.org/blog/author/mark-allen 2026-04-03 daily 0.8 https://phrma.org/blog/author/alexander-hardy 2026-04-03 daily 0.8 https://phrma.org/blog/author/miguel-fernandez-alcalde 2026-04-03 daily 0.8 https://phrma.org/blog/author/jean-michel-boers 2026-04-03 daily 0.8 https://phrma.org/blog/author/tracey-merchant 2026-04-03 daily 0.8 https://phrma.org/blog/author/lucy-vereshchagina-phd 2026-04-03 daily 0.8 https://phrma.org/blog/author/james-c-stansel 2026-04-03 daily 0.8 https://phrma.org/blog/author/renuka-iyer 2026-04-03 daily 0.8 https://phrma.org/blog/author/caroline-dunne 2026-04-03 daily 0.8 https://phrma.org/blog/author/ken-keller 2026-04-03 daily 0.8 https://phrma.org/blog/author/julie-kim 2026-04-03 daily 0.8 https://phrma.org/blog/author/douglas-j-langa 2026-04-03 daily 0.8 https://phrma.org/blog/author/david-loew 2026-04-03 daily 0.8 https://phrma.org/blog/author/vasant-vas-narasimhan 2026-04-03 daily 0.8 https://phrma.org/blog/author/richard-f-pops 2026-04-03 daily 0.8 https://phrma.org/blog/author/tarek-rabah 2026-04-03 daily 0.8 https://phrma.org/blog/author/david-ricks 2026-04-03 daily 0.8 https://phrma.org/blog/author/chris-round 2026-04-03 daily 0.8 https://phrma.org/blog/author/jennifer-taubert 2026-04-03 daily 0.8 https://phrma.org/blog/author/jean-christophe-tellier 2026-04-03 daily 0.8 https://phrma.org/blog/author/chris-viehbacher 2026-04-03 daily 0.8 https://phrma.org/blog/author/emma-walmsley 2026-04-03 daily 0.8 https://phrma.org/blog/author/tatsuyuki-yasuno 2026-04-03 daily 0.8 https://phrma.org/blog/author/michael-petroutsas 2026-04-03 daily 0.8 https://phrma.org/blog/author/kyle-gano-ph-d 2026-04-03 daily 0.8 https://phrma.org/blog/author/ashley-magargee 2026-04-03 daily 0.8 https://phrma.org/blog/author/pascal-soriot 2026-04-03 daily 0.8 https://phrma.org/blog/author/tsutomu-nakagawa 2026-04-03 daily 0.8 https://phrma.org/blog/author/steve-schaefer 2026-04-03 daily 0.8 https://phrma.org/blog/author/elcin-barker-ergun 2026-04-03 daily 0.8 https://phrma.org/blog/author/thomas-gibbs 2026-04-03 daily 0.8 https://phrma.org/blog/author/barry-greene 2026-04-03 daily 0.8 https://phrma.org/blog/author/karyn-schwartz 2026-04-03 daily 0.8 https://phrma.org/blog/author/lauren-neves 2026-04-03 daily 0.8 https://phrma.org/blog/author/rachel-licata 2026-04-03 daily 0.8 https://phrma.org/blog/author/randy-burkholder 2026-04-03 daily 0.8 https://phrma.org/blog/author/ken-e 2026-04-03 daily 0.8 https://phrma.org/blog/author/daniel-o-day 2026-04-03 daily 0.8 https://phrma.org/blog/author/albert-bourla 2026-04-03 daily 0.8 https://phrma.org/blog/author/chris-boerner 2026-04-03 daily 0.8 https://phrma.org/blog/author/robert-a-bradway 2026-04-03 daily 0.8 https://phrma.org/blog/author/robert-m-davis 2026-04-03 daily 0.8 https://phrma.org/blog/author/sebastian-guth 2026-04-03 daily 0.8 https://phrma.org/blog/author/tom-wilbur 2026-04-03 daily 0.8 https://phrma.org/blog/author/stami-turk 2026-04-03 daily 0.8 https://phrma.org/blog/author/reid-porter 2026-04-03 daily 0.8 https://phrma.org/blog/author/tim-mcclung 2026-04-03 daily 0.8 https://phrma.org/blog/author/yolanda-hutchins 2026-04-03 daily 0.8 https://phrma.org/blog/author/anjam-aziz 2026-04-03 daily 0.8 https://phrma.org/blog/author/brad-bailey 2026-04-03 daily 0.8 https://phrma.org/blog/author/will-may 2026-04-03 daily 0.8 https://phrma.org/blog/author/mike-doustdar 2026-04-03 daily 0.8 https://phrma.org/international 2026-04-03 daily 0.8 https://phrma.org/pipeline-collaborations 2026-04-03 daily 0.8 https://phrma.org/policy-issues 2026-04-03 daily 0.8 https://phrma.org/policy-issues/340bmarkup 2026-04-03 daily 0.8 https://phrma.org/policy-issues/340b 2026-04-03 daily 0.8 https://phrma.org/policy-issues/research-development 2026-04-03 daily 0.8 https://phrma.org/policy-issues/research-development/clinical-trials 2026-04-03 daily 0.8 https://phrma.org/policy-issues/research-development/biopharmaceutical-manufacturing 2026-04-03 daily 0.8 https://phrma.org/policy-issues/research-development/economic-impact 2026-04-03 daily 0.8 https://phrma.org/policy-issues/research-development/pdufa 2026-04-03 daily 0.8 https://phrma.org/policy-issues/innovative-medicines 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/cancer 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/digital-health 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/amr 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/cell-gene-therapies 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/mental-health 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/therapies 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/pediatrics 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/vaccines 2026-04-03 daily 0.8 https://phrma.org/policy-issues/future-of-medicine/rare-diseases 2026-04-03 daily 0.8 https://phrma.org/policy-issues/intellectual-property 2026-04-03 daily 0.8 https://phrma.org/policy-issues/government-price-setting 2026-04-03 daily 0.8 https://phrma.org/policy-issues/government-price-setting/inflation-reduction-act 2026-04-03 daily 0.8 https://phrma.org/policy-issues/government-price-setting/value-assessments 2026-04-03 daily 0.8 https://phrma.org/policy-issues/cost-of-medicines 2026-04-03 daily 0.8 https://phrma.org/policy-issues/pbms-middlemen 2026-04-03 daily 0.8 https://phrma.org/policy-issues/medicare-medicaid 2026-04-03 daily 0.8 https://phrma.org/policy-issues/medicare-medicaid/medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/policy-issues/medicare-medicaid/medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/policy-issues/health-insurance 2026-04-03 daily 0.8 https://phrma.org/policy-issues/safety 2026-04-03 daily 0.8 https://phrma.org/policy-issues/innovation-ecosystem 2026-04-03 daily 0.8 https://phrma.org/policy-issues/patient-access-affordability 2026-04-03 daily 0.8 https://phrma.org/access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/resources 2026-04-03 daily 0.8 https://phrma.org/resources/forbes-healthcare-summit 2026-04-03 daily 0.8 https://phrma.org/resources/informa-medicaid-drug-rebate-program-summit 2026-04-03 daily 0.8 https://phrma.org/resources/innovation-day-2019 2026-04-03 daily 0.8 https://phrma.org/resources/live-with-the-19th-prioritizing-mental-health 2026-04-03 daily 0.8 https://phrma.org/resources/making-medicare-work-better-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/modern-healthcare-leadership-symposium 2026-04-03 daily 0.8 https://phrma.org/resources/pathways-to-patient-affordability 2026-04-03 daily 0.8 https://phrma.org/resources/people-v-cancer 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-media-briefing-at-asco 2026-04-03 daily 0.8 https://phrma.org/resources/reuters-pharma-usa-2024 2026-04-03 daily 0.8 https://phrma.org/resources/the-art-of-the-possible-reimagining-the-biopharmaceutical-supply-chain 2026-04-03 daily 0.8 https://phrma.org/resources/the-future-of-fighting-cancer 2026-04-03 daily 0.8 https://phrma.org/resources/the-future-of-health-care-summit 2026-04-03 daily 0.8 https://phrma.org/resources/the-future-of-science-how-women-are-leading-medical-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/the-inflation-reduction-act-unfinished-business 2026-04-03 daily 0.8 https://phrma.org/resources/the-post-midterm-health-care-agenda 2026-04-03 daily 0.8 https://phrma.org/resources/the-state-of-care-disrupting-alzheimers 2026-04-03 daily 0.8 https://phrma.org/resources/turning-point-documentary-screening-plus-conversation 2026-04-03 daily 0.8 https://phrma.org/resources/whats-really-driving-the-cost-of-health-care-in-2023 2026-04-03 daily 0.8 https://phrma.org/resources/one-pagers-and-infographics 2026-04-03 daily 0.8 https://phrma.org/resources/polling-blogs 2026-04-03 daily 0.8 https://phrma.org/resources/press-room-redirect 2026-04-03 daily 0.8 https://phrma.org/resources/related-resources-out-of-pockets 2026-04-03 daily 0.8 https://phrma.org/resources/terri-foy 2026-04-03 daily 0.8 https://phrma.org/resources/policy-solutions-promoting-value-driven-health-care 2026-04-03 daily 0.8 https://phrma.org/resources/costs-in-context-videos-and-graphics 2026-04-03 daily 0.8 https://phrma.org/resources/prescription-medicine-insulin-costs-in-context 2026-04-03 daily 0.8 https://phrma.org/resources/september-2023-polling-doc 2026-04-03 daily 0.8 https://phrma.org/resources/a-delicate-balance_pharmaceutical-innovation-and-access 2026-04-03 daily 0.8 https://phrma.org/resources/bio_phrma-principles-on-responsible-sharing-of-truthful-and-non_misleading-cod15 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-positions-on-quality-and-performance-measurement 2026-04-03 daily 0.8 https://phrma.org/resources/after-covid-19-preventing-the-next-pandemic 2026-04-03 daily 0.8 https://phrma.org/resources/asco-media-briefing 2026-04-03 daily 0.8 https://phrma.org/resources/bamberg-health-us-northeast-healthcare-innovation-summit 2026-04-03 daily 0.8 https://phrma.org/resources/bridging-the-gap-new-collaborations-to-drive-antimicrobial-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/bridging-the-gender-and-racial-health-gap 2026-04-03 daily 0.8 https://phrma.org/resources/deconstructing-the-prescription-drug-supply-chain 2026-04-03 daily 0.8 https://phrma.org/resources/fierce-biotech-summit 2026-04-03 daily 0.8 https://phrma.org/resources/fierce-jpm-week-2024-patient-affordability-outlook 2026-04-03 daily 0.8 https://phrma.org/resources/fierce-pharmas-jp-morgan-health-care-conference 2026-04-03 daily 0.8 https://phrma.org/resources/better-health-care 2026-04-03 daily 0.8 https://phrma.org/resources/five-reasons-tying-va-prices-to-medicare-part-d-misses-the-mark-september-2021 2026-04-03 daily 0.8 https://phrma.org/resources/health-care-communications 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-recognizes-2016-research-and-hope-award-recipients 2026-04-03 daily 0.8 https://phrma.org/resources/progress-in-treating-diabetes 2026-04-03 daily 0.8 https://phrma.org/resources/sources-of-adherence-research-funding 2026-04-03 daily 0.8 https://phrma.org/resources/stopping-the-spread-of-ebola 2026-04-03 daily 0.8 https://phrma.org/resources/the-state-of-care-future-of-medicare 2026-04-03 daily 0.8 https://phrma.org/resources/the-state-of-care-patient-access-and-affordability 2026-04-03 daily 0.8 https://phrma.org/resources/media-contacts 2026-04-03 daily 0.8 https://phrma.org/resources/press-room 2026-04-03 daily 0.8 https://phrma.org/resources/state-map 2026-04-03 daily 0.8 https://phrma.org/resources/the-value-collaborative 2026-04-03 daily 0.8 https://phrma.org/resources/340b-morning-consult-polling 2026-04-03 daily 0.8 https://phrma.org/resources/poll-memo-july-2020 2026-04-03 daily 0.8 https://phrma.org/resources/the-value-collaborative-videos 2026-04-03 daily 0.8 https://phrma.org/resources/vermonts-2016-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/resources/a-day-in-the-life 2026-04-03 daily 0.8 https://phrma.org/resources/resource-library 2026-04-03 daily 0.8 https://phrma.org/resources/card-the-dangers-of-the-latest-drug 2026-04-03 daily 0.8 https://phrma.org/resources/ifpma-right-rail 2026-04-03 daily 0.8 https://phrma.org/resources/statement-by-imc-amiif-and-phrma-on-promoting-ethics-and-business-integrity-in-healthcare 2026-04-03 daily 0.8 https://phrma.org/resources/emerging-value-in-oncology 2026-04-03 daily 0.8 https://phrma.org/resources/clinical-trial-diversity-principles-executive-summary 2026-04-03 daily 0.8 https://phrma.org/resources/direct-to-consumer-advertising-principles 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-principles-for-clinical-trial-data-sharing 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-principles-for-responsible-clinical-trial-data-sharing-certifications 2026-04-03 daily 0.8 https://phrma.org/resources/principles-for-value-assessment-frameworks 2026-04-03 daily 0.8 https://phrma.org/resources/a-history-of-medicare 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-principles-on-responsible-sharing-of-truthful-and-non-misleading-information-about-medicines-with-health-care-professionals-and-payers 2026-04-03 daily 0.8 https://phrma.org/resources/new-yorks-2016-exchange-plans 2026-04-03 daily 0.8 https://phrma.org/resources/financial-times-us-pharma-and-biotech-summit 2026-04-03 daily 0.8 https://phrma.org/resources/lets-talk-about-cost 2026-04-03 daily 0.8 https://phrma.org/resources/share-the-savings-states 2026-04-03 daily 0.8 https://phrma.org/resources/share-the-savings2 2026-04-03 daily 0.8 https://phrma.org/resources/poc-share-the-savings-if-insurers-dont-pay-full-price-for-medicines-seniors-shouldnt-either 2026-04-03 daily 0.8 https://phrma.org/resources/industry-economic-impact 2026-04-03 daily 0.8 https://phrma.org/resources/the-washington-post-global-womens-summit 2026-04-03 daily 0.8 https://phrma.org/resources/americas-physician-groups-annual-fall-conference 2026-04-03 daily 0.8 https://phrma.org/resources/bamberg-health-north-america-rare-disease-summit 2026-04-03 daily 0.8 https://phrma.org/resources/press-release-launch-of-us-consensus-framework-to-advance-health-equity-and-ethical-collaboration 2026-04-03 daily 0.8 https://phrma.org/resources/industry-profile-2020 2026-04-03 daily 0.8 https://phrma.org/resources/code-on-interactions-with-health-care-professionals 2026-04-03 daily 0.8 https://phrma.org/resources/the-atlantic-people-v-cancer 2026-04-03 daily 0.8 https://phrma.org/resources/the-rise-of-the-superbugs-tackling-antibiotic-and-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-policy-solutions_delivering-innovative-treatments-to-patients 2026-04-03 daily 0.8 https://phrma.org/resources/policy-prescriptions-for-cost-and-coverage 2026-04-03 daily 0.8 https://phrma.org/resources/costs-in-context-videos-and-graphics1 2026-04-03 daily 0.8 https://phrma.org/resources/reuters-pharma-and-patient-usa-2024 2026-04-03 daily 0.8 https://phrma.org/resources/the-hill-us-healthcares-annual-checkup 2026-04-03 daily 0.8 https://phrma.org/resources/fierce-jpm-week-addressing-patient-affordability-with-340b 2026-04-03 daily 0.8 https://phrma.org/resources/the-state-of-care-innovation-and-access 2026-04-03 daily 0.8 https://phrma.org/resources/leading-on-value-solutions-for-an-evolving-health-care-system 2026-04-03 daily 0.8 https://phrma.org/resources/justine-dellaringa 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-letter-on-cms-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-principles-on-conduct-of-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-data-how-race-ethnicity-travel-through-the-system-and-get-lost-along-the-way 2026-04-03 daily 0.8 https://phrma.org/resources/adherence 2026-04-03 daily 0.8 https://phrma.org/resources/us-consensus-framework-to-advance-ethical-collaboration 2026-04-03 daily 0.8 https://phrma.org/resources/community-guidelines 2026-04-03 daily 0.8 https://phrma.org/resources/americas-biopharmaceutical-companies-continue-to-expand-advanced-manufacturing-across-the-country 2026-04-03 daily 0.8 https://phrma.org/resources/americas-biopharmaceutical-companies 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-alaska-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-california-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-colorado-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-connecticut-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-maryland-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-massachusetts-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-minnesota-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-nevada-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-new-mexico-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-new-york-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-oregon-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-texas-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-washington-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/barriers-between-black-patients-and-their-health-care 2026-04-03 daily 0.8 https://phrma.org/resources/biomarkers-and-surrogate-endpoints 2026-04-03 daily 0.8 https://phrma.org/resources/bsufaiii 2026-04-03 daily 0.8 https://phrma.org/resources/closing-the-gender-gap-in-innovation-the-biopharmaceutical-industry-leads-the-way 2026-04-03 daily 0.8 https://phrma.org/resources/colorado-share-the-savings-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/debunking-the-false-narrative-about-biopharmaceutical-patents 2026-04-03 daily 0.8 https://phrma.org/resources/driving-medical-innovation-and-patient-access-through-the-indo-pacific-economic-framework 2026-04-03 daily 0.8 https://phrma.org/resources/executive-summary-comment-letter-to-hhs-on-blueprint-to-lower-drug-prices-and-reduce-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/resources/four-things-affecting-the-hispanic-patient-experience 2026-04-03 daily 0.8 https://phrma.org/resources/getting-the-facts-straight-on-medicare-part-b-and-the-proposed-international-pricing-index-model 2026-04-03 daily 0.8 https://phrma.org/resources/government-price-setting-policies-do-not-address-systemic-health-equity-issues 2026-04-03 daily 0.8 https://phrma.org/resources/patient-assistance 2026-04-03 daily 0.8 https://phrma.org/resources/11-billion-vaccine-doses-in-2021 2026-04-03 daily 0.8 https://phrma.org/resources/infographics-on-obtaining-patents-and-maintaining-patents 2026-04-03 daily 0.8 https://phrma.org/resources/out-of-pocket-trends-in-medicare-part-d-show-rising-costs-for-seniors 2026-04-03 daily 0.8 https://phrma.org/resources/the-dangers-of-government-negotiation 2026-04-03 daily 0.8 https://phrma.org/resources/3rd-annual-pathways-to-success-virtual-graduate-summit-and-career-expo 2026-04-03 daily 0.8 https://phrma.org/resources/addressing-the-unmet-medical-needs-of-older-americans 2026-04-03 daily 0.8 https://phrma.org/resources/americas-biopharmaceutical-research-companies-are-committed-to-fighting-mental-illness 2026-04-03 daily 0.8 https://phrma.org/resources/by-the-numbers-340b-is-driving-up-health-care-costs 2026-04-03 daily 0.8 https://phrma.org/resources/government-negotiation-threatens-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/government-price-setting-threatens-patient-access-to-treatments 2026-04-03 daily 0.8 https://phrma.org/resources/government-price-setting-threatens-the-many-significant-innovations-generated-after-initial-fda-approval 2026-04-03 daily 0.8 https://phrma.org/resources/implications-of-speaker-pelosis-drug-pricing-plan 2026-04-03 daily 0.8 https://phrma.org/resources/making-coupons-count-a-case-study-for-patients-with-hiv 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-letter-to-hrsa-and-hhs-regarding-duplicate-discounting-in-340b 2026-04-03 daily 0.8 https://phrma.org/resources/the-dangers-of-the-latest-drug-pricing-plan-in-the-reconciliation-package 2026-04-03 daily 0.8 https://phrma.org/resources/value-based-contracts-2009-q2-2019 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-preparing-for-the-next-public-health-emergency-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-10-things-you-should-know-about-medicine-spending-and-costs 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-better-use-of-medicines-can-improve-health-outcomes-and-reduce-the-use-of-costly-medical-care 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-government-mandated-price-controls-harm-patients-and-undermine-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-hospital-consolidation-increases-health-care-costs-for-patients-and-the-healthcare-system 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-ip-incentives-fuel-biopharmaceutical-innovation-and-competition 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-medicines-are-transforming-the-trajectory-of-many-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-the-biopharmaceutical-industry-fuels-the-economy-and-global-competitiveness 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-the-dynamic-u-s-research-and-development-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-the-importance-of-strong-trade-agreements-in-driving-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/2019-industry-profile-toolkit-understanding-the-pharmaceutical-distribution-and-payment-system-and-how-it-could-work-better-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-10-things-you-should-know-about-medicine-spending-and-costs 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-2020-importance-of-trade-agreements 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-about-phrma 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-better-use-of-medicines-can-improve-health-outcomes-and-reduce-the-use-of-costly-medical-care 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-ensuring-the-safety-and-continuity-of-the-drug-supply-chain 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-how-the-us-health-care-system-can-better-accommodate-cell-and-gene-therapies 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-innovative-contracting-opportunities-and-challenges 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-medicines-are-transforming-the-trajectory-of-many-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-the-biopharmaceutical-industry-fueling-the-economy-and-global-competitiveness 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-the-biopharmaceutical-research-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/2020-industry-profile-toolkit-the-dynamic-us-research-and-development-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-10-things-you-should-know-about-medicine-spending-and-costs 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-about-phrma 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-better-use-of-medicines-can-improve-health-outcomes-and-reduce-the-use-of-costly-medical-care 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-government-price-setting-threatens-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-how-the-us-health-care-system-can-better-accommodate-cell-and-gene-therapies 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-innovative-contracting-opportunities-and-challenges 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-making-medicines-more-affordable-for-commercially-insured-patients-and-medicare-beneficiaries 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-medicines-are-transforming-the-trajectory-of-many-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-preparing-for-the-next-public-health-emergency-amr 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-preserving-the-340b-program-and-protecting-the-safety-net 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-the-biopharmaceutical-industrys-role-in-fueling-the-us-economy-and-global-competitiveness 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-the-biopharmaceutical-research-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-the-dynamic-us-research-and-development-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/2021-industry-profile-toolkit-the-importance-of-strong-trade-policy-in-driving-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/2022-industry-profile-toolkit-the-340b-program-once-a-safety-net-program-now-a-program-that-fails-vulnerable-patients 2026-04-03 daily 0.8 https://phrma.org/resources/340b-the-federal-safety-net-program-benefitting-everyone-but-patients 2026-04-03 daily 0.8 https://phrma.org/resources/340b-the-unintentional-profit-stream-that-was-supposed-to-help-patients 2026-04-03 daily 0.8 https://phrma.org/resources/4-things-to-know-about-340b-and-contract-pharmacies 2026-04-03 daily 0.8 https://phrma.org/resources/4-things-to-know-about-biopharmaceutical-efforts-to-fight-cancer 2026-04-03 daily 0.8 https://phrma.org/resources/4-things-you-need-to-know-about-marketing-and-promotion-of-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/ads 2026-04-03 daily 0.8 https://phrma.org/resources/americans-with-mental-health-conditions-face-administrative-and-financial-barriers-to-care-pes-3 2026-04-03 daily 0.8 https://phrma.org/resources/americans-with-mental-health 2026-04-03 daily 0.8 https://phrma.org/resources/biologics-what-makes-them-different 2026-04-03 daily 0.8 https://phrma.org/resources/biopharmaceutical-trade-supports-americas-economy-and-a-large-diverse-workforce 2026-04-03 daily 0.8 https://phrma.org/resources/making-coupons-count-for-patients-at-the-pharmacy-counter 2026-04-03 daily 0.8 https://phrma.org/resources/3-things-that-support-robust-biopharmaceutical-research-and-development 2026-04-03 daily 0.8 https://phrma.org/resources/accelerated-approval-bringing-patients-access-to-needed-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/biopharmaceutical-innovation-in-fighting-hiv-aids 2026-04-03 daily 0.8 https://phrma.org/resources/4-truths-about-state-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/resources/antimicrobial-resistance-a-growing-public-health-threat 2026-04-03 daily 0.8 https://phrma.org/resources/2022-morning-consult-state-poll-health-care-issues-and-policy-solutions 2026-04-03 daily 0.8 https://phrma.org/resources/2021-phrma-scholars 2026-04-03 daily 0.8 https://phrma.org/resources/explainer-vertical-integration-may-allow-insurers-to-skirt-medical-loss-ratio-requirements 2026-04-03 daily 0.8 https://phrma.org/resources/americans-reject-medicare-negotiation-and-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/resources/health-insurance-companies-and-pharmacy-benefit-managers-pose-barriers-to-care 2026-04-03 daily 0.8 https://phrma.org/resources/hold-pbms-accountable-rein-in-middlemen-tactics-that-harm-patients 2026-04-03 daily 0.8 https://phrma.org/resources/impact-of-industry-sponsored-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/resources/infographic-how-medicine-purchased-at-a-canadian-internet-pharmacy-could-actually-be-fake 2026-04-03 daily 0.8 https://phrma.org/resources/infographic-the-realities-of-drug-importation-from-canada 2026-04-03 daily 0.8 https://phrma.org/resources/infographic-voters-frustrated-by-hurdles-imposed-by-health-insurance-companies-and-pharmacy-benefit-managers 2026-04-03 daily 0.8 https://phrma.org/resources/international-reference-pricing-outsources-decisions-about-americans-medicines-and-health 2026-04-03 daily 0.8 https://phrma.org/resources/key-findings-from-the-patient-experience-survey 2026-04-03 daily 0.8 https://phrma.org/resources/lessons-learned-from-europe-price-setting-policies-erode-biopharmaceutical-leadership 2026-04-03 daily 0.8 https://phrma.org/resources/making-medicines-more-affordable 2026-04-03 daily 0.8 https://phrma.org/resources/marketing-and-promotion-of-medicines-4-things-you-need-to-know 2026-04-03 daily 0.8 https://phrma.org/resources/mat-one-pager-espanol 2026-04-03 daily 0.8 https://phrma.org/resources/mat-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/may-2024-registered-voter-survey-results 2026-04-03 daily 0.8 https://phrma.org/resources/medicaid-by-the-numbers 2026-04-03 daily 0.8 https://phrma.org/resources/meet-mat-brochure 2026-04-03 daily 0.8 https://phrma.org/resources/michigan-share-the-savings-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/morning-consult-september-2024-registered-voter-survey 2026-04-03 daily 0.8 https://phrma.org/resources/nearly-half-of-every-dollar-spent-on-medicines-goes-to-someone-who-doesnt-make-them 2026-04-03 daily 0.8 https://phrma.org/resources/nevada-share-the-savings-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/new-hampshire-share-the-savings-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/new-survey-americans-overwhelming-support-strong-reforms-that-rein-in-pbm-abuses 2026-04-03 daily 0.8 https://phrma.org/resources/ohio-share-the-savings-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/patient-experience-survey-insurer-and-pbm-imposed-barriers-stand-between-patients-and-health-care 2026-04-03 daily 0.8 https://phrma.org/resources/patient-journey-through-a-technology-driven-health-care-system 2026-04-03 daily 0.8 https://phrma.org/resources/patients-deserve-better-than-treatment-delays 2026-04-03 daily 0.8 https://phrma.org/resources/pdufa-vi 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-call-for-public-input-on-icer-value-framework 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-member-companies-raise-concerns-with-impact-of-proposed-international-pricing-index-model 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-usmca-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/prescriber-requirements-to-help-combat-the-opioid-crisis 2026-04-03 daily 0.8 https://phrma.org/resources/protect-copay-assistance-end-insurer-and-middlemen-games-that-drive-up-costs-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/realities-of-importation 2026-04-03 daily 0.8 https://phrma.org/resources/rfi-comments-on-hhs-blueprint-to-lower-drug-prices-and-reduce-out-of-pocket-costs 2026-04-03 daily 0.8 https://phrma.org/resources/setting-the-record-straight-on-the-bayh-dole-act-and-march-in 2026-04-03 daily 0.8 https://phrma.org/resources/sharing-negotiated-savings-with-patients-at-the-pharmacy-counter 2026-04-03 daily 0.8 https://phrma.org/resources/sharing-rebates-can-save-americans-with-diabetes-500-each-year-and-improve-adherence 2026-04-03 daily 0.8 https://phrma.org/resources/significant-pharmaceutical-backlogs-remain-in-brazil 2026-04-03 daily 0.8 https://phrma.org/resources/south-carolina-share-the-savings-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/standardized-plans-can-improve-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/testimony-of-lori-m-reilly-perspectives-on-the-340b-drug-discount-program 2026-04-03 daily 0.8 https://phrma.org/resources/the-danger-of-waiving-trips-intellectual-property-rights-at-the-wto 2026-04-03 daily 0.8 https://phrma.org/resources/the-dangers-of-h-r-3 2026-04-03 daily 0.8 https://phrma.org/resources/the-ira-could-lead-to-higher-out-of-pocket-costs-for-3-and-a-half-million-medicare-patients-in-2026 2026-04-03 daily 0.8 https://phrma.org/resources/the-potential-economic-impacts-of-a-significant-shift-in-us-biopharmaceutical-industry-revenues 2026-04-03 daily 0.8 https://phrma.org/resources/the-united-states-vs-other-countries-availability-of-cancer-medicines-varies 2026-04-03 daily 0.8 https://phrma.org/resources/the-united-states-vs-other-countries-availability-of-new-medicines-varies 2026-04-03 daily 0.8 https://phrma.org/resources/the-united-states-vs-other-countries-availability-of-part-b-medicines-varies 2026-04-03 daily 0.8 https://phrma.org/resources/the-us-market-for-biosimilars-and-biologics-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/three-things-to-know-about-how-insurers-and-pbms-impose-barriers-to-care-for-mental-health-patients 2026-04-03 daily 0.8 https://phrma.org/resources/transforming-biopharmaceutical-research-and-development-through-digital-health 2026-04-03 daily 0.8 https://phrma.org/resources/washington-share-the-savings-one-pager 2026-04-03 daily 0.8 https://phrma.org/resources/what-is-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/resources/what-voters-are-looking-for-this-election-cycle 2026-04-03 daily 0.8 https://phrma.org/resources/who-pandemic-agreement-pros-and-cons-for-us-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/wto-twelfth-ministerial-conference 2026-04-03 daily 0.8 https://phrma.org/resources/for-profit-pharmacies-make-billions-off-340b-program-without-clear-benefit-to-patients 2026-04-03 daily 0.8 https://phrma.org/resources/value-assessments-should-include-all-the-outcomes-that-matter-to-patients-and-families 2026-04-03 daily 0.8 https://phrma.org/resources/how-will-international-reference-pricing-affect-you 2026-04-03 daily 0.8 https://phrma.org/resources/the-biosimilar-red-tape-elimination-act-provides-a-new-profit-source-for-pbms 2026-04-03 daily 0.8 https://phrma.org/resources/pediatric-drug-development-issue-brief-progress-in-a-critical-but-challenging-space 2026-04-03 daily 0.8 https://phrma.org/resources/stop-pharmacy-benefit-managers-from-gaming-the-system 2026-04-03 daily 0.8 https://phrma.org/resources/what-is-pdufa-vi 2026-04-03 daily 0.8 https://phrma.org/resources/pocket-card-what-is-pdufa 2026-04-03 daily 0.8 https://phrma.org/resources/patient-experience-survey-protecting-lifelines-to-access-and-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/spurring-innovation-in-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/innovative-contracts-2009-2021 2026-04-03 daily 0.8 https://phrma.org/resources/morning-consult-national-poll-may-2024 2026-04-03 daily 0.8 https://phrma.org/resources/supply-chain-backgrounder 2026-04-03 daily 0.8 https://phrma.org/resources/share-the-savings-if-insurers-dont-pay-full-price-for-medicines-seniors-shouldnt-either 2026-04-03 daily 0.8 https://phrma.org/resources/what-is-hatch-waxman 2026-04-03 daily 0.8 https://phrma.org/resources/how-icer-assessment-of-new-migraine-treatments-ignores-patient-needs 2026-04-03 daily 0.8 https://phrma.org/resources/how-the-340b-program-is-contributing-to-health-inequities 2026-04-03 daily 0.8 https://phrma.org/resources/medicare-prescription-payment-plan-overview-for-health-care-providers 2026-04-03 daily 0.8 https://phrma.org/resources/regulatory-data-protection-promotes-biopharmaceutical-innovation-and-patient-access 2026-04-03 daily 0.8 https://phrma.org/resources/medicare-part-d-fact-sheets 2026-04-03 daily 0.8 https://phrma.org/resources/the-long-uncertain-and-expensive-road-for-biopharmaceutical-startups 2026-04-03 daily 0.8 https://phrma.org/resources/the-public-health-success-of-vaccines 2026-04-03 daily 0.8 https://phrma.org/resources/understanding-prescription-drug-shortages 2026-04-03 daily 0.8 https://phrma.org/resources/the-ahip-premium-dollar-corrected 2026-04-03 daily 0.8 https://phrma.org/resources/2017-u-s-biopharmaceutical-exports 2026-04-03 daily 0.8 https://phrma.org/resources/2018-u-s-biopharmaceutical-exports 2026-04-03 daily 0.8 https://phrma.org/resources/2020-us-biopharmaceutical-exports 2026-04-03 daily 0.8 https://phrma.org/resources/340b-spotlight-myth-vs-fact 2026-04-03 daily 0.8 https://phrma.org/resources/a-patients-journey-an-example-of-accessing-new-alzheimers-treatments-through-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/resources/accumulator-adjustment-programs-from-payers-lead-to-surprise-out-of-pocket-costs-and-nonadherence 2026-04-03 daily 0.8 https://phrma.org/resources/americans-support-protecting-us-intellectual-property-and-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/arthritis-case-study-personalized-vs-general-treatment 2026-04-03 daily 0.8 https://phrma.org/resources/cancer-moonshot-print-ad 2026-04-03 daily 0.8 https://phrma.org/resources/foreign-threats-to-american-intellectual-property 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-graphics 2026-04-03 daily 0.8 https://phrma.org/resources/340b-covered-entities-and-for-profit-corporations-capturing-massive-profit-margins-on-medicines-dispensed-through-contract-pharmacies 2026-04-03 daily 0.8 https://phrma.org/resources/share-the-savings 2026-04-03 daily 0.8 https://phrma.org/resources/340b-then-and-now 2026-04-03 daily 0.8 https://phrma.org/resources/10-things-you-should-know-about-medicine-spending-and-costs 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-flow-of-payment-for-a-3000-hiv-medicine 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-flow-of-payment-for-a-100-blood-pressure-medicine 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-medical-product-communications-that-are-consistent-with-the-fda-required-labeling-questions-and-answers 2026-04-03 daily 0.8 https://phrma.org/resources/january-2024-morning-consult-poll-about-trips-waiver-expansion 2026-04-03 daily 0.8 https://phrma.org/resources/the-inflation-reduction-act-discourages-vital-r-and-d-in-cancer-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/hospitals-make-9-times-more-than-physicians-offices-on-provider-administered-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/infographic-on-addressing-amr 2026-04-03 daily 0.8 https://phrma.org/resources/lets-talk-about-medicare-ad-diabetes 2026-04-03 daily 0.8 https://phrma.org/resources/robust-competition-in-the-us-market-balances-affordability-and-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/the-success-of-bayh-dole 2026-04-03 daily 0.8 https://phrma.org/resources/understanding-prescription-medicine-spending 2026-04-03 daily 0.8 https://phrma.org/resources/public-private-collaboration-fuels-the-us-biopharmaceutical-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/the-dangers-of-drug-importation-counterfeit-cancer-drugs 2026-04-03 daily 0.8 https://phrma.org/resources/the-dangers-of-drug-importation 2026-04-03 daily 0.8 https://phrma.org/resources/medicine-development-in-a-complex-collaborative-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/the-vaccine-life-cycle-safety-at-every-phase 2026-04-03 daily 0.8 https://phrma.org/resources/more-than-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-list-price 2026-04-03 daily 0.8 https://phrma.org/resources/research-shows-voters-support-rebate-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-amicus-brief-with-the-us-supreme-court-in-support-of-fda 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-letter-on-oig-safe-harbor-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-national-institutes-of-health-transforming-discoveries-into-products-maximizing-nihs-levers-to-catalyze-technology-transfer 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-the-2019-national-trade-estimate-report 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-the-2020-national-trade-estimate-report 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-the-2021-national-trade-estimate-report 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-the-part-d-6pc-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-ustr-on-the-us-taiwan-initiative-on-21st-century-trade 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-files-amicus-brief-with-the-us-court-of-appeals-for-the-fifth-circuit-in-support-of-fda 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-japan-industry-vision-report 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2018 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2020 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2021 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2022 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2023 2026-04-03 daily 0.8 https://phrma.org/resources/promoting-a-proactive-policy-agenda 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-the-negotiating-objectives-for-a-us-japan-trade-agreement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-files-amicus-brief-with-us-court-of-appeals-in-support-of-fda 2026-04-03 daily 0.8 https://phrma.org/resources/86-of-aarp-members-support-the-medicare-rebate-rule-that-aarp-opposes 2026-04-03 daily 0.8 https://phrma.org/resources/amgen-ceo-robert-a-bradway-becomes-phrma-board-chairman 2026-04-03 daily 0.8 https://phrma.org/resources/analysis-finds-higher-outpatient-drug-spending-at-340b-hospitals 2026-04-03 daily 0.8 https://phrma.org/resources/biopharmaceutical-industry-takes-bold-new-policy-position-on-how-payments-should-work 2026-04-03 daily 0.8 https://phrma.org/resources/analysis-shows-how-insurers-and-middlemen-drive-up-out-of-pocket-costs-for-patients-at-the-pharmacy 2026-04-03 daily 0.8 https://phrma.org/resources/avaleres-elizabeth-carpenter-to-join-phrma-as-evp-for-policy-and-research 2026-04-03 daily 0.8 https://phrma.org/resources/daniel-o-day-new-chair-of-phrma-board 2026-04-03 daily 0.8 https://phrma.org/resources/eight-in-10-registered-voters-support-requiring-health-insurance 2026-04-03 daily 0.8 https://phrma.org/resources/eli-lilly-and-company-chairman-and-ceo-david-ricks-becomes-phrma-board-chairman 2026-04-03 daily 0.8 https://phrma.org/resources/equitable-breakthroughs-in-medicine-development-reaches-next-phase-driving-diversity-in-clinical-trials-in-georgia-south-carolina-tennessee-and-texas 2026-04-03 daily 0.8 https://phrma.org/resources/final-benefits-and-payment-rule-a-win-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/five-key-strategies-for-enhancing-diversity-in-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/resources/hospital-practices-increase-costs-of-medicines-for-patients-and-employers-new-report-shows 2026-04-03 daily 0.8 https://phrma.org/resources/house-drug-pricing-plan-will-throw-sand-in-the-gears-of-medical-progress 2026-04-03 daily 0.8 https://phrma.org/resources/latest-drug-pricing-proposal-not-the-balanced-approach-we-need 2026-04-03 daily 0.8 https://phrma.org/resources/misleading-drug-pricing-report-fails-to-address-real-affordability-challenges-patients-face 2026-04-03 daily 0.8 https://phrma.org/resources/nearly-1-in-5-hospitals-marks-up-medicine-prices-at-least-700-percent 2026-04-03 daily 0.8 https://phrma.org/resources/neurocrine-biosciences-joins-phrma 2026-04-03 daily 0.8 https://phrma.org/resources/nevada-addresses-sb-539s-most-significant-flaws 2026-04-03 daily 0.8 https://phrma.org/resources/new-analysis-finds-more-than-half-of-brand-medicine-spending-goes-to-the-supply-chain-middlemen-and-other-stakeholders 2026-04-03 daily 0.8 https://phrma.org/resources/new-analysis-finds-nearly-50-percent-of-brand-medicine-spending-goes-to-the-supply-chain-and-others 2026-04-03 daily 0.8 https://phrma.org/resources/new-analysis-inflation-reduction-act-undermines-cancer-medicine-development 2026-04-03 daily 0.8 https://phrma.org/resources/new-analysis-shows-340b-hospitals-with-highest-operating-margins-provide-lowest-levels-charity-care 2026-04-03 daily 0.8 https://phrma.org/resources/new-analysis-shows-contract-pharmacies-financially-gain-from-340b-program-with-no-clear-benefit-to-patients 2026-04-03 daily 0.8 https://phrma.org/resources/new-analysis-shows-hospitals-mark-up-medicine-prices-500-percent 2026-04-03 daily 0.8 https://phrma.org/resources/new-analysis-the-ira-could-lead-to-higher-out-of-pocket-costs-for-3-point-5-million-medicare-patients 2026-04-03 daily 0.8 https://phrma.org/resources/new-data-show-340b-hospitals-are-reimbursed-on-average-three-times-what-they-pay-for-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/new-ipsos-poll-shows-americans-are-frustrated-with-abusive-insurance-practices-that-exacerbate-access-and-affordability-challenges 2026-04-03 daily 0.8 https://phrma.org/resources/new-let-s-talk-about-cost-ads-highlight-how-copay-accumulator-programs-leave-patients-financially-exposed 2026-04-03 daily 0.8 https://phrma.org/resources/new-milliman-analysis-finds-insulin-costs-20-percent-less-today-than-in-2007 2026-04-03 daily 0.8 https://phrma.org/resources/new-poll-shows-that-support-for-medicare-negotiation-plummets-once-americans-learn-about-the-policy-arguments 2026-04-03 daily 0.8 https://phrma.org/resources/new-report-finds-largest-pbms-restrict-access-to-more-than-1150-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/new-survey-reveals-insurance-design-leads-to-access-and-affordability-issues-for-most-vulnerable-patients 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-2018-special-301-submission-calls-for-urgent-action-to-address-serious-access-and-ip-barriers 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-2020-special-301-report-urges-ustr-to-protect-us-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-applauds-courts-decision-to-strike-down-patient-assistance-penalty 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-appoints-ambassador-hans-klemm-as-new-japan-representative 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-appoints-new-leadership-to-board-of-directors 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-the-negotiating-objectives-for-a-us-european-union-trade-agreement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-ustr-regarding-us-uk-trade-agreement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-decries-damaging-foreign-practices-in-special-301-filing 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-files-amicus-brief-with-us-supreme-court-in-support-of-fda 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-joins-top-academic-leaders-to-announce-new-community-based-initiative-to-enhance-clinical-trial-diversity 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-litigation-asserts-340b-administrative-dispute-resolution-final-rule-is-unlawful-and-unconstitutional 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-makes-down-payment-on-las-growing-bioscience-sector 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-members-take-new-approach-to-dtc-television-advertising 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-names-anne-esposito-senior-vice-president-of-federal-advocacy 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-names-jennifer-bryant-executive-vice-president-of-policy-and-research 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-names-lori-reilly-chief-operating-officer 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-responds-to-hhs-dtc-rule-launches-website-providing-patients-with-cost-information 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-s-roadmap-to-health-program-makes-first-stop-in-the-bronx-with-nys-assembly-member-marcos-crespo-and-new-york-health-works 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-shares-condolences-upon-the-death-of-former-japanese-prime-minister-shinzo-abe 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2019 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-21st-century-cures-act-house-passage 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-340b-access-act 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-administration-s-drug-importation-scheme 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-administrations-importation-plan 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-administrations-part-d-senior-savings-model 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-biosimilars-action-plan 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-cms-final-guidance-on-the-price-setting-provisions-in-the-ira 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-cms-initial-price-setting-offer-to-biopharmaceutical-companies 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-comments-to-cms-regarding-proposed-part-d-rule-and-rfi-exploring-pass-through-rebates-to-seniors-at-point-of-sale 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-congressional-user-fees-agreement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-democrats-drug-pricing-deal-in-reconciliation-package 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-drug-pricing-executive-orders 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-efforts-to-support-real-world-evidence 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-fda-authorizing-floridas-importation-plan 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-fda-draft-guidance-on-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-first-list-of-medicines-subject-to-government-price-setting 2026-04-03 daily 0.8 https://phrma.org/resources/americans-sound-the-alarm-on-abusive-insurance-practices-and-call-for-and-patient-centered-solutions 2026-04-03 daily 0.8 https://phrma.org/resources/25-years-of-progress-against-hepatitis-c 2026-04-03 daily 0.8 https://phrma.org/resources/august-polling-data-update-2 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-cancer-medicines-value-in-context 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-medicines-in-340b 2026-04-03 daily 0.8 https://phrma.org/resources/pwc-fy2022-budget-revenue-effects 2026-04-03 daily 0.8 https://phrma.org/resources/2017-direct-to-consumer-advertising-survey-results 2026-04-03 daily 0.8 https://phrma.org/resources/2021-voter-solutions-data 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-autoimmune-diseases-2016-report 2026-04-03 daily 0.8 https://phrma.org/resources/researching-cancer-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/report-insurance-barriers-contribute-to-health-disparities-among-commercially-insured-americans 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-report 2026-04-03 daily 0.8 https://phrma.org/resources/innovation-in-the-biopharmaceutical-pipeline 2026-04-03 daily 0.8 https://phrma.org/resources/2005-2015-a-decade-of-innovation-in-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/practical-solutions-for-americans-true-affordability-concerns 2026-04-03 daily 0.8 https://phrma.org/resources/2017-state-of-vaccines 2026-04-03 daily 0.8 https://phrma.org/resources/new-era-of-medicine-vaccines 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-florida-importation-proposal 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-government-price-setting-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-help-act 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-hhs-speech-and-part-b-proposal 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-house-leadership-partisan-drug-pricing-proposal 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-house-passage-of-reconciliation-spending-bill 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-house-passage-of-the-patient-protection-and-affordable-care-enhancement-act 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-house-pbm-transparency-bills 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-jama-clinical-trials-study 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-latest-drug-pricing-proposal 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-new-cms-medicaid-guidance 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-nih-heal-partnership-committee 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-part-d-provision-in-budget-deal 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-passage-of-prescription-drug-board-in-the-minnesota-legislature 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-pasteur-act-introduction 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-patent-trial-and-appeal-board-reform-act-of-2022 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-political-giving 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-president-bidens-remarks-to-lower-prescription-drug-prices 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-president-bidens-state-of-the-union-address 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-president-trumps-drug-pricing-blueprint 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-presidents-fy2019-budget 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-proposed-march-in-framework 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-signing-the-us-mexico-canada-agreement-usmca 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-speaker-pelosi-s-radical-plan 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-tennessee-medicaid-demonstration 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-340b-drug-pricing-program 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-administrations-proposed-rule-to-reform-the-rebate-system 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-buy-american-executive-order 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-eu-pharmaceutical-legislation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-fda-and-latest-us-supreme-court-decision 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-hatch-waxman-integrity-act-of-2019 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-indo-pacific-economic-framework 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-inflation-reduction-act-becoming-law 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-nomination-of-dr-robert-califf-to-lead-the-us-food-and-drug-administration 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-presidents-budget-for-fiscal-year-2024 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-proposed-biosimilar-user-fee-act-iii-performance-goals-letter 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-proposed-prescription-drug-user-fee-act-vii-performance-goals-letter 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-senate-finance-committee-hearing-on-drug-pricing 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-state-of-the-union-address 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-trips-waiver-agreement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-united-states-mexico-canada-agreement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-united-states-mexico-canada-agreement-2019 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-war-in-ukraine 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-us-international-trade-commission-report-on-expanding-the-trips-waiver 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-us-supreme-court-decision-impacting-fda-drug-approval 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-user-fee-legislative-text 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-white-house-cancer-moonshot-event 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-white-house-drug-pricing-event 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-wto-trips-waiver-negotiations 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-opposing-senate-finance-committee-drug-pricing-legislation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-welcomes-2019-special-301-report 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-welcomes-genentech-and-gilead-sciences-to-association 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-welcomes-genmab-to-the-association 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-debra-deshong-announces-she-is-stepping-down-to-pursue-new-opportunities 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-steve-ubl-cbo-report-makes-clear-patients-face-future-with-less-hope-under-congress-drug-pricing-plan 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-steve-ubl-congratulates-xavier-becerra 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-steve-ubl-describes-ken-frazier-as-a-pivotal-leader-in-the-biopharma-research-industry 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-steve-ubl-says-white-house-drug-pricing-proposal-not-a-serious-plan-to-lower-what-patients-pay 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-ubl-calls-senate-passage-of-partisan-drug-pricing-plan-a-tragic-loss-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/press-release-nica-gcca-phrma-litigation-asserts-price-setting-provisions-in-the-inflation-reduction-act-are-unconstitutional 2026-04-03 daily 0.8 https://phrma.org/resources/robert-zirkelbach-returns-to-leadership-role-at-phrma 2026-04-03 daily 0.8 https://phrma.org/resources/sanofi-ceo-olivier-brandicourt-becomes-phrma-board-chairman 2026-04-03 daily 0.8 https://phrma.org/resources/seniors-patients-taking-prescription-medicines-reject-government-negotiation-when-they-learn-about-consequences-according-to-new-ipsos-poll 2026-04-03 daily 0.8 https://phrma.org/resources/sharing-negotiated-discounts-at-the-pharmacy-counter-could-save-seniors-with-diabetes-more-than-350-annually 2026-04-03 daily 0.8 https://phrma.org/resources/speaker-pelosis-drug-pricing-plan-could-result-in-56-fewer-new-medicines-over-10-years 2026-04-03 daily 0.8 https://phrma.org/resources/statement-on-biosimilar-user-fee-act-reauthorization 2026-04-03 daily 0.8 https://phrma.org/resources/statement-on-litigation-challenging-constitutionality-of-minnesotas-hf-3100 2026-04-03 daily 0.8 https://phrma.org/resources/statement-on-litigation-challenging-constitutionality-of-oregons-hb-4005-and-hb-2658 2026-04-03 daily 0.8 https://phrma.org/resources/statement-on-litigation-challenging-legality-of-the-administrations-most-favored-nation-rule 2026-04-03 daily 0.8 https://phrma.org/resources/statement-on-phrma-litigation-challenging-constitutionality-of-provisions-in-arkansas-act-1103 2026-04-03 daily 0.8 https://phrma.org/resources/statement-prescription-drug-user-fee-act-reauthorization 2026-04-03 daily 0.8 https://phrma.org/resources/steve-tilton-returns-to-phrma-as-senior-vice-president-of-federal-advocacy 2026-04-03 daily 0.8 https://phrma.org/resources/takeda-pharmaceuticals-usa-president-ramona-sequeira-becomes-phrma-board-chair-elect 2026-04-03 daily 0.8 https://phrma.org/resources/takedas-ramona-sequeira-becomes-board-chair-of-phrma 2026-04-03 daily 0.8 https://phrma.org/resources/the-pasteur-act-a-meaningful-policy-reform 2026-04-03 daily 0.8 https://phrma.org/resources/vaccine-approval-important-step-forward-against-pandemic 2026-04-03 daily 0.8 https://phrma.org/resources/vas-narasimhan-of-novartis-becomes-chair-of-phrma-board 2026-04-03 daily 0.8 https://phrma.org/resources/bristol-myers-squibb-ceo-giovanni-caforio-becomes-phrma-board-chairman 2026-04-03 daily 0.8 https://phrma.org/resources/data-show-over-half-of-patients-out-of-pocket-spending-for-brand-medicines-is-based-on-list-price 2026-04-03 daily 0.8 https://phrma.org/resources/new-report-shows-how-supply-chain-shapes-brand-name-medicine-prices 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-president-trumps-signing-of-pdufa-vi-reauthorization 2026-04-03 daily 0.8 https://phrma.org/resources/statement-on-workforce-authorities-modernization-act 2026-04-03 daily 0.8 https://phrma.org/resources/in-honor-of-visionary-leader-phrma-announces-the-kenneth-c-frazier-phrma-scholars-program 2026-04-03 daily 0.8 https://phrma.org/resources/july-2021-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/july-value-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/june-omi-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2016-medicines-in-development-for-osteoporosis 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2016-medicines-in-development-for-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2017-medicines-in-development-for-alzheimer-s 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2017-medicines-in-development-for-mental-illness 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2018-medicines-in-development-for-cancer 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2018-medicines-in-development-for-skin-disease 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2019-medicines-in-development-for-asthma 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-medicines-in-development-for-vaccines-2017 2026-04-03 daily 0.8 https://phrma.org/resources/march-2022-phrma-letter-to-senator-elizabeth-warren 2026-04-03 daily 0.8 https://phrma.org/resources/may-june-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/media-briefing-on-the-biopharmaceutical-supply-chain 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-alzheimer-s-disease 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-cancer-2018-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-cancer-2020-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-cancer-2023-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-cell-and-gene-therapy-2018-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-cell-and-gene-therapy-2018-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-cell-and-gene-therapy-2020-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-children-2012-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-children-2020-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-chronic-illness-older-americans-2023-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-diabetes-2019-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-heart-disease-and-stroke-2018-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-heart-disease-and-stroke-2018-report 2026-04-03 daily 0.8 https://phrma.org/resources/2022-mrp-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/2022-national-trade-estimate-report-on-foreign-trade-barriers-nte 2026-04-03 daily 0.8 https://phrma.org/resources/2024-national-trade-estimate-report-on-foreign-trade-barriers-nte 2026-04-03 daily 0.8 https://phrma.org/resources/a-decade-of-innovation-in-chronic-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/a-decade-of-innovation-in-rare-diseases 2026-04-03 daily 0.8 https://phrma.org/resources/a-look-at-company-efforts-to-enhance-clinical-trial-diversity 2026-04-03 daily 0.8 https://phrma.org/resources/addressing-the-growing-crises-of-mental-health-and-substance-use-disorders-in-the-united-states 2026-04-03 daily 0.8 https://phrma.org/resources/advancing-analytical-methodologies-for-unmeasured-confounding-in-real-world-evidence 2026-04-03 daily 0.8 https://phrma.org/resources/american-viewpoint-survey-march-2022 2026-04-03 daily 0.8 https://phrma.org/resources/americans-managing-an-autoimmune-condition-face-administrative-and-financial-barriers-to-care 2026-04-03 daily 0.8 https://phrma.org/resources/americans-want-a-bipartisan-approach-to-tackle-health-care-affordability-and-coverage-issues 2026-04-03 daily 0.8 https://phrma.org/resources/analysis-of-access-restrictions-to-new-medicines-in-the-united-kingdom 2026-04-03 daily 0.8 https://phrma.org/resources/april-2021-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/april-2023-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/april-consumer-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/august-2021-polling-data-medicare 2026-04-03 daily 0.8 https://phrma.org/resources/august-2021-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/barriers-to-value-based-agreements-for-drugs 2026-04-03 daily 0.8 https://phrma.org/resources/biopharmaceutical-company-communications-with-health-care-stakeholders 2026-04-03 daily 0.8 https://phrma.org/resources/biopharmaceutical-digital-health-lexicon 2026-04-03 daily 0.8 https://phrma.org/resources/biopharmaceutical-industry-efforts-to-fight-covid-19-lessons-learned-and-preparing-for-future-pandemics 2026-04-03 daily 0.8 https://phrma.org/resources/biopharmaceutical-manufacturing-in-the-u-s 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-biopharmaceuticals-in-perspective-fall-2020 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-biopharmaceuticals-in-perspective 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-rare-diseases-and-the-orphan-drug-act 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-value-of-personalized-medicine 2026-04-03 daily 0.8 https://phrma.org/resources/copay-accumulators-and-maximizers-payer-management-approach 2026-04-03 daily 0.8 https://phrma.org/resources/corporate-venture-capital-report 2026-04-03 daily 0.8 https://phrma.org/resources/covid-19-vaccines-global-production-and-uptake 2026-04-03 daily 0.8 https://phrma.org/resources/december-2021-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/disparities-in-data-solutions-and-barriers-to-implementation 2026-04-03 daily 0.8 https://phrma.org/resources/fall-health-care-priorities-for-consumers 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-part-2 2026-04-03 daily 0.8 https://phrma.org/resources/gene-therapies-can-bring-hope-to-patients-with-blood-disorders 2026-04-03 daily 0.8 https://phrma.org/resources/health-care-landscape-national-study-data 2026-04-03 daily 0.8 https://phrma.org/resources/health-care-landscape-poll-californias-52nd-congressional-district 2026-04-03 daily 0.8 https://phrma.org/resources/health-care-landscape-poll-new-jerseys-5th-congressional-district 2026-04-03 daily 0.8 https://phrma.org/resources/health-care-landscape-poll 2026-04-03 daily 0.8 https://phrma.org/resources/health-care-policy-should-get-us-closer-to-health-equity-the-inflation-reduction-act-fails-to-do-so 2026-04-03 daily 0.8 https://phrma.org/resources/healthy-aging-the-role-of-innovative-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/implications-of-the-drug-pricing-provisions-in-reconciliation 2026-04-03 daily 0.8 https://phrma.org/resources/industry-profile-2019 2026-04-03 daily 0.8 https://phrma.org/resources/january-2022-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-copd-2012-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-biologics-2013-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-asthma-and-allergy-2019-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-hiv-2017-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-immuno-oncology-2017-report 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-2017-immuno-oncology-medicines-in-development 2026-04-03 daily 0.8 https://phrma.org/resources/bsufa-iii-phrma-priorities 2026-04-03 daily 0.8 https://phrma.org/resources/deductibles-and-coinsurance-drive-high-out-of-pocket-costs-for-commercially-insured-patients-taking-brand-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/commercially-insured-patients-with-chronic-conditions-face-high-cost-sharing-for-brand-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/global-access-to-new-medicines-report 2026-04-03 daily 0.8 https://phrma.org/resources/covered-by-insurance-but-still-exposed-barriers-to-care-for-insured-americans 2026-04-03 daily 0.8 https://phrma.org/resources/eqbmed-2022-year-end-update 2026-04-03 daily 0.8 https://phrma.org/resources/industry-profile-2022 2026-04-03 daily 0.8 https://phrma.org/resources/a-sustained-commitment-to-advancing-diversity-equity-and-inclusion 2026-04-03 daily 0.8 https://phrma.org/resources/how-the-iras-drug-price-setting-program-threatens-seniors-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/faced-with-high-cost-sharing-for-brand-medicines-many-commercially-insured-patients-with-chronic-conditions-use-manufacturer-cost-sharing-assistance 2026-04-03 daily 0.8 https://phrma.org/resources/applying-icer-assessments-in-medicaid-could-limit-patients-access-to-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/data-shows-americans-reject-so-called-medicare-negotiation 2026-04-03 daily 0.8 https://phrma.org/resources/colorado-prescription-medicine-affordability-poll-january-2022 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-biopharmaceuticals-in-perspective-summer-2019 2026-04-03 daily 0.8 https://phrma.org/resources/commercially-insured-patients-pay-undiscounted-list-prices-for-one-in-five-brand-prescriptions-accounting-for-half-of-out-of-pocket-spending-brand-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/delivering-results-for-patients-the-value-of-value-based-contracts 2026-04-03 daily 0.8 https://phrma.org/resources/ebola-the-biopharm-industry-committed-to-advancements 2026-04-03 daily 0.8 https://phrma.org/resources/how-icer-s-flawed-budget-impact-threshold-can-harm-patient-access 2026-04-03 daily 0.8 https://phrma.org/resources/industry-profile-2021 2026-04-03 daily 0.8 https://phrma.org/resources/list-of-medicines-in-development-for-hiv-2017 2026-04-03 daily 0.8 https://phrma.org/resources/medicare-part-d-pocket-card 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-autoimmune-disease-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/alzheimer-s-medicines-setbacks-and-stepping-stones 2026-04-03 daily 0.8 https://phrma.org/resources/dtc-annual-report 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-50-state-poll-fall-2021 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-collaborative-actions-to-reach-equity-cares-grant-2023 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-in-the-who-pandemic-agreement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-need-for-timely-reauthorization-of-pandemic-and-all-hazards-preparedness-act 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-part-one-of-the-medicare-prescription-payment-plan-draft-guidance-for-part-d 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-litigation-challenging-340b-administrative-dispute-resolution-final-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-litigation-challenging-constitutionality-of-provisions-in-arkansas-act-1103 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-litigation-challenging-final-rule-on-drug-importation-from-canada 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-litigation-challenging-legality-of-the-administrations-most-favored-nation-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-litigation-challenging-the-medicaid-accumulator-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-response-to-the-senate-request-for-information-on-the-340b-drug-pricing-program 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2024 2026-04-03 daily 0.8 https://phrma.org/resources/point-of-sale-rebate-analysis-in-the-commercial-market 2026-04-03 daily 0.8 https://phrma.org/resources/premium-impacts-of-pos-rebate-implementation-in-the-aca-market-in-the-state-of-arkansas 2026-04-03 daily 0.8 https://phrma.org/resources/progress-built-on-commitment-phrma-equity-in-2022 2026-04-03 daily 0.8 https://phrma.org/resources/role-of-bayh-doyle-in-fostering-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/september-2021-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/stem 2026-04-03 daily 0.8 https://phrma.org/resources/tackling-impediments-to-trade 2026-04-03 daily 0.8 https://phrma.org/resources/the-inflation-reduction-acts-price-setting-policies-do-more-harm-than-good-for-underserved-communities 2026-04-03 daily 0.8 https://phrma.org/resources/the-pharmaceutical-supply-chain-and-impacts-of-advance-price-notification 2026-04-03 daily 0.8 https://phrma.org/resources/the-us-vs-other-countries-availability-of-medicines-varies 2026-04-03 daily 0.8 https://phrma.org/resources/trends-in-out-of-pocket-spending-for-brand-medicines-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/resources/trends-in-profitability-and-compensation-of-pbms-and-pbm-contracting-entities 2026-04-03 daily 0.8 https://phrma.org/resources/understanding-medicare-part-b-pocket-card 2026-04-03 daily 0.8 https://phrma.org/resources/what-is-the-orange-book 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-infectious-diseases-2020-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-mental-illness-2019-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-mental-illness-2019-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-mental-illnesses-2017-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-parkinsons-disease-2014-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-rare-diseases-2016-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-sickle-cell-disease-2019-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-sickle-cell-disease-2019-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-skin-diseases-2018-update 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-vaccines-2017-update 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-vaccines-2020-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-women-2013-report 2026-04-03 daily 0.8 https://phrma.org/resources/memorandum-2020-election-data 2026-04-03 daily 0.8 https://phrma.org/resources/memorandum-minnesota-voter-data 2026-04-03 daily 0.8 https://phrma.org/resources/milliman-report-reducing-part-d-beneficiary-costs-through-point-of-sale-rebates 2026-04-03 daily 0.8 https://phrma.org/resources/milliman-study-on-limitations-in-using-icer-s-potential-budget-impact-work-to-guide-private-payer-budget-decisions 2026-04-03 daily 0.8 https://phrma.org/resources/moran-company-study-on-hospital-charges-and-reimbursement-for-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/mrp-survey-results-50-state-poll 2026-04-03 daily 0.8 https://phrma.org/resources/october-2021-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/omi-battleground-survey-may-2022 2026-04-03 daily 0.8 https://phrma.org/resources/oregon-july-polling-data 2026-04-03 daily 0.8 https://phrma.org/resources/overview-and-101-digital-health 2026-04-03 daily 0.8 https://phrma.org/resources/patient-experience-survey-barriers-to-health-care-access-in-the-patient-experience 2026-04-03 daily 0.8 https://phrma.org/resources/patient-experience-survey-data-document 2026-04-03 daily 0.8 https://phrma.org/resources/patient-experience-survey-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-osteoporosis-2016-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-neurological-disorders-2018-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-neurological-disorders-2018-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/nearly-a-decade-of-treatment-advances-bring-cures-to-the-vast-majority-of-hepatitis-c-patients 2026-04-03 daily 0.8 https://phrma.org/resources/prescription-medicines-costs-in-context 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-alabama 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-colorado 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-connecticut 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-florida 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-georgia 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-illinois 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-indiana 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-iowa 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-maine 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-maryland 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-massachusetts 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-michigan 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-minnesota 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-montana 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-nebraska 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-nevada 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-new-jersey 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-litigation-challenging-constitutionality-of-provisions-in-louisiana-act-358 2026-04-03 daily 0.8 https://phrma.org/resources/prescription-medicines-insulin-costs-in-context 2026-04-03 daily 0.8 https://phrma.org/resources/prescription-medicine-insulin-costs-in-context-en-espanol 2026-04-03 daily 0.8 https://phrma.org/resources/more-than-half-of-every-dollar-spent-on-medicines-goes-to-someone-who-doesnt-make-them 2026-04-03 daily 0.8 https://phrma.org/resources/morning-consult-pbm-poll-may-2024 2026-04-03 daily 0.8 https://phrma.org/resources/morning-consult-national-tracking-poll-july-2022 2026-04-03 daily 0.8 https://phrma.org/resources/morning-consult-national-tracking-poll-august-2022 2026-04-03 daily 0.8 https://phrma.org/resources/prescription-medicines-international-costs-in-context 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-collaborative-actions-to-reach-equity-cares-grant-2024 2026-04-03 daily 0.8 https://phrma.org/resources/small-molecule-medicines-why-theyre-vital-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-comments-to-us-food-and-drug-administrations-draft-guidance-on-decentralized-clinical-trials-for-drugs-biological-products-and-devices 2026-04-03 daily 0.8 https://phrma.org/resources/slides 2026-04-03 daily 0.8 https://phrma.org/resources/september-2024-registered-voter-survey-results 2026-04-03 daily 0.8 https://phrma.org/resources/the-biopharmaceutical-industrys-sustained-commitment-to-inspiring-and-advancing-tomorrows-stem-workforce 2026-04-03 daily 0.8 https://phrma.org/resources/nica-gcca-phrma-litigation-asserts-price-setting-provisions-in-the-inflation-reduction-act-are-unconstitutional 2026-04-03 daily 0.8 https://phrma.org/resources/new-50-state-poll-shows-perils-of-so-called-medicare-negotiation 2026-04-03 daily 0.8 https://phrma.org/resources/recent-polling-on-medicare-negotiation-misleads-independent-non-partisan-polling-actually-shows-voter-support-evaporating 2026-04-03 daily 0.8 https://phrma.org/resources/national-health-expenditures-2018-data-release 2026-04-03 daily 0.8 https://phrma.org/resources/using-icer-s-value-assessments-would-limit-access-to-life-saving-medicines-in-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-leukemia-and-lymphoma-2015-report 2026-04-03 daily 0.8 https://phrma.org/resources/revisiting-the-pharmaceutical-supply-chain-2013-2018 2026-04-03 daily 0.8 https://phrma.org/resources/women-girls-and-stem 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-advancing-inclusive-worker-centered-trade-policy 2026-04-03 daily 0.8 https://phrma.org/resources/milliman-report-on-impact-of-moving-medicines-from-part-b-to-part-d-july-2018 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-neurodegenerative-diseases-2021-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/the-prescription-drug-user-fee-act-vii 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-testimony-on-fda-user-fee-reauthorization 2026-04-03 daily 0.8 https://phrma.org/resources/milken-institute-future-of-health-summit 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-medicines-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-medicines-in-medicaid 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-medicines-in-veterans-affairs 2026-04-03 daily 0.8 https://phrma.org/resources/building-a-better-health-care-system-summary 2026-04-03 daily 0.8 https://phrma.org/resources/the-biopharmaceutical-research-ecosystem-five-things-you-need-to-know 2026-04-03 daily 0.8 https://phrma.org/resources/chart-pack-medicines-in-medicare-part-b 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-new-mexico 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-new-york 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-north-carolina-piedmont-triad-region 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-north-carolina-southeastern 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-north-carolina 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-ohio 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-oregon 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-pennsylvania 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-south-carolina 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-tennessee 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-texas 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-vermont 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-virginia 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-washington 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-west-virginia 2026-04-03 daily 0.8 https://phrma.org/resources/wtops-the-health-care-agenda-2024-real-policies-for-real-people 2026-04-03 daily 0.8 https://phrma.org/resources/building-a-better-health-care-system-print-ad 2026-04-03 daily 0.8 https://phrma.org/resources/prescription-drug-shortages 2026-04-03 daily 0.8 https://phrma.org/resources/the-randd-challenges-in-tackling-ebola 2026-04-03 daily 0.8 https://phrma.org/resources/americas-biopharmaceutical-industry-is-central-to-a-diverse-randd-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/barriers-to-results-based-contracts 2026-04-03 daily 0.8 https://phrma.org/resources/worried-about-affording-your-medicine-mat-is-here-to-help 2026-04-03 daily 0.8 https://phrma.org/resources/share-the-savings-hospitals 2026-04-03 daily 0.8 https://phrma.org/resources/the-unique-r-and-d-ecosystem-delivering-new-treatments-and-cures-to-patients 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-insulin-patients-in-high-deductible-health-plans 2026-04-03 daily 0.8 https://phrma.org/resources/whats-the-deal-with-these-prescription-drug-middlemen 2026-04-03 daily 0.8 https://phrma.org/resources/together-type-2-diabetes 2026-04-03 daily 0.8 https://phrma.org/resources/together-migraine 2026-04-03 daily 0.8 https://phrma.org/resources/together-car-t 2026-04-03 daily 0.8 https://phrma.org/resources/together-asthma 2026-04-03 daily 0.8 https://phrma.org/resources/strong-ip-protections-lead-to-stronger-treatments-for-all 2026-04-03 daily 0.8 https://phrma.org/resources/spending-on-medicines-the-big-picture 2026-04-03 daily 0.8 https://phrma.org/resources/science-of-hope-incorporating-the-patient-perspective 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-submission-to-the-world-health-organization-on-international-pandemic-preparedness 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-submission-to-pandemic-fund-g20-pledging-event 2026-04-03 daily 0.8 https://phrma.org/resources/innovation-spotlight-collaboration-fueling-biopharmaceutical-advancements 2026-04-03 daily 0.8 https://phrma.org/resources/how-does-health-insurance-cover-your-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/health-insurance-coverage-101 2026-04-03 daily 0.8 https://phrma.org/resources/health-coverage-hurdles 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar 2026-04-03 daily 0.8 https://phrma.org/resources/drug-discovery 2026-04-03 daily 0.8 https://phrma.org/resources/clinical-trials-what-you-need-to-know 2026-04-03 daily 0.8 https://phrma.org/resources/a-new-era-in-cancer-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-your-backyard-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/resources/innovation-spotlight-battling-cancer-together-phrma-octobe 2026-04-03 daily 0.8 https://phrma.org/resources/ubl-pbs-newshour-segment-external-content-promo 2026-04-03 daily 0.8 https://phrma.org/resources/an-open-letter-from-americas-biopharmaceutical-companies 2026-04-03 daily 0.8 https://phrma.org/resources/letter-to-florida-governor-ron-desantis-on-hb-19 2026-04-03 daily 0.8 https://phrma.org/resources/letter-to-president-biden-from-31-phrma-board-members 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-ceos-express-grave-concern-with-the-inflation-reduction-act-of-2022 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-oral-hearing-statement-to-usitc-on-covid-19-diagnostics-and-therapeutics-supply-demand-and-trips-agreement-flexibilities 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-rfk-hhs-nomination 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-2024-us-election 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-president-bidens-address-to-joint-session-of-congress 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-the-department-of-commerce-on-negotiating-objectives-for-indo-pacific-economic-framework-ipef 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-the-office-of-science-and-technology-policy-regarding-clinical-research-infrastructure-and-emergency-clinical-trials 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-ustr-on-negotiating-objectives-for-indo-pacific-economic-framework-ipef 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-ustr-on-the-us-eu-trade-and-technology-council-global-trade-challenges-working-group 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-international-pricing-index-model-comments 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-petition-to-hhs-for-rulemaking-regarding-an-administrative-dispute-resolution-process-for-the-340b-drug-pricing-program 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-response-to-request-for-input-on-modernizing-the-340b-drug-pricing-program 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-submission-to-the-uspto-on-initiatives-to-ensure-the-robustness-and-reliability-of-patent-rights 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-submission-to-the-uspto-on-joint-uspto-fda-collaboration-initiatives 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-letter-to-nist-on-the-bayh-dole-act 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-on-oig-regulatory-sprint-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-on-the-health-care-innovation-caucus-request-for-information 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-cms-proposed-rule-on-changes-to-medicaid 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-inflation-reduction-act-price-setting-guidance 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-medicaid-drug-rebate-program-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-medicare-prescription-payment-plan-draft-part-two-guidance 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-promoting-supply-chain-resilience 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-section-1557-nondiscrimination-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-the-florida-agency-on-health-care-administration-s-request-for-information-on-importation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-the-national-strategy-for-expanding-american-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-usitc-on-covid-19-diagnostics-and-therapeutics-supply-demand-and-trips-agreement-flexibilities 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-final-written-submission-to-usitc-on-covid-19-diagnostics-and-therapeutics-supply-demand-and-trips-agreement-flexibilities 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-cures-2-0-call-to-action-comments 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-in-response-to-2019-hospital-outpatient-prospective-payment-system-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-ftc-on-the-impact-of-pharmacy-benefit-managers-business-practices 2026-04-03 daily 0.8 https://phrma.org/resources/2025-national-trade-estimate-report-on-foreign-trade-barriers-nte 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-administrations-proposed-rule-on-drug-importation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-nists-rfi-draft-march-in-rights 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-usitc-on-distributional-effects-of-trade-and-trade-policy-on-us-workers 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-cms-on-proposed-national-coverage-determination-for-monoclonal-antibodies-for-the-treatment-of-alzheimers-disease 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-cms-on-plan-to-amend-tennessees-section-1115-demonstration 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-2024-comments-to-the-nih-office-of-science-policy-draft-nih-intramural-research-program-policy 2026-04-03 daily 0.8 https://phrma.org/resources/part-d-comment-letter-february-2021 2026-04-03 daily 0.8 https://phrma.org/resources/part-d-comment-letter-april-2020 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-letter-on-cms-proposed-rule-january-2021 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comment-letter-on-cms-proposed-rule-march-2020 2026-04-03 daily 0.8 https://phrma.org/resources/entities-that-don-t-make-medicines-get-half-of-what-is-spent-on-those-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/research-in-wisconsin 2026-04-03 daily 0.8 https://phrma.org/resources/advancing-biopharmaceutical-innovation-in-diabetes 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-principles-on-interactions-with-patient-organizations 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-principles-on-clinical-pathway-programs 2026-04-03 daily 0.8 https://phrma.org/resources/infographic-value-assessment-should-include-all-aspects-of-value-that-matter-to-patients 2026-04-03 daily 0.8 https://phrma.org/resources/inflation-reduction-act-already-impacting-r-and-d 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-executive-summary 2026-04-03 daily 0.8 https://phrma.org/resources/340b-drug-discount-program-pocket-card 2026-04-03 daily 0.8 https://phrma.org/resources/the-bayh-dole-act-spurring-american-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/the-us-biosimilars-market-continues-to-increase-competition-and-savings-but-reforms-are-needed-to-realize-its-full-potential 2026-04-03 daily 0.8 https://phrma.org/resources/harms-of-trips-waiver-expansion 2026-04-03 daily 0.8 https://phrma.org/resources/40-years-of-cancer-immunotherapy-research 2026-04-03 daily 0.8 https://phrma.org/resources/policies-to-help-patients-pay-less-for-their-medicines-share-the-savings 2026-04-03 daily 0.8 https://phrma.org/resources/policies-to-help-patients-pay-less-for-their-medicines-offer-lower-more-predictable-cost-sharing-options 2026-04-03 daily 0.8 https://phrma.org/resources/policies-to-help-patients-pay-less-for-their-medicines-cover-medicines-from-day-one 2026-04-03 daily 0.8 https://phrma.org/resources/policies-to-help-patients-pay-less-for-their-medicines-cap-patient-cost-sharing 2026-04-03 daily 0.8 https://phrma.org/resources/hold-pharmacy-benefit-managers-accountable-under-state-law 2026-04-03 daily 0.8 https://phrma.org/resources/the-prescription-drug-user-fee-act-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/understanding-medicine-abandonment-as-a-barrier-to-health-equity 2026-04-03 daily 0.8 https://phrma.org/resources/access-denied-patients-speak-out-on-health-insurance-barriers-and-the-need-for-policy-change 2026-04-03 daily 0.8 https://phrma.org/resources/how-the-biopharmaceutical-industry-has-responded-to-covid-19 2026-04-03 daily 0.8 https://phrma.org/resources/understanding-the-emergency-use-authorization-process-for-covid-19-vaccines 2026-04-03 daily 0.8 https://phrma.org/resources/building-a-better-health-care-system-phrmas-patient-centered-agenda 2026-04-03 daily 0.8 https://phrma.org/resources/statement-on-revisions-to-the-phrma-code-on-interactions-with-health-care-professionals 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-principles-for-payment-and-delivery-system-reforms 2026-04-03 daily 0.8 https://phrma.org/resources/gaps-in-available-data-exacerbate-health-disparities-and-create-barriers-to-change 2026-04-03 daily 0.8 https://phrma.org/resources/americas-biopharmaceutical-companies-continue-to-expand-advanced-manufacturing-across-the-united-states 2026-04-03 daily 0.8 https://phrma.org/resources/follow-the-dollar-report-2025 2026-04-03 daily 0.8 https://phrma.org/resources/endpoints-at-jpm25-healthcare-policy-under-the-new-administration 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-cms-on-contract-year-2026-medicare-advantage-and-part-d-proposed-rule 2026-04-03 daily 0.8 https://phrma.org/resources/rare-disease-medicines-in-development 2026-04-03 daily 0.8 https://phrma.org/resources/fierce-jpm-week 2026-04-03 daily 0.8 https://phrma.org/resources/addressing-disparities-in-medication-access-and-adherence 2026-04-03 daily 0.8 https://phrma.org/resources/strong-us-trade-policy-fuels-american-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-unfair-and-non-reciprocal-trade-practices 2026-04-03 daily 0.8 https://phrma.org/resources/report-the-pharmaceutical-supply-chain-2013-2023 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2025 2026-04-03 daily 0.8 https://phrma.org/resources/analysis-of-quarterly-changes-in-average-sales-price-of-part-b-medicines-from-q1-to-q2-2022 2026-04-03 daily 0.8 https://phrma.org/resources/fact-sheet-on-challenges-with-amr 2026-04-03 daily 0.8 https://phrma.org/resources/patient-experience 2026-04-03 daily 0.8 https://phrma.org/resources/working-together-to-fight-covid-19-vaccine-manufacturing-collaborations 2026-04-03 daily 0.8 https://phrma.org/resources/setting-up-a-pharmaceutical-manufacturing-process-and-supply-chain-a-complex-lengthy-undertaking 2026-04-03 daily 0.8 https://phrma.org/resources/health-care-practitioner-and-patient-experiences-inappropriate-pbm-and-insurance-utilization-management-practices-can-impede-patient-access-to-quality-care 2026-04-03 daily 0.8 https://phrma.org/resources/inappropriate-pbm-and-insurance-utilization-management-practices-can-impede-patient-access-to-quality-care 2026-04-03 daily 0.8 https://phrma.org/resources/3-myths-critics-get-wrong-about-intellectual-property 2026-04-03 daily 0.8 https://phrma.org/resources/artificial-intelligence-and-biopharmaceutical-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/its-time-to-protect-patients-and-fix-the-pill-penalty 2026-04-03 daily 0.8 https://phrma.org/resources/how-intellectual-property-drives-us-innovation-and-biopharmas-impact 2026-04-03 daily 0.8 https://phrma.org/resources/strong-us-trade-policy-fuels-american-leadership-in-biopharmaceutical-innovation-and-manufacturing 2026-04-03 daily 0.8 https://phrma.org/resources/foreign-reference-pricing-is-bad-for-americans 2026-04-03 daily 0.8 https://phrma.org/resources/growing-momentum-to-address-the-340b-hospital-markup-program 2026-04-03 daily 0.8 https://phrma.org/resources/policies-to-help-patients-pay-less-for-their-medicines-make-insurance-work 2026-04-03 daily 0.8 https://phrma.org/resources/medicare-part-d-plans-and-pbms-initially-denied-more-than-70-of-patients-their-prescribed-medicines-for-four-chronic-conditions 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-draft-guidance-of-medicare-drug-price-negotiation-program 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-foreign-nations-freeloading-on-american-financed-innovation 2026-04-03 daily 0.8 https://phrma.org/resources/doj-and-ftc-listening-session-on-lowering-americans-drug-prices-through-competition-remarks 2026-04-03 daily 0.8 https://phrma.org/resources/340b-the-hospital-markup-program 2026-04-03 daily 0.8 https://phrma.org/resources/2025-phrma-annual-membership-survey 2026-04-03 daily 0.8 https://phrma.org/resources/development-of-new-medicines-relies-on-private-sector-expertise-and-investment 2026-04-03 daily 0.8 https://phrma.org/resources/amr-ecosystem 2026-04-03 daily 0.8 https://phrma.org/resources/pdufa-driving-efficiencies-in-the-drug-review-process 2026-04-03 daily 0.8 https://phrma.org/resources/biopharma-as-a-strategic-asset-insights 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-members-have-produced-vaccines-across-the-united-states 2026-04-03 daily 0.8 https://phrma.org/resources/industry-collaboration-and-partnerships-are-supporting-covid-19-vaccine-manufacturing 2026-04-03 daily 0.8 https://phrma.org/resources/for-a-healthier-us-methods-to-fight-prescription-abuse 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-2025-special-301-hearing-statement 2026-04-03 daily 0.8 https://phrma.org/resources/2025-policy-agenda-solutions-for-a-healthier-america 2026-04-03 daily 0.8 https://phrma.org/resources/clinical-trial-data-sharing-fact-sheet 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-awards-nearly-500k-to-community-based-projects-to-address-inequities-in-diagnosis-treatment-and-adherence 2026-04-03 daily 0.8 https://phrma.org/resources/mounting-pressure-on-pbms-scrutiny-from-every-corner 2026-04-03 daily 0.8 https://phrma.org/resources/pbms-and-commercial-insurers-are-blocking-prescription-access 2026-04-03 daily 0.8 https://phrma.org/resources/persistent-growth-in-pbm-formulary-exclusions-continues-to-raise-concerns-about-patient-access 2026-04-03 daily 0.8 https://phrma.org/resources/thanks-to-americas-ip-system-medicine-costs-go-down-over-time 2026-04-03 daily 0.8 https://phrma.org/resources/ipay-2027-list-underscores-urgent-need-to-fix-the-pill-penalty 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-congratulates-president-donald-trump-on-his-inauguration 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-biopharmaceutical-companies-pledge-on-covid-19-vaccines 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-hhs-confirmation 2026-04-03 daily 0.8 https://phrma.org/resources/dr-albert-bourla-of-pfizer-becomes-new-chair-of-phrma-board 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-welcomes-astrazeneca-to-the-association 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-most-favored-nation-executive-order 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-maha-commission-report 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-this-weeks-acip-meetings 2026-04-03 daily 0.8 https://phrma.org/resources/stat-phrma-ceo-most-favored-nation-policy-isn-t-the-way-to-lower-drug-prices 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-make-our-children-healthy-again-strategy 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-application-process-for-the-340b-rebate-model-pilot-program 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-section-301-investigation-of-acts-policies-and-practices-of-brazil 2026-04-03 daily 0.8 https://phrma.org/resources/medicare-program-request-for-information-on-medicare 2026-04-03 daily 0.8 https://phrma.org/resources/comments-on-congressional-social-determinants-of-health-caucus-request-for-information 2026-04-03 daily 0.8 https://phrma.org/resources/comments-to-omb-on-methods-and-leading-practices-for-advancing-equity-for-underserved-communities-through-government 2026-04-03 daily 0.8 https://phrma.org/resources/comments-on-cms-request-for-information-on-closing-the-health-equity-gap-in-cms-quality-programs 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-nih-request-for-information-on-advancing-and-strengthening-racial-equity-in-the-biomedical-research-workforce 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-comments-to-the-office-of-science-and-technology-policy-networking-and-information-technology-research-and-development-national-coordination-offices-request-for-information-on-the-development-of-an-artificial-intelligence-action-plan 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-comments-to-the-food-and-drug-administration-on-the-considerations-for-the-use-of-artificial-intelligence-to-support-regulatory-decision-making-for-drug-and-biological-products 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-to-us-department-of-commerce-on-232-investigation 2026-04-03 daily 0.8 https://phrma.org/resources/2022-industry-profile-toolkit-addressing-a-growing-public-health-emergency-antimicrobial-resistance 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-releases-new-innovation-report-and-2025-policy-agenda-for-achieving-a-healthier-america 2026-04-03 daily 0.8 https://phrma.org/resources/the-advancements-and-innovations-in-combatting-hiv-aids 2026-04-03 daily 0.8 https://phrma.org/resources/prea-and-bpca-spurring-pediatric-drug-development 2026-04-03 daily 0.8 https://phrma.org/resources/about-phrma 2026-04-03 daily 0.8 https://phrma.org/resources/americas-ip-system-balances-innovation-and-affordability-but-middlemen-in-the-pharmaceutical-supply-chain-harm-access 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-today-s-white-house-announcement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-acip-meeting 2026-04-03 daily 0.8 https://phrma.org/resources/kyowa-kirin-joins-phrma-strengthening-industry-presence-in-d-c 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-autism 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-announces-major-actions-as-part-of-industry-s-commitment-to-american-patients-and-workers 2026-04-03 daily 0.8 https://phrma.org/resources/test-comment 2026-04-03 daily 0.8 https://phrma.org/resources/government-price-setting-policies-hurt-patients 2026-04-03 daily 0.8 https://phrma.org/resources/the-facts-about-mental-health-medications 2026-04-03 daily 0.8 https://phrma.org/resources/the-340b-hospital-markup-program-is-costing-taxpayers-employers-billions 2026-04-03 daily 0.8 https://phrma.org/resources/medicare-enrollment-options-help-might-be-available 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-submits-post-hearing-comments-in-brazil-section-301-investigation 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-on-cms-proposed-rule-cy-2026 2026-04-03 daily 0.8 https://phrma.org/resources/2026-national-trade-estimate-report-on-foreign-trade-barriers-submission 2026-04-03 daily 0.8 https://phrma.org/resources/the-prescription-drug-user-fee-act 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-comments-regarding-the-2026-joint-review-of-the-usmca 2026-04-03 daily 0.8 https://phrma.org/resources/pharmacy-benefit-manager-reform-act 2026-04-03 daily 0.8 https://phrma.org/resources/340b-access-act-a-major-step-to-prevent-medicine-markups 2026-04-03 daily 0.8 https://phrma.org/resources/what-you-need-to-know-about-vaccine-ingredients 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-cms-releasing-ipay-2027-mfps 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-december-acip-meeting 2026-04-03 daily 0.8 https://phrma.org/resources/comment-test-resource 2026-04-03 daily 0.8 https://phrma.org/resources/the-importance-of-the-biosimilar-user-fee-act-in-bringing-new-options-to-patients-and-increasing-competition 2026-04-03 daily 0.8 https://phrma.org/resources/the-prescription-drug-user-fee-act-ensuring-the-timely-availability-of-safe-and-effective-medicines-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-changes-to-the-childhood-vaccine-schedule 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-the-white-house-s-great-healthcare-plan-announcement 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-welcomes-stemline-therapeutics-as-newest-member 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-responds-to-congressional-hearings-with-health-insurance-ceos 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-ipay-2028-selected-drug-list 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-special-301-submission-2026 2026-04-03 daily 0.8 https://phrma.org/resources/bipartisan-pbm-reforms-signed-into-law-advancing-transparency-and-lowering-costs-for-patients 2026-04-03 daily 0.8 https://phrma.org/resources/340b-rebate-model-pilot-wouldnt-have-hurt-cash-flow-for-providers 2026-04-03 daily 0.8 https://phrma.org/resources/hospital-mark-ups-hurt-patients-according-to-new-50-state-poll 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-compounding-concerns 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-ftc-settlement-with-express-scripts 2026-04-03 daily 0.8 https://phrma.org/resources/changes-to-america-s-childhood-vaccine-schedule-fail-to-protect-our-nation-s-kids 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-launches-campaign-highlighting-the-importance-of-america-s-global-leadership-in-medicine-development 2026-04-03 daily 0.8 https://phrma.org/resources/navigating-the-patient-experience-the-barriers-and-burdens-standing-between-patients-and-care 2026-04-03 daily 0.8 https://phrma.org/resources/access-denied-patients-speak-out-on-insurance-barriers-and-the-need-for-policy-change 2026-04-03 daily 0.8 https://phrma.org/resources/merck-s-robert-davis-becomes-new-chair-of-phrma-board 2026-04-03 daily 0.8 https://phrma.org/resources/innovation-at-risk-americans-speak-out-on-u-s-pharmaceutical-leadership-and-the-need-for-affordable-access 2026-04-03 daily 0.8 https://phrma.org/resources/phrmas-comments-on-cms-mfn-medicare-proposals-globe-and-guard 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-president-trump-s-state-of-the-union-address 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-2026-special-301-hearing-statement 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-vaccines-2024-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-chronic-diseases-2024-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-cancer-2023-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-mental-illness-2023-report 2026-04-03 daily 0.8 https://phrma.org/resources/medicines-in-development-for-leading-chronic-diseases-affecting-older-americans-2023 2026-04-03 daily 0.8 https://phrma.org/resources/americas-leadership-is-at-risk 2026-04-03 daily 0.8 https://phrma.org/resources/high-income-country-spending-on-innovative-medicines 2026-04-03 daily 0.8 https://phrma.org/resources/high-income-country-spending-on-innovative-medicine 2026-04-03 daily 0.8 https://phrma.org/resources/future-of-medicine-cell-gene-therapies 2026-04-03 daily 0.8 https://phrma.org/resources/seniors-face-growing-barriers-to-medicines-in-medicare-part-d 2026-04-03 daily 0.8 https://phrma.org/resources/340b-rebate-model-a-shield-against-program-abuse-and-rising-costs 2026-04-03 daily 0.8 https://phrma.org/resources/340b-health-survey-misleads-ignores-the-problem-rebate-models-are-designed-to-solve 2026-04-03 daily 0.8 https://phrma.org/resources/rebate-model-addressing-long-term-fraud-and-abuse-in-the-340b-program 2026-04-03 daily 0.8 https://phrma.org/resources/340b-rebate-model-accountability-over-alarmism 2026-04-03 daily 0.8 https://phrma.org/resources/faq-340b-rebate-based-rapid-verification-model 2026-04-03 daily 0.8 https://phrma.org/resources/american-preparedness-for-the-annual-flu-season-relies-on-a-coordinated-national-strategy 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-cms-guard-and-globe-proposed-rules 2026-04-03 daily 0.8 https://phrma.org/resources/phrma-statement-on-section-232-tariff-announcement 2026-04-03 daily 0.8 https://phrma.org/resources/certification-submission 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/clinical-trials 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/stem 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/economic-impact 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/alaska 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/arkansas 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/arizona 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/district-of-columbia 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/delaware 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/connecticut 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/colorado 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/california 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/idaho 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/hawaii 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/georgia 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/maine 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/louisiana 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/kentucky 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/kansas 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/iowa 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/new-mexico 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/north-dakota 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/north-carolina 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/new-jersey 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/new-york 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/oklahoma 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/ohio 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/oregon 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/puerto-rico 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/pennsylvania 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/indiana 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/illinois 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/montana 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/missouri 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/mississippi 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/minnesota 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/michigan 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/massachusetts 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/maryland 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/new-hampshire 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/nevada 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/nebraska 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/wyoming 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/wisconsin 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/west-virginia 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/washington 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/virginia 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/vermont 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/utah 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/texas 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/tennessee 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/south-dakota 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/south-carolina 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/rhode-island 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/florida 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/alabama 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/programs-and-initiatives 2026-04-03 daily 0.8 https://phrma.org/resources/state-map/340b 2026-04-03 daily 0.8 https://phrma.org/resources/cares-grant-request-for-proposals-rfp-2025 2026-04-03 daily 0.8 https://phrma.org/our-agenda 2026-04-03 daily 0.8 https://phrma.org/polling 2026-04-03 daily 0.8 https://phrma.org/importation 2026-04-03 daily 0.8 https://phrma.org/trips-waiver 2026-04-03 daily 0.8 https://phrma.org/states 2026-04-03 daily 0.8 https://phrma.org/moonshot 2026-04-03 daily 0.8 https://phrma.org/privacy-policy 2026-04-03 daily 0.8 https://phrma.org/media-contacts 2026-04-03 daily 0.8 https://phrma.org/terms-of-service 2026-04-03 daily 0.8 https://phrma.org/newsroom 2026-04-03 daily 0.8 https://phrma.org/events 2026-04-03 daily 0.8 https://phrma.org/sitemap 2026-04-03 daily 0.8 https://phrma.org/search 2026-04-03 daily 0.8 https://phrma.org/unsubscribe 2026-04-03 daily 0.8 https://phrma.org/eqbmed 2026-04-03 daily 0.8 https://phrma.org/survey 2026-04-03 daily 0.8 https://phrma.org/test-page 2026-04-03 daily 0.8 https://phrma.org/blog-alerts 2026-04-03 daily 0.8 https://phrma.org/newsletter 2026-04-03 daily 0.8 https://phrma.org/preference-center 2026-04-03 daily 0.8 https://phrma.org/membership 2026-04-03 daily 0.8